Term	Overlap	P-value	Adjusted P-value	Old P-value	Old Adjusted P-value	Odds Ratio	Combined Score	Genes
Neuronal System	85/411	5.796732774509034E-34	8.057458556567557E-31	0	0	6.188204901778521	473.58702612095544	GABRB3;GABRB2;GABRB1;PRKAG1;PRKAG2;ABAT;IL1RAP;GRIK2;PRKAG3;SLC6A3;SLC6A4;RPS6KA3;TUBB1;KCNH2;PRKAB2;CHRNB4;KCND1;CHRNB3;KCND2;SLC32A1;KCND3;PDPK1;CACNA2D1;CACNA2D3;HTR3C;CACNA2D2;HTR3D;HTR3B;GABRG3;PRKAB1;GABRG2;CACNB1;KCNMA1;KCNQ2;KCNQ3;KCNQ4;KCNQ5;KCNA10;GRIA1;CHRNA1;PRKAA1;CHRNA3;PRKAA2;CHRNA2;CHRNA5;CHRNA7;NRXN1;CHRNA6;SLC1A1;CACNA1B;CHRNA9;SLC1A2;NRXN2;GLRA1;GRIN2A;GLRA2;CHRNG;KCNN3;CACNG2;KCNJ1;GRIA4;KCNJ3;MAPK3;GABRA2;GABRQ;GABRA1;KCNJ5;GABBR2;KCNJ6;GABBR1;NLGN4X;GABRA6;GABRA5;KCNJ9;GABRA4;NTRK3;GAD1;GABRA3;GRIN2C;GRIN2B;GRIN2D;GRIN1;GRIN3B;GRIN3A;GLRB
Transmission Across Chemical Synapses	68/269	5.804763758340276E-33	4.034310812046492E-30	0	0	7.912821553542547	587.3420709906223	GABRB3;GABRB2;GABRB1;PRKAG1;PRKAG2;ABAT;GRIK2;PRKAG3;SLC6A3;SLC6A4;RPS6KA3;TUBB1;PRKAB2;CHRNB4;CHRNB3;SLC32A1;PDPK1;CACNA2D1;CACNA2D3;HTR3C;CACNA2D2;HTR3D;HTR3B;GABRG3;PRKAB1;GABRG2;CACNB1;CHRNA1;GRIA1;CHRNA3;PRKAA1;CHRNA2;PRKAA2;CHRNA5;CHRNA7;CHRNA6;SLC1A1;CACNA1B;CHRNA9;SLC1A2;GLRA1;GRIN2A;GLRA2;CHRNG;CACNG2;GRIA4;KCNJ3;MAPK3;GABRA2;GABRQ;GABBR2;GABRA1;KCNJ5;GABBR1;KCNJ6;GABRA6;GABRA5;KCNJ9;GABRA4;GAD1;GABRA3;GRIN2C;GRIN2B;GRIN2D;GRIN1;GRIN3B;GRIN3A;GLRB
Neurotransmitter Receptors and Postsynaptic Signal Transmission	56/204	2.547659632361143E-29	1.1804156296606629E-26	0	0	8.745103203081278	575.7757807219767	GABRB3;GABRB2;GABRB1;PRKAG1;PRKAG2;GRIK2;PRKAG3;RPS6KA3;TUBB1;PRKAB2;CHRNB4;CHRNB3;PDPK1;HTR3C;HTR3D;HTR3B;GABRG3;PRKAB1;GABRG2;CHRNA1;GRIA1;CHRNA3;PRKAA1;CHRNA2;PRKAA2;CHRNA5;CHRNA7;CHRNA6;CHRNA9;GLRA1;GRIN2A;GLRA2;CHRNG;CACNG2;GRIA4;KCNJ3;MAPK3;GABRA2;GABRQ;GABBR2;GABRA1;KCNJ5;GABBR1;KCNJ6;GABRA6;GABRA5;KCNJ9;GABRA4;GABRA3;GRIN2C;GRIN2B;GRIN2D;GRIN1;GRIN3B;GRIN3A;GLRB
Amine Ligand-Binding Receptors	21/43	1.0093443440153887E-17	3.5074715954534758E-15	0	0	21.2999681393373	833.5667049607009	CHRM2;CHRM3;CHRM1;CHRM4;CHRM5;HTR1D;HTR2B;HTR1A;HTR2C;HTR1B;ADRA1D;HTR2A;ADRA1B;ADRA1A;HRH1;HTR6;HTR7;ADRB3;HRH2;HRH4;DRD2
Extracellular Matrix Organization	49/300	1.3729622419390072E-15	3.81683503259044E-13	0	0	4.449487075851184	152.2694824810616	ITGB1;APP;ITGB5;ELN;NCAN;ITGB3;ITGB2;CTSV;FGF2;CTSS;HAPLN1;ICAM1;CAPN8;CAPNS1;CTSL;TNN;CTSK;CAPN3;ITGB8;ITGAV;ITGB7;MADCAM1;CAPN1;ITGB6;CTSD;CTSB;FGB;FGA;ITGA4;PHYKPL;CTRB2;CTRB1;FGG;MMP11;CEACAM1;VCAN;PXDN;ITGA6;CD47;CEACAM8;ITGA5;CD44;NRXN1;PSEN1;NCSTN;ELANE;VCAM1;MFAP4;CAPN11
Class A 1 (Rhodopsin-like Receptors)	50/333	2.193626919558671E-14	5.081902363644254E-12	0	0	4.024935801846685	126.58678680353209	CHRM2;APP;CHRM3;CXCL6;CHRM1;CXCL8;PTGDR2;CHRM4;CHRM5;HTR2B;HTR2C;ADRA1D;CXCL1;HTR2A;ADRA1B;CXCL3;ADRA1A;CXCL2;CXCL5;EDNRA;HTR6;HTR7;C3AR1;PROK2;ANXA1;NPY5R;TACR3;OPRM1;ADRB3;OPRD1;PTGER4;PTGER1;PTGER2;PTGER3;OPRL1;CXCR4;HRH1;HRH2;HRH4;PPY;CGA;DRD2;HTR1D;HTR1A;HTR1B;OPRK1;PPBP;POMC;GNRH1;PF4
Signal Transduction	193/2613	5.652501285598061E-14	1.1224252552830436E-11	0	0	1.9475128075008459	59.407112089475824	APP;VIPR2;MYLK;RPS6KA3;HTR6;GJA1;EDNRA;HTR7;C3AR1;PROK2;GOLGA7;SKP1;MED1;PRKAB2;PRKAB1;GABRG3;GABRG2;NISCH;AR;TIAM1;TP53;CFTR;IQGAP2;CRHR2;NCSTN;CD19;RDH16;PPY;ATP6V0A2;CGA;NGFR;FZD3;ICMT;PPBP;GRIN2B;GRIN2D;NET1;CYLD;PDE3A;GNRH1;GRB2;GABRB3;GABRB2;GABRB1;PTGDR2;PRKAG1;PRKAG2;PTPRJ;PCSK5;PRKAG3;GPRC6A;IKBKB;C1QBP;RSPO3;CTSD;RSPO4;ANXA1;MST1;TACR3;GAB2;KREMEN2;SORCS3;ADRB3;ANGPTL3;PLIN3;PPARG;MGLL;PPARD;OPRD1;PTGER4;PTGER1;PTGER2;PTGER3;XIAP;CXCR4;EGFR;GABRQ;GABBR2;GABRA1;GABBR1;GCGR;AKR1C3;VEGFC;GRIN1;APITD1;CENPL;TACC3;PF4;CHRM2;CHRM3;DGKE;CHRM1;EPO;CHRM4;SPPL2B;CHRM5;PLAT;IL1RAP;NR3C1;FGF1;FGF2;TNF;FGF4;ABHD12;CDH5;TUBB1;IL6R;RAG1;RBX1;PGR;RTN4R;PSEN2;CSF2RB;PSEN1;CSF2RA;KLC3;HRH1;KLC2;DDRGK1;HRH2;HRH4;DRD2;HTR1D;HTR1A;HTR1B;TNFRSF10A;SMAD5;ESR1;NFKB1;NFKBIA;IL6;GNAS;CNTN1;BCL2;MYD88;BCL2L1;ITGB1;CXCL6;FLT1;CXCL8;ITGB5;ITGB3;HTR2B;HTR2C;ADRA1D;CXCL1;HTR2A;ADRA1B;CXCL3;ADRA1A;CXCL2;CXCL5;IFT52;ITGB8;PDE4A;ITGAV;ITGB6;FGB;FGA;TRPC6;NPY5R;PDPK1;FGG;OPRM1;AKT1S1;ITGA5;PPP1R12B;ITGB3BP;PRKAA1;PRKAA2;OPRL1;ABHD17C;IL1RL1;ERBB3;E2F3;TAS1R2;E2F4;BUB1;MAPK3;NTRK1;NTRK2;ANGPT1;NTRK3;OPRK1;PTPN12;MAPK14;MAPK13;POMC;MAPK11;FMNL2;ABHD17B;LEP;BCAR1
GPCR Ligand Binding	59/467	2.4171956509363925E-13	4.199877443501982E-11	0	0	3.3084789539287596	96.11461601169898	CHRM2;CHRM3;APP;CXCL6;CHRM1;VIPR2;CXCL8;PTGDR2;CHRM4;CHRM5;HTR2B;HTR2C;ADRA1D;CXCL1;HTR2A;ADRA1B;CXCL3;ADRA1A;CXCL2;CXCL5;GPRC6A;HTR6;EDNRA;HTR7;C3AR1;PROK2;ANXA1;NPY5R;TACR3;OPRM1;ADRB3;OPRD1;PTGER4;PTGER1;PTGER2;PTGER3;OPRL1;CXCR4;CRHR2;HRH1;HRH2;HRH4;PPY;TAS1R2;CGA;DRD2;GABBR2;FZD3;GABBR1;GCGR;HTR1D;HTR1A;HTR1B;OPRK1;PPBP;POMC;GNAS;GNRH1;PF4
GPCR Downstream Signalling	71/633	3.316236946605858E-13	5.121743728646826E-11	0	0	2.9092990295205885	83.59805452990551	CHRM2;ITGB1;CHRM3;APP;CXCL6;DGKE;CHRM1;VIPR2;CXCL8;PTGDR2;CHRM4;CHRM5;HTR2B;HTR2C;ADRA1D;CXCL1;HTR2A;ADRA1B;CXCL3;ADRA1A;CXCL2;CXCL5;GPRC6A;ABHD12;RPS6KA3;HTR6;EDNRA;HTR7;C3AR1;PROK2;PDE4A;ANXA1;TRPC6;NPY5R;PDPK1;TACR3;OPRM1;TIAM1;ADRB3;ITGA5;MGLL;OPRD1;PTGER4;PTGER1;PTGER2;PTGER3;OPRL1;CXCR4;EGFR;CRHR2;HRH1;HRH2;HRH4;PPY;TAS1R2;CGA;MAPK3;GABBR2;GABBR1;GCGR;HTR1D;HTR1B;OPRK1;PPBP;NET1;POMC;PDE3A;GNAS;GNRH1;GRB2;PF4
Signaling by Interleukins	57/452	6.734186866194931E-13	9.360519744010955E-11	0	0	3.295757949984563	92.36826072908603	ITGB1;APP;CNTF;CXCL8;ITGB2;CXCL1;IL1RAP;FGF2;TNF;CXCL2;ICAM1;IKBKB;RPS6KA3;CA1;IL18RAP;IL6R;SKP1;RAG1;IKBIP;IL11;ANXA1;SERPINB2;IL1R1;IRAK3;GAB2;OPRM1;OSMR;RBX1;IL1B;PRTN3;TP53;OPRD1;CTF1;CSF2RB;PTGS2;CSF2RA;IL22RA2;IL1RL1;IL1RL2;ALOX5;MAPK3;VCAM1;OSM;PTPN12;MAPK14;NFKB1;NFKB2;NFKBIA;POMC;MAPK11;IL6;CD4;BCL2;GRB2;MYD88;IL18R1;BCL2L1
Signaling by GPCR	74/706	2.9948838708590612E-12	3.7844441640855407E-10	0	0	2.69624588174094	71.54250007243098	CHRM2;ITGB1;CHRM3;APP;CXCL6;DGKE;CHRM1;VIPR2;CXCL8;PTGDR2;CHRM4;CHRM5;HTR2B;HTR2C;ADRA1D;CXCL1;HTR2A;ADRA1B;CXCL3;ADRA1A;CXCL2;CXCL5;GPRC6A;ABHD12;RPS6KA3;HTR6;EDNRA;HTR7;C3AR1;PROK2;PDE4A;ANXA1;TRPC6;NPY5R;PDPK1;TACR3;OPRM1;TIAM1;ADRB3;ITGA5;MGLL;OPRD1;PTGER4;PTGER1;PTGER2;PTGER3;OPRL1;CXCR4;EGFR;CRHR2;HRH1;HRH2;HRH4;PPY;TAS1R2;CGA;DRD2;MAPK3;GABBR2;FZD3;GABBR1;GCGR;HTR1D;HTR1A;HTR1B;OPRK1;PPBP;NET1;POMC;PDE3A;GNAS;GNRH1;GRB2;PF4
Acetylcholine Binding and Downstream Events	10/14	2.131897849926778E-11	2.2794907779986317E-9	0	0	55.12975778546713	1354.6166221715353	CHRNA1;CHRNA3;CHRNB4;CHRNA2;CHRNB3;CHRNA5;CHRNG;CHRNA7;CHRNA6;CHRNA9
Postsynaptic Nicotinic Acetylcholine Receptors	10/14	2.131897849926778E-11	2.2794907779986317E-9	0	0	55.12975778546713	1354.6166221715353	CHRNA1;CHRNA3;CHRNB4;CHRNA2;CHRNB3;CHRNA5;CHRNG;CHRNA7;CHRNA6;CHRNA9
Highly Calcium Permeable Postsynaptic Nicotinic Acetylcholine Receptors	9/11	2.925811753942081E-11	2.7957488444214543E-9	0	0	99.12960829493088	2404.3751733200793	CHRNA1;CHRNA3;CHRNB4;CHRNA2;CHRNB3;CHRNA5;CHRNA7;CHRNA6;CHRNA9
Immune System	158/2150	3.01699515585049E-11	2.7957488444214543E-9	0	0	1.8898249465176422	45.77944959709934	FCN1;APP;FCN2;CNTF;FCN3;IL1RAP;EPX;MPO;FGF2;TNF;ICAM1;RPS6KA3;IL18RAP;TUBB1;C3AR1;CAPN1;IL6R;GOLGA7;RAG1;SKP1;CHRNB4;NUP210;IL1R1;CD300A;HLA-B;HLA-C;HLA-A;HLA-F;PRLR;HLA-G;RBX1;HLA-E;SERPING1;MASP2;PRTN3;CD300C;TP53;LY96;LPO;CSF2RB;PSEN1;IQGAP2;PLA2G6;CSF2RA;FBXO41;IL22RA2;ANAPC11;NCSTN;KLC3;KLC2;CD19;NLRP4;BTLA;ATP6V0A2;NLRP3;ELANE;ATG5;BTNL8;VCAM1;HSPA5;SIGLEC12;GGH;PPBP;NFKB1;NFKB2;NFKBIA;CYLD;IL6;RAET1E;BCL2;GRB2;NIT2;MYD88;BCL2L1;ITGB1;SIGLEC9;CXCL8;ITGB5;TNFAIP6;ITGB2;CTSZ;HBB;PTPRJ;CXCL1;CTSV;ECSIT;TREM1;ORM2;CXCL2;CTSS;IKBKB;CTSO;CA1;CTSL;CTSK;ITGB7;ITGAV;MADCAM1;CTSF;LRRFIP1;CTSD;CTSB;IKBIP;FGB;IL11;FGA;SERPINB2;ANXA1;ITGA4;MME;PDPK1;FGG;IRAK3;GAB2;OPRM1;OSMR;CEACAM1;IL1B;TNFRSF25;CD47;CEACAM8;CD44;LTF;OPRD1;COLEC11;COLEC10;CTF1;SFTPA2;GSTP1;FGL2;PTGS2;CPN2;IL1RL1;PGRMC1;IL1RL2;ALOX5;CD59;RILP;MAPK3;PLA2G2A;OSM;PTPN12;MAPK14;TARBP2;MAPK13;POMC;MAPK11;CD4;NFASC;APITD1;PRKRA;POLR3F;SFTPA1;SIGLEC8;SIGLEC7;SIGLEC6;IL18R1;C1QC
GABA Receptor Activation	18/60	4.913054163280021E-11	4.268215804349518E-9	0	0	9.519873607184433	225.9688630073574	GABRB3;GABRA2;GABRQ;GABRB2;GABBR2;GABRA1;KCNJ5;GABRB1;GABBR1;KCNJ6;GABRA6;GABRA5;KCNJ9;GABRA4;GABRA3;GABRG3;GABRG2;KCNJ3
Endosomal Vacuolar Pathway	9/12	1.1246583813572063E-10	8.855692439220866E-9	0	0	66.08294930875576	1513.8527592823966	CTSL;HLA-B;HLA-C;CTSV;HLA-A;HLA-F;HLA-G;CTSS;HLA-E
Lipophagy	8/9	1.1467803158703279E-10	8.855692439220866E-9	0	0	176.03682393555812	4029.287963651981	PRKAB2;PRKAA2;PRKAG1;PLIN3;PRKAG2;PLIN2;PRKAB1;PRKAG3
L1CAM Interactions	24/120	3.70541821287443E-10	2.710805955734452E-8	0	0	5.576494724501758	121.09946502692613	ITGB1;CNTN6;ITGB3;NCAN;L1CAM;EGFR;RPS6KA3;SCN10A;NFASC;SCN8A;SCN9A;TUBB1;KCNQ2;KCNQ3;CNTN1;CNTN2;SCN7A;ITGAV;SCN4A;ITGA5;SCN2A;SCN4B;SCN1A;MAPK3
Activation of PPARGC1A (PGC-1alpha) by Phosphorylation	8/10	5.512638037329462E-10	3.8312834359439755E-8	0	0	88.0138089758343	1876.3494639848511	MAPK11;PRKAB2;PRKAA2;PRKAG1;PRKAG2;MAPK14;PRKAB1;PRKAG3
Cytokine Signaling in Immune System	72/776	1.5019878759812739E-9	9.681872047300656E-8	0	0	2.3400762281197065	47.54210335878717	ITGB1;APP;CNTF;CXCL8;ITGB2;PTPRJ;CXCL1;IL1RAP;FGF2;TNF;CXCL2;ICAM1;IKBKB;RPS6KA3;CA1;IL18RAP;TUBB1;IL6R;RAG1;SKP1;IKBIP;IL11;ANXA1;SERPINB2;NUP210;IL1R1;HLA-B;HLA-C;IRAK3;GAB2;HLA-A;OPRM1;OSMR;HLA-F;PRLR;HLA-G;RBX1;HLA-E;IL1B;TNFRSF25;PRTN3;TP53;CD44;OPRD1;CTF1;CSF2RB;PTGS2;CSF2RA;IL22RA2;IL1RL1;IL1RL2;ALOX5;MAPK3;VCAM1;OSM;PTPN12;MAPK14;TARBP2;NFKB1;NFKB2;NFKBIA;POMC;MAPK11;IL6;CD4;APITD1;PRKRA;BCL2;GRB2;MYD88;IL18R1;BCL2L1
Innate Immune System	95/1149	1.5323826261914708E-9	9.681872047300656E-8	0	0	2.082621556171351	42.26980770777792	FCN1;APP;FCN2;FCN3;SIGLEC9;TNFAIP6;ITGB2;CTSZ;HBB;PTPRJ;CXCL1;CTSV;ECSIT;EPX;MPO;TREM1;ORM2;CTSS;IKBKB;RPS6KA3;CTSL;CTSK;C3AR1;ITGAV;CAPN1;LRRFIP1;CTSD;GOLGA7;CTSB;SKP1;IKBIP;FGB;FGA;CHRNB4;MME;PDPK1;CD300A;FGG;HLA-B;HLA-C;IRAK3;GAB2;HLA-E;CEACAM1;IL1B;SERPING1;MASP2;PRTN3;CD47;CEACAM8;TP53;CD44;LTF;COLEC11;COLEC10;SFTPA2;GSTP1;FGL2;LY96;LPO;PSEN1;IQGAP2;PLA2G6;CPN2;PGRMC1;NCSTN;CD19;ALOX5;NLRP4;ATP6V0A2;NLRP3;CD59;ELANE;ATG5;MAPK3;PLA2G2A;GGH;PPBP;MAPK14;NFKB1;NFKB2;MAPK13;NFKBIA;MAPK11;CYLD;CD4;NFASC;BCL2;POLR3F;GRB2;SFTPA1;NIT2;MYD88;BCL2L1;C1QC
Hemostasis	67/707	2.434558601028133E-9	1.4713201980126541E-7	0	0	2.3888136574074075	47.3785365569093	ITGB1;APP;DGKE;ITGB3;ITGB2;HBB;PLAT;HBD;TREM1;ORM2;ABHD12;THBD;VPREB1;C1QBP;TUBB1;HABP4;ITGAV;PF4V1;FGB;FGA;SERPINB2;TRPC6;ITGA4;PDPK1;SERPINF2;HBE1;FGG;GP1BA;PSG2;SERPINB8;CEACAM1;PSG5;PSG4;KCNMA1;SERPING1;ITGA6;PRTN3;ITGA5;CD47;CEACAM8;TP53;MGLL;CD44;SELPLG;SERPINC1;KLC3;KLC2;MAPK3;ANGPT4;ANGPT2;PPIL2;ANGPT1;HBG2;HSPA5;HBG1;CABLES1;VEGFC;TNFRSF10A;PPBP;L1CAM;MAPK14;ALB;GNAS;GRB2;BCAR1;CD244;PF4
Activation of NMDA Receptors and Postsynaptic Events	20/93	2.857547346339175E-9	1.654996171421439E-7	0	0	6.090056105241285	119.81151387647219	GRIA1;PRKAB2;PRKAA1;PRKAA2;PDPK1;PRKAG1;PRKAG2;GRIN2C;PRKAB1;GRIN2B;PRKAG3;GRIN1;GRIN2D;RPS6KA3;GRIN2A;GRIN3B;GRIN3A;TUBB1;GRIA4;MAPK3
Interaction Between L1 and Ankyrins	12/31	3.061992824160038E-9	1.702468010232981E-7	0	0	13.948767873440827	273.45443351567894	NFASC;SCN10A;SCN8A;SCN9A;KCNQ2;KCNQ3;SCN7A;SCN4A;L1CAM;SCN2A;SCN4B;SCN1A
Integrin Cell Surface Interactions	19/85	3.576992088637148E-9	1.9123150012329368E-7	0	0	6.394063007699371	124.3564919248397	ITGB1;FGB;FGA;VCAM1;ITGB5;ITGA4;ITGB3;ITGB2;FGG;ICAM1;ITGB8;ITGAV;ITGB7;MADCAM1;ITGA6;ITGB6;CD47;ITGA5;CD44
Presynaptic Nicotinic Acetylcholine Receptors	8/12	5.605128571567478E-9	2.7825459694567125E-7	0	0	44.00230149597238	836.025416511837	CHRNA1;CHRNA3;CHRNB4;CHRNA2;CHRNB3;CHRNA5;CHRNG;CHRNA6
Serotonin Receptors	8/12	5.605128571567478E-9	2.7825459694567125E-7	0	0	44.00230149597238	836.025416511837	HTR6;HTR7;HTR1D;HTR1A;HTR2B;HTR1B;HTR2C;HTR2A
Highly Calcium Permeable Nicotinic Acetylcholine Receptors	7/9	1.0147094308901488E-8	4.86360727219761E-7	0	0	76.92356321839081	1415.8611390534036	CHRNA1;CHRNA3;CHRNB4;CHRNA2;CHRNB3;CHRNA5;CHRNA6
Toll-like Receptor Cascades	27/174	1.0632266777030931E-8	4.926283606690998E-7	0	0	4.100456182472989	75.2818021621302	APP;SFTPA2;ITGB2;LY96;CTSV;ECSIT;CTSS;IKBKB;RPS6KA3;CTSL;CTSK;SKP1;CTSB;MAPK3;FGB;IKBIP;FGA;FGG;IRAK3;MAPK14;NFKB1;NFKB2;NFKBIA;MAPK11;SFTPA1;TP53;MYD88
Signaling by ERBB4	15/58	1.9244272084947847E-8	8.628883289702421E-7	0	0	7.721361894998111	137.1781198291539	GABRB3;GABRQ;GABRB2;GABRA1;GABRB1;PSEN2;PSEN1;GABRG3;ESR1;GABRG2;EGFR;NCSTN;ERBB3;PGR;GRB2
Toll Like Receptor 2 (TLR2) Cascade	21/118	4.0327793836522856E-8	1.6986555585686902E-6	0	0	4.811952018498892	81.92937743061997	FGB;IKBIP;APP;FGA;SFTPA2;FGG;LY96;IRAK3;ECSIT;MAPK14;NFKB1;NFKB2;NFKBIA;IKBKB;RPS6KA3;MAPK11;SFTPA1;TP53;MYD88;SKP1;MAPK3
Toll Like Receptor TLR1 TLR2 Cascade	21/118	4.0327793836522856E-8	1.6986555585686902E-6	0	0	4.811952018498892	81.92937743061997	FGB;IKBIP;APP;FGA;SFTPA2;FGG;LY96;IRAK3;ECSIT;MAPK14;NFKB1;NFKB2;NFKBIA;IKBKB;RPS6KA3;MAPK11;SFTPA1;TP53;MYD88;SKP1;MAPK3
Post NMDA Receptor Activation Events	17/80	5.286366624085361E-8	2.1611910610231327E-6	0	0	5.980435585086748	100.2054849117279	GRIA1;PRKAB2;PRKAA1;PRKAA2;PDPK1;PRKAG1;PRKAG2;GRIN2C;PRKAB1;GRIN2B;PRKAG3;GRIN1;GRIN2D;RPS6KA3;GRIN2A;TUBB1;MAPK3
Interleukin-4 and Interleukin-13 Signaling	20/112	7.97127780900817E-8	3.165736044148959E-6	0	0	4.827507483131247	78.90481779471929	ITGB1;OPRD1;VCAM1;CXCL8;ANXA1;ITGB2;OSM;OPRM1;PTGS2;FGF2;TNF;ICAM1;POMC;IL6;IL1B;ALOX5;BCL2;IL6R;TP53;BCL2L1
Muscarinic Acetylcholine Receptors	5/5	1.6034444554281042E-7	6.191077202902958E-6	0	0	95615.0	1495986.7013979622	CHRM2;CHRM3;CHRM1;CHRM4;CHRM5
Lectin Pathway of Complement Activation	6/8	1.8145388265605748E-7	6.816780997078916E-6	0	0	65.85878300803674	1022.2774366943977	FCN1;COLEC11;FCN2;COLEC10;FCN3;MASP2
Potassium Channels	18/103	4.929559526583108E-7	1.803180984723821E-5	0	0	4.693336985550914	68.16061032553233	KCNH2;GABBR2;KCNJ5;GABBR1;KCNJ6;KCND1;KCND2;KCND3;KCNJ9;KCNQ2;KCNMA1;KCNQ3;KCNQ4;KCNQ5;KCNA10;KCNN3;KCNJ1;KCNJ3
Toll Like Receptor 4 (TLR4) Cascade	22/148	5.178838863856351E-7	1.845791287374443E-5	0	0	3.8794579040193073	56.14939130201092	FGB;IKBIP;APP;FGA;SFTPA2;ITGB2;FGG;LY96;IRAK3;ECSIT;MAPK14;NFKB1;NFKB2;NFKBIA;IKBKB;RPS6KA3;MAPK11;SFTPA1;TP53;MYD88;SKP1;MAPK3
Formation of Fibrin Clot (Clotting Cascade)	11/39	5.871259031656316E-7	1.9498975782399928E-5	0	0	8.66236390630155	124.28782735075747	FGB;THBD;FGA;SERPINC1;C1QBP;FGG;SERPING1;GP1BA;PRTN3;PF4V1;PF4
MyD88 MAL(TIRAP) Cascade Initiated on Plasma Membrane	19/115	5.891776855113648E-7	1.9498975782399928E-5	0	0	4.388998154623154	62.95815092325753	FGB;IKBIP;APP;FGA;FGG;LY96;IRAK3;ECSIT;MAPK14;NFKB1;NFKB2;NFKBIA;IKBKB;RPS6KA3;MAPK11;TP53;MYD88;SKP1;MAPK3
Toll Like Receptor TLR6 TLR2 Cascade	19/115	5.891776855113648E-7	1.9498975782399928E-5	0	0	4.388998154623154	62.95815092325753	FGB;IKBIP;APP;FGA;FGG;LY96;IRAK3;ECSIT;MAPK14;NFKB1;NFKB2;NFKBIA;IKBKB;RPS6KA3;MAPK11;TP53;MYD88;SKP1;MAPK3
Phase 0 - Rapid Depolarisation	10/32	6.680890664452049E-7	2.1596367496717087E-5	0	0	10.014155394778232	142.38971674787314	CACNB1;SCN10A;SCN8A;SCN9A;SCN7A;CACNA2D2;SCN4A;SCN2A;SCN4B;SCN1A
Antigen processing-Cross Presentation	17/96	8.400006745206613E-7	2.6536384945084528E-5	0	0	4.765204592287312	66.66456009024685	FGB;FGA;ITGB5;FGG;HLA-B;HLA-C;LY96;CTSV;HLA-A;HLA-F;HLA-G;CTSS;HLA-E;IKBKB;CTSL;ITGAV;MYD88
G Alpha (Q) Signalling Events	27/219	1.278157645555993E-6	3.948086949606289E-5	0	0	3.1319669117647058	42.50107555152894	APP;CHRM3;DGKE;CHRM1;PTGER1;CHRM5;HTR2B;HTR2C;ADRA1D;HTR2A;ADRA1B;ADRA1A;EGFR;GPRC6A;ABHD12;RPS6KA3;EDNRA;HRH1;PROK2;MAPK3;ANXA1;TRPC6;GCGR;TACR3;GNRH1;GRB2;MGLL
Cell Surface Interactions at the Vascular Wall	28/233	1.3692463872480544E-6	4.1375053875539036E-5	0	0	3.0434887529087304	41.09090268278778	ITGB1;SELPLG;ITGB3;ITGB2;TREM1;THBD;VPREB1;ITGAV;PF4V1;ANGPT4;ANGPT2;PPIL2;ITGA4;ANGPT1;TNFRSF10A;PSG2;L1CAM;CEACAM1;PSG5;PSG4;GRB2;ITGA6;CD47;CEACAM8;ITGA5;CD44;CD244;PF4
Common Pathway of Fibrin Clot Formation	8/22	2.4458431951171485E-6	7.233451151516673E-5	0	0	12.565510438928161	162.36047615151574	FGB;FGA;THBD;SERPINC1;FGG;PRTN3;PF4V1;PF4
Neutrophil Degranulation	44/478	3.058522011516501E-6	8.81803080972897E-5	0	0	2.2745946304789197	28.881844470890496	FCN1;SIGLEC9;TNFAIP6;GSTP1;ITGB2;FGL2;CTSZ;HBB;PTPRJ;CXCL1;PSEN1;IQGAP2;EPX;ORM2;MPO;CTSS;NCSTN;PGRMC1;ALOX5;C3AR1;ITGAV;CD59;CAPN1;GOLGA7;CTSD;ELANE;CTSB;CHRNB4;MME;CD300A;HLA-B;HLA-C;GGH;PPBP;MAPK14;NFKB1;NFASC;CEACAM1;PRTN3;CD47;CEACAM8;NIT2;CD44;LTF
Degradation of the Extracellular Matrix	20/140	3.171953528679486E-6	8.81803080972897E-5	0	0	3.695643718397511	46.79114715665168	PHYKPL;CTRB2;ELN;CTRB1;PSEN1;CTSV;CTSS;MMP11;CAPN8;NCSTN;CAPN11;CAPNS1;CTSL;CTSK;CAPN3;CAPN1;CTSD;ELANE;CD44;CTSB
Interleukin-1 Family Signaling	20/140	3.171953528679486E-6	8.81803080972897E-5	0	0	3.695643718397511	46.79114715665168	IKBIP;APP;IL1R1;IRAK3;IL1RAP;PTPN12;NFKB1;RBX1;NFKB2;NFKBIA;IKBKB;IL1RL1;IL1RL2;IL18RAP;IL1B;ALOX5;TP53;MYD88;IL18R1;SKP1
Metabolism of Angiotensinogen to Angiotensins	7/17	4.0228070909346474E-6	1.0964121287057176E-4	0	0	15.378275862068966	191.0524810197167	ACE2;ACE;MME;CTSZ;REN;CTSD;CES1
Turbulent Flow Shear Stress Activates Signaling by PIEZO1 and Integrins in Endothelial Cells	9/31	4.850521077585285E-6	1.2965815957391436E-4	0	0	9.002356514453288	110.15665509198017	ITGB1;IKBKB;NFKBIA;CAPNS1;ITGB3;NLRP3;ITGAV;ITGA5;NFKB1
Presynaptic Depolarization and Calcium Channel Opening	6/12	5.144857891726973E-6	1.349311786698206E-4	0	0	21.94833524684271	267.27613362035316	CACNB1;CACNA2D1;CACNA1B;CACNA2D3;CACNA2D2;CACNG2
Diseases Associated With the TLR Signaling Cascade	9/35	1.4506496827069546E-5	3.6661873799321215E-4	0	0	7.615783410138249	84.8467876482469	IKBKB;FGB;NFKBIA;FGA;FGG;LY96;NFKB1;MYD88;NFKB2
Diseases of Immune System	9/35	1.4506496827069546E-5	3.6661873799321215E-4	0	0	7.615783410138249	84.8467876482469	IKBKB;FGB;NFKBIA;FGA;FGG;LY96;NFKB1;MYD88;NFKB2
Prostanoid Ligand Receptors	5/9	1.7427809428819504E-5	4.3219382381603437E-4	0	0	27.40682339449541	300.3087156952528	PTGER4;PTGDR2;PTGER1;PTGER2;PTGER3
Ficolins Bind to Repetitive Carbohydrate Structures on the Target Cell Surface	4/5	1.7723056084542415E-5	4.3219382381603437E-4	0	0	87.61512027491409	958.5658541728482	FCN1;FCN2;FCN3;MASP2
Activation of AMPK Downstream of NMDARs	8/28	1.8804255361818254E-5	4.506537060849547E-4	0	0	8.793095512082854	95.68143012567441	PRKAA1;PRKAB2;PRKAA2;TUBB1;PRKAG1;PRKAG2;PRKAB1;PRKAG3
Signal Transduction by L1	7/21	2.0616311041184458E-5	4.697815138892852E-4	0	0	10.982183908045977	118.4914825296249	ITGB1;ITGB3;ITGAV;ITGA5;L1CAM;EGFR;MAPK3
Synaptic Adhesion-Like Molecules	7/21	2.0616311041184458E-5	4.697815138892852E-4	0	0	10.982183908045977	118.4914825296249	GRIA1;GRIN2A;GRIN2C;GRIN2B;GRIN1;GRIN2D;GRIA4
Unblocking of NMDA Receptors, Glutamate Binding and Activation	7/21	2.0616311041184458E-5	4.697815138892852E-4	0	0	10.982183908045977	118.4914825296249	GRIA1;GRIN2A;GRIN2C;GRIN2B;GRIN1;GRIN2D;GRIA4
G Alpha (I) Signalling Events	31/316	2.576907202771047E-5	5.777259696535089E-4	0	0	2.422039732901995	25.59208451810905	OPRD1;CHRM2;APP;CXCL6;CXCL8;PTGDR2;CHRM4;PTGER3;OPRL1;CXCR4;CXCL1;CXCL3;CXCL2;CXCL5;HRH4;C3AR1;PPY;PDE4A;TAS1R2;GABBR2;GABBR1;ANXA1;NPY5R;HTR1D;HTR1B;OPRK1;PPBP;OPRM1;POMC;GNAS;PF4
TRAF6 Mediated Induction of NFkB and MAP Kinases Upon TLR7 8 or 9 Activation	15/102	3.735132385026097E-5	8.241006373311547E-4	0	0	3.8075046003680293	38.81805083766165	IKBIP;APP;LY96;ECSIT;MAPK14;NFKB1;NFKB2;NFKBIA;IKBKB;RPS6KA3;MAPK11;TP53;MYD88;SKP1;MAPK3
MyD88 Dependent Cascade Initiated on Endosome	15/103	4.197445445266016E-5	9.116326826437128E-4	0	0	3.7640397595443997	37.93568407564733	IKBIP;APP;LY96;ECSIT;MAPK14;NFKB1;NFKB2;NFKBIA;IKBKB;RPS6KA3;MAPK11;TP53;MYD88;SKP1;MAPK3
Fibronectin Matrix Formation	4/6	5.131537574144518E-5	0.0010973595735478275	0	0	43.805269186712486	432.6874281322361	ITGB1;CEACAM1;CEACAM8;ITGA5
Signaling by Receptor Tyrosine Kinases	44/536	5.211023563613965E-5	0.0010974731444580927	0	0	2.000224480035917	19.72651218990867	GABRB3;ITGB1;GABRB2;GABRB1;FLT1;ITGB3;PSEN2;PTPRJ;PLAT;PSEN1;FGF1;FGF2;PCSK5;EGFR;FGF4;CDH5;RPS6KA3;NCSTN;ERBB3;ATP6V0A2;ITGAV;CTSD;MAPK3;NTRK1;GABRQ;GABRA1;NTRK2;PDPK1;NTRK3;MST1;VEGFC;PTPN12;GAB2;MAPK14;GABRG3;GRIN2B;ESR1;GABRG2;MAPK13;TIAM1;MAPK11;PGR;GRB2;BCAR1
Cardiac Conduction	17/130	5.444041065247234E-5	0.0011176899744060368	0	0	3.3254784935171844	32.650890800600976	KCNH2;KCND1;KCND2;MME;KCND3;CACNA2D2;CACNB1;SCN10A;FXYD3;SCN8A;SCN9A;SCN7A;SCN4A;SCN2A;SCN4B;SCN1A;CES1
Interleukin-6 Family Signaling	7/24	5.467835846015144E-5	0.0011176899744060368	0	0	9.042731575388776	88.74575260648241	IL11;CNTF;IL6;CTF1;OSM;OSMR;IL6R
Regulated Proteolysis of p75NTR	5/11	5.936350550620904E-5	0.001188229547996783	0	0	18.269304281345565	177.79378003312144	NGFR;NCSTN;PSEN2;PSEN1;NFKB1
Nucleotide-binding Domain, Leucine Rich Repeat Containing Receptor (NLR) Signaling Pathways	11/61	6.0642172456696364E-5	0.001188229547996783	0	0	4.8453348729792145	47.050721151023836	IKBKB;APP;CYLD;MAPK11;BCL2;NLRP3;MAPK14;NFKB1;MAPK13;NFKB2;BCL2L1
Peptide Ligand-Binding Receptors	22/198	6.0693739501993945E-5	0.001188229547996783	0	0	2.7700292397660817	26.8960698183702	OPRD1;APP;CXCL6;ANXA1;CXCL8;NPY5R;OPRL1;TACR3;CXCR4;OPRK1;CXCL1;PPBP;OPRM1;CXCL3;CXCL2;CXCL5;POMC;EDNRA;C3AR1;PPY;PROK2;PF4
Axon Guidance	44/541	6.469611970994427E-5	0.001248994533289202	0	0	1.979570097656769	19.09455572098353	ITGB1;NCAN;ITGB3;PSEN2;CXCR4;CACNA1D;PSEN1;EGFR;RPS6KA3;NCSTN;RPS19;TUBB1;SCN9A;SCN7A;ITGAV;CACNA1S;SCN1A;MAPK3;EPHA4;TRPC6;EPHA8;CNTN6;GAB2;L1CAM;GRIN2B;RBX1;GRIN1;CACNB1;TIAM1;SCN10A;NFASC;RPS28;LHX3;SCN8A;KCNQ2;KCNQ3;CNTN1;CNTN2;GRB2;SCN4A;ITGA5;SCN2A;SCN4B;EPHA3
Toll Like Receptor 7 8 (TLR7 8) Cascade	15/107	6.588266998886809E-5	0.0012544782367743374	0	0	3.5996292746898013	34.65591724346448	IKBIP;APP;LY96;ECSIT;MAPK14;NFKB1;NFKB2;NFKBIA;IKBKB;RPS6KA3;MAPK11;TP53;MYD88;SKP1;MAPK3
Voltage Gated Potassium Channels	9/43	8.455352674325118E-5	0.00158823516450161	0	0	5.821394686907021	54.5937715397325	KCNH2;KCND1;KCND2;KCND3;KCNQ2;KCNQ3;KCNQ4;KCNA10;KCNQ5
Toll Like Receptor 9 (TLR9) Cascade	15/110	9.093299828085599E-5	0.001654936885868113	0	0	3.485407253632922	32.43306545725497	IKBIP;APP;LY96;ECSIT;MAPK14;NFKB1;NFKB2;NFKBIA;IKBKB;RPS6KA3;MAPK11;TP53;MYD88;SKP1;MAPK3
MyD88 Cascade Initiated on Plasma Membrane	14/98	9.286696194080059E-5	0.001654936885868113	0	0	3.6769022788721513	34.13762048488459	IKBIP;APP;ECSIT;MAPK14;NFKB1;NFKB2;NFKBIA;IKBKB;RPS6KA3;MAPK11;TP53;MYD88;SKP1;MAPK3
Toll Like Receptor 10 (TLR10) Cascade	14/98	9.286696194080059E-5	0.001654936885868113	0	0	3.6769022788721513	34.13762048488459	IKBIP;APP;ECSIT;MAPK14;NFKB1;NFKB2;NFKBIA;IKBKB;RPS6KA3;MAPK11;TP53;MYD88;SKP1;MAPK3
Toll Like Receptor 5 (TLR5) Cascade	14/98	9.286696194080059E-5	0.001654936885868113	0	0	3.6769022788721513	34.13762048488459	IKBIP;APP;ECSIT;MAPK14;NFKB1;NFKB2;NFKBIA;IKBKB;RPS6KA3;MAPK11;TP53;MYD88;SKP1;MAPK3
Nervous System Development	45/567	9.500979867049955E-5	0.0016716913943290428	0	0	1.927325099469496	17.849980245698575	ITGB1;NCAN;ITGB3;PSEN2;CXCR4;CACNA1D;PSEN1;EGFR;RPS6KA3;NCSTN;RPS19;MPZ;TUBB1;SCN9A;SCN7A;ITGAV;CACNA1S;SCN1A;MAPK3;EPHA4;TRPC6;EPHA8;CNTN6;GAB2;L1CAM;GRIN2B;RBX1;GRIN1;CACNB1;TIAM1;SCN10A;NFASC;RPS28;LHX3;SCN8A;KCNQ2;KCNQ3;CNTN1;CNTN2;GRB2;SCN4A;ITGA5;SCN2A;SCN4B;EPHA3
TP53 Regulates Transcription of Death Receptors and Ligands	5/12	9.809144778484309E-5	0.0017043389052616487	0	0	15.658584534731324	144.522634259796	IGFBP3;TNFRSF10A;TP53;TP63;TP73
PI5P, PP2A and IER3 Regulate PI3K AKT Signaling	15/111	1.0095510551494323E-4	0.0017324199411596118	0	0	3.448919663573086	31.73293951047132	NTRK2;NTRK3;IL1RAP;GAB2;FGF1;FGF2;ESR1;EGFR;FGF4;IL1RL1;ERBB3;CD19;GRB2;MYD88;MAPK3
Elastic Fibre Formation	9/44	1.0220031307560299E-4	0.0017324199411596118	0	0	5.654772876892692	51.95930930632367	ITGB1;MFAP4;ITGB5;ELN;ITGB3;ITGB8;ITGAV;ITGB6;ITGA5
IkBA Variant Leads to EDA-ID	4/7	1.1556699653545317E-4	0.0019353990986057817	0	0	29.201985490645285	264.73527585931777	IKBKB;NFKBIA;NFKB1;NFKB2
Integrin Signaling	7/27	1.2503749524843112E-4	0.002069072838039515	0	0	7.6851149425287355	69.06533568123756	FGB;FGA;PDPK1;ITGB3;FGG;GRB2;BCAR1
Immunoregulatory Interactions Between a Lymphoid and a non-Lymphoid Cell	23/223	1.3088105777870915E-4	0.0021402902389694787	0	0	2.548179156908665	22.78383452630168	ITGB1;SIGLEC9;VCAM1;ITGA4;SIGLEC12;CD300A;ITGB2;HLA-B;HLA-C;HLA-A;HLA-F;HLA-G;TREM1;ICAM1;HLA-E;RAET1E;CD19;ITGB7;MADCAM1;CD300C;SIGLEC8;SIGLEC7;SIGLEC6
Interleukin-1 Signaling	14/102	1.4394655789298937E-4	0.0023265780868750607	0	0	3.509032971663331	31.041145871222593	IKBIP;APP;IL1R1;IRAK3;IL1RAP;NFKB1;RBX1;NFKB2;NFKBIA;IKBKB;IL1B;TP53;MYD88;SKP1
Interleukin-10 Signaling	9/46	1.4682992657677376E-4	0.00234590342461742	0	0	5.348549009839332	47.20755369527809	IL6;CXCL8;IL1R1;IL1B;CXCL1;PTGS2;CXCL2;TNF;ICAM1
Synthesis of Bile Acids and Bile Salts via 24-Hydroxycholesterol	5/13	1.5364923192959812E-4	0.002399690251484735	0	0	13.700544724770642	120.30226741488185	AKR1C1;AKR1D1;AKR1C3;AKR1C2;AKR1C4
Trafficking and Processing of Endosomal TLR	5/13	1.5364923192959812E-4	0.002399690251484735	0	0	13.700544724770642	120.30226741488185	CTSL;CTSK;CTSV;CTSS;CTSB
TRP Channels	7/28	1.6044879220417294E-4	0.00247804245737556	0	0	7.318773946360153	63.94804876821221	TRPC6;TRPA1;TRPV3;TRPM8;TRPV1;TRPM5;TRPM4
Molecules Associated With Elastic Fibres	8/37	1.6455415900526083E-4	0.0025135195716188196	0	0	6.0613467719534935	52.80809453766722	ITGB1;MFAP4;ITGB5;ELN;ITGB3;ITGB8;ITGAV;ITGB6
ER-Phagosome Pathway	12/80	1.8106982536644377E-4	0.0027357288832538787	0	0	3.8874532471948315	33.49673782044159	IKBKB;FGB;FGA;FGG;HLA-B;HLA-C;LY96;HLA-A;HLA-F;HLA-G;MYD88;HLA-E
Death Receptor Signaling	18/157	1.8604198148802265E-4	0.002780627465251091	0	0	2.8618855788477484	24.582275511538512	RTN4R;NGFR;SPPL2B;PSEN2;XIAP;TNFRSF10A;PSEN1;SORCS3;TNF;NFKB1;NET1;NFKBIA;IKBKB;TIAM1;CYLD;NCSTN;MYD88;ITGB3BP
Negative Regulation of the PI3K AKT Network	15/118	2.0218923251879512E-4	0.002978324395369589	0	0	3.2133444461964724	27.333692763667372	NTRK2;NTRK3;IL1RAP;GAB2;FGF1;FGF2;ESR1;EGFR;FGF4;IL1RL1;ERBB3;CD19;GRB2;MYD88;MAPK3
Energy Dependent Regulation of mTOR by LKB1-AMPK	7/29	2.0355454500727406E-4	0.002978324395369589	0	0	6.9857366771159874	59.37580367716348	PRKAA1;PRKAB2;PRKAA2;PRKAG1;PRKAG2;PRKAB1;PRKAG3
ZBP1(DAI) Mediated Induction of Type I IFNs	6/21	2.1512432531120256E-4	0.00311482096023512	0	0	8.7752009184845	74.10038032322225	IKBKB;NFKBIA;NLRP4;NFKB1;MYD88;NFKB2
AMPK Inhibits chREBP Transcriptional Activation Activity	4/8	2.230981628522353E-4	0.003132388347117243	0	0	21.900343642611684	184.13587064949712	PRKAB2;PRKAA2;ADIPOQ;PRKAG2
Defective CSF2RA Causes SMDP4	4/8	2.230981628522353E-4	0.003132388347117243	0	0	21.900343642611684	184.13587064949712	SFTPA2;CSF2RB;SFTPA1;CSF2RA
Defective CSF2RB Causes SMDP5	4/8	2.230981628522353E-4	0.003132388347117243	0	0	21.900343642611684	184.13587064949712	SFTPA2;CSF2RB;SFTPA1;CSF2RA
Carnitine Shuttle	5/14	2.303984165396342E-4	0.0031708296929712034	0	0	12.177624872579	101.99613875628427	PRKAB2;PRKAA2;PRKAG2;THRSP;PPARD
Synthesis of Bile Acids and Bile Salts via 27-Hydroxycholesterol	5/14	2.303984165396342E-4	0.0031708296929712034	0	0	12.177624872579	101.99613875628427	AKR1C1;AKR1D1;AKR1C3;AKR1C2;AKR1C4
Platelet Aggregation (Plug Formation)	8/39	2.426457821471266E-4	0.003306643501808882	0	0	5.669698207060396	47.19404549633787	FGB;FGA;PDPK1;ITGB3;FGG;GP1BA;GRB2;BCAR1
Muscle Contraction	21/204	2.5909088473610183E-4	0.0034964692211959373	0	0	2.5390684847556306	20.968469632986015	KCNH2;MYBPC1;ANXA1;KCND1;KCND2;MME;ITGB5;KCND3;CACNA2D2;MYLK;CACNB1;SCN10A;FXYD3;SCN8A;SCN9A;SCN7A;SCN4A;SCN2A;SCN4B;SCN1A;CES1
Regulation of TLR by Endogenous Ligand	6/22	2.84885389926614E-4	0.003807602807673014	0	0	8.226320321469576	67.1549374467334	FGB;FGA;SFTPA2;FGG;LY96;SFTPA1
Antigen Presentation Folding, Assembly and Peptide Loading of Class I MHC	7/31	3.1768584609475335E-4	0.00420555548639721	0	0	6.4029214559386975	51.57199515430139	HSPA5;HLA-B;HLA-C;HLA-A;HLA-F;HLA-G;HLA-E
p130Cas Linkage to MAPK Signaling for Integrins	5/15	3.331594921673897E-4	0.004287886056598812	0	0	10.959288990825687	87.74981295829055	FGB;FGA;ITGB3;FGG;BCAR1
Eicosanoid Ligand-Binding Receptors	5/15	3.331594921673897E-4	0.004287886056598812	0	0	10.959288990825687	87.74981295829055	PTGER4;PTGDR2;PTGER1;PTGER2;PTGER3
GRB2 SOS Provides Linkage to MAPK Signaling for Integrins	5/15	3.331594921673897E-4	0.004287886056598812	0	0	10.959288990825687	87.74981295829055	FGB;FGA;ITGB3;FGG;GRB2
P75 NTR Receptor-Mediated Signalling	13/98	3.46356047281902E-4	0.004406694144902847	0	0	3.370016339869281	26.85243602887348	RTN4R;NGFR;PSEN2;PSEN1;SORCS3;NFKB1;NET1;NFKBIA;IKBKB;TIAM1;NCSTN;MYD88;ITGB3BP
MTOR Signalling	8/41	3.4873119132324687E-4	0.004406694144902847	0	0	5.3255221954876735	42.397596073703234	PRKAA1;PRKAB2;PRKAA2;AKT1S1;PRKAG1;PRKAG2;PRKAB1;PRKAG3
Long-term Potentiation	6/23	3.7122859045484775E-4	0.004648718384975121	0	0	7.742013912338758	61.15178752095022	GRIA1;GRIN2A;GRIN2C;GRIN2B;GRIN1;GRIN2D
Adrenoceptors	4/9	3.876357099299951E-4	0.004786328602928797	0	0	17.519358533791525	137.6223495367034	ADRB3;ADRA1D;ADRA1B;ADRA1A
MAPK1 MAPK3 Signaling	25/271	3.891044116050029E-4	0.004786328602928797	0	0	2.2516365128440015	17.679090737232563	ITGB3;CSF2RB;ABHD17C;FGF1;FGF2;CSF2RA;EGFR;FGF4;ERBB3;GOLGA7;IL6R;MAPK3;FGB;FGA;ICMT;ANGPT1;FGG;GRIN2B;GRIN2D;GRIN1;RBX1;IL6;ABHD17B;GRB2;BCL2L1
Protein-protein Interactions at Synapses	12/88	4.4818882757630493E-4	0.0054647585116759986	0	0	3.47678734408275	26.807059288480442	GRIA1;GRIN2A;NLGN4X;NRXN1;NTRK3;NRXN2;IL1RAP;GRIN2C;GRIN2B;GRIA4;GRIN1;GRIN2D
p75NTR Signals via NF-kB	5/16	4.671743378046877E-4	0.005598037323694102	0	0	9.962468723936613	76.40026040381716	IKBKB;NFKBIA;NGFR;NFKB1;MYD88
NRIF Signals Cell Death From the Nucleus	5/16	4.671743378046877E-4	0.005598037323694102	0	0	9.962468723936613	76.40026040381716	NGFR;NCSTN;PSEN2;PSEN1;ITGB3BP
Assembly and Cell Surface Presentation of NMDA Receptors	8/43	4.898236774916949E-4	0.005819272749687658	0	0	5.020680585237547	38.26494172544643	GRIN2A;GRIN3B;GRIN3A;TUBB1;GRIN2C;GRIN2B;GRIN1;GRIN2D
Selective Autophagy	12/89	4.977512642359218E-4	0.005863341163457045	0	0	3.43145409503791	26.097615546719258	PRKAB2;PRKAA2;TUBB1;PRKAG1;PRKAG2;PLIN3;PLIN2;PRKAB1;PRKAG3;CFTR;TOMM5;ATG5
Metabolism of Amino Acids and Derivatives	30/358	5.56163246601232E-4	0.006462794067872886	0	0	2.0295807296915944	15.21058865674425	OAT;SLC25A2;ODC1;HNMT;FTCD;GCSH;TPO;RPS19;CGA;SLC36A4;AASS;DUOX2;PHYKPL;AGXT2;BHMT2;PYCR1;BBOX1;ASNS;KMO;AZIN1;SLC25A15;BHMT;GLUD2;RPS28;CPS1;BCAT1;SLC25A12;ASPA;BCAT2;SLC25A13
Platelet Activation, Signaling and Aggregation	24/262	5.57939056219242E-4	0.006462794067872886	0	0	2.2325553902686512	16.724654723136762	FGB;APP;FGA;DGKE;TRPC6;HSPA5;PDPK1;ITGB3;SERPINF2;FGG;VEGFC;GP1BA;PPBP;MAPK14;ORM2;ABHD12;ALB;HABP4;SERPING1;GRB2;MGLL;BCAR1;PF4;MAPK3
Inflammasomes	6/25	6.042195713164347E-4	0.006941034744874746	0	0	6.926339960118436	51.33507352673371	APP;BCL2;NLRP3;NFKB1;NFKB2;BCL2L1
Diseases Associated With Surfactant Metabolism	4/10	6.236648346924755E-4	0.007105689510020828	0	0	14.598701794578083	107.73692226080931	SFTPA2;CSF2RB;SFTPA1;CSF2RA
IL-6-type Cytokine Receptor Ligand Interactions	5/17	6.380641719911973E-4	0.007152493540869066	0	0	9.13178516819572	67.1831982005408	IL11;CNTF;CTF1;OSM;OSMR
RIP-mediated NFkB Activation via ZBP1	5/17	6.380641719911973E-4	0.007152493540869066	0	0	9.13178516819572	67.1831982005408	IKBKB;NFKBIA;NFKB1;MYD88;NFKB2
Inwardly Rectifying K+ Channels	7/35	6.973696623728541E-4	0.007754750645586138	0	0	5.487068965517241	39.881086812201865	GABBR2;KCNJ5;GABBR1;KCNJ6;KCNJ9;KCNJ1;KCNJ3
Cellular Responses to Mechanical Stimuli	12/93	7.44626576136135E-4	0.008149849927789193	0	0	3.261314493684436	23.490034128016383	ITGB1;IKBKB;NFKBIA;CDH5;CAPNS1;PDPK1;ITGB3;GNAS;NLRP3;ITGAV;ITGA5;NFKB1
Response of Endothelial Cells to Shear Stress	12/93	7.44626576136135E-4	0.008149849927789193	0	0	3.261314493684436	23.490034128016383	ITGB1;IKBKB;NFKBIA;CDH5;CAPNS1;PDPK1;ITGB3;GNAS;NLRP3;ITGAV;ITGA5;NFKB1
Chemokine Receptors Bind Chemokines	9/57	7.795605309020033E-4	0.008465540140263943	0	0	4.120463709677419	29.48925317045633	CXCL6;CXCL8;CXCR4;CXCL1;PPBP;CXCL3;CXCL2;CXCL5;PF4
Acetylcholine Inhibits Contraction of Outer Hair Cells	3/5	7.86247397563769E-4	0.00847196808227627	0	0	32.816361556064074	234.57919747852634	KCNMA1;CHRNA9;CHRNA10
Cell Recruitment (Pro-Inflammatory Response)	6/27	9.370650422544698E-4	0.009867578854043282	0	0	6.266032474987699	43.691527207958295	APP;IL1B;C3AR1;NLRP3;NFKB1;NFKB2
Purinergic Signaling in Leishmaniasis Infection	6/27	9.370650422544698E-4	0.009867578854043282	0	0	6.266032474987699	43.691527207958295	APP;IL1B;C3AR1;NLRP3;NFKB1;NFKB2
Syndecan Interactions	6/27	9.370650422544698E-4	0.009867578854043282	0	0	6.266032474987699	43.691527207958295	ITGB1;ITGB5;ITGB3;ITGAV;ITGA6;FGF2
Constitutive Signaling by Aberrant PI3K in Cancer	11/83	9.759531629263846E-4	0.010199811251636652	0	0	3.3609346933538617	23.29832181468914	NTRK2;ERBB3;CD19;NTRK3;GRB2;GAB2;FGF1;FGF2;ESR1;EGFR;FGF4
MyD88-independent TLR4 Cascade	13/110	0.0010560983591592083	0.010793946464936026	0	0	2.951245704467354	20.225400196343834	IKBIP;APP;LY96;MAPK14;NFKB1;NFKB2;NFKBIA;IKBKB;RPS6KA3;MAPK11;TP53;SKP1;MAPK3
PI3K AKT Signaling in Cancer	13/110	0.0010560983591592083	0.010793946464936026	0	0	2.951245704467354	20.225400196343834	NTRK2;PDPK1;NTRK3;GAB2;FGF1;FGF2;ESR1;EGFR;FGF4;ERBB3;CD19;AKT1S1;GRB2
TRIF (TICAM1)-mediated TLR4 Signaling	13/110	0.0010560983591592083	0.010793946464936026	0	0	2.951245704467354	20.225400196343834	IKBIP;APP;LY96;MAPK14;NFKB1;NFKB2;NFKBIA;IKBKB;RPS6KA3;MAPK11;TP53;SKP1;MAPK3
Mitochondrial Biogenesis	12/97	0.0010864475590316221	0.01102308107338653	0	0	3.107188031281877	21.206067456697657	MED1;MAPK11;PRKAB2;GLUD2;PRKAA2;TGS1;PRKAG1;PRKAG2;PPARA;MAPK14;PRKAB1;PRKAG3
MyD88 Deficiency (TLR2 4)	5/19	0.0011145762467471452	0.011226528862163274	0	0	7.8264252948885975	53.214064759020594	FGB;FGA;FGG;LY96;MYD88
CREB1 Phosphorylation Through NMDA Receptor-Mediated Activation of RAS Signaling	6/28	0.0011488703818614103	0.011488703818614103	0	0	5.980899697317608	40.48456708371106	RPS6KA3;PDPK1;GRIN2B;MAPK3;GRIN1;GRIN2D
Peptide Hormone Metabolism	11/86	0.0013135281100654132	0.013041457664220888	0	0	3.22598922247883	21.404562847161607	POMC;ACE2;ACE;MME;LEP;CTSZ;REN;CGA;CTSD;CES1;CRHR2
Aspartate and Asparagine Metabolism	4/12	0.0013701435452993023	0.013377317024856311	0	0	10.947880870561283	72.17762436825467	ASNS;SLC25A12;ASPA;SLC25A13
Reversible Hydration of Carbon Dioxide	4/12	0.0013701435452993023	0.013377317024856311	0	0	10.947880870561283	72.17762436825467	CA12;CA1;CA3;CA2
Activation of G Protein Gated Potassium Channels	6/29	0.0013954755169814138	0.013377317024856311	0	0	5.720561074227525	37.60994347635175	GABBR2;KCNJ5;GABBR1;KCNJ6;KCNJ9;KCNJ3
G Protein Gated Potassium Channels	6/29	0.0013954755169814138	0.013377317024856311	0	0	5.720561074227525	37.60994347635175	GABBR2;KCNJ5;GABBR1;KCNJ6;KCNJ9;KCNJ3
Inhibition of Voltage Gated Ca2+ Channels via Gbeta Gamma Subunits	6/29	0.0013954755169814138	0.013377317024856311	0	0	5.720561074227525	37.60994347635175	GABBR2;KCNJ5;GABBR1;KCNJ6;KCNJ9;KCNJ3
IRAK4 Deficiency (TLR2 4)	5/20	0.0014329196492279558	0.013549376275012643	0	0	7.304281345565749	47.82873521218251	FGB;FGA;FGG;LY96;MYD88
Signalling to RAS	5/20	0.0014329196492279558	0.013549376275012643	0	0	7.304281345565749	47.82873521218251	NTRK1;MAPK11;GRB2;MAPK14;MAPK13
Platelet Degranulation	14/128	0.001476319175622012	0.013860601395799355	0	0	2.7050273424000326	17.63191823782963	FGB;APP;FGA;HSPA5;ITGB3;SERPINF2;FGG;VEGFC;PPBP;ORM2;ALB;HABP4;SERPING1;PF4
RAF MAP Kinase Cascade	23/265	0.0014867550288345651	0.013860601395799355	0	0	2.101259024135328	13.681632377384316	FGB;FGA;ICMT;ANGPT1;ITGB3;FGG;CSF2RB;ABHD17C;FGF1;GRIN2B;FGF2;CSF2RA;EGFR;GRIN2D;GRIN1;FGF4;RBX1;ERBB3;ABHD17B;GRB2;GOLGA7;BCL2L1;MAPK3
MAPK Family Signaling Cascades	26/314	0.0014957483520646785	0.013860601395799355	0	0	1.9980986421203812	12.997888677306081	ITGB3;CSF2RB;ABHD17C;FGF1;FGF2;CSF2RA;EGFR;FGF4;ERBB3;GOLGA7;IL6R;RAG1;MAPK3;FGB;FGA;ICMT;ANGPT1;FGG;GRIN2B;GRIN2D;GRIN1;RBX1;IL6;ABHD17B;GRB2;BCL2L1
G Alpha (S) Signalling Events	16/158	0.0015971701129829689	0.014702426867856468	0	0	2.483977032929283	15.99562449042933	ITGB1;PTGER4;VIPR2;PTGER2;GCGR;CRHR2;POMC;HTR6;HTR7;ADRB3;HRH2;GNAS;PDE3A;PDE4A;ITGA5;CGA
SUMOylation of Intracellular Receptors	6/30	0.0016804610805966937	0.015367374355456608	0	0	5.4819173363949485	35.02225440850003	AR;PGR;PPARG;NR3C1;PPARA;ESR1
ECM Proteoglycans	10/76	0.0017306458840130265	0.015722861299203313	0	0	3.330362448009507	21.17864268864798	ITGB1;APP;VCAN;ITGB5;TNN;ITGB3;NCAN;ITGAV;ITGB6;HAPLN1
Adaptive Immune System	56/854	0.001770935705278579	0.015984419677514447	0	0	1.5663397226317926	9.924715720981489	ITGB1;SIGLEC9;ITGB5;ITGB2;PTPRJ;CTSV;TREM1;CTSS;ICAM1;IKBKB;CTSO;CTSL;CTSK;TUBB1;ITGAV;ITGB7;MADCAM1;CTSF;CTSD;CTSB;SKP1;FGB;FGA;ITGA4;PDPK1;CD300A;FGG;HLA-B;HLA-C;HLA-A;HLA-F;HLA-G;RBX1;HLA-E;CD300C;LY96;FBXO41;ANAPC11;KLC3;KLC2;CD19;BTLA;RILP;BTNL8;VCAM1;HSPA5;SIGLEC12;NFKB1;NFKBIA;CD4;RAET1E;GRB2;SIGLEC8;SIGLEC7;SIGLEC6;MYD88
Mitochondrial tRNA Aminoacylation	5/21	0.001813482296237343	0.0161585922549353	0	0	6.847405389908257	43.22429008353864	PARS2;NARS2;TARS2;EARS2;WARS2
Negative Regulation of NMDA Receptor-Mediated Neuronal Transmission	5/21	0.001813482296237343	0.0161585922549353	0	0	6.847405389908257	43.22429008353864	GRIN2A;GRIN2C;GRIN2B;GRIN1;GRIN2D
Dissolution of Fibrin Clot	4/13	0.001910810303626873	0.016810293177476923	0	0	9.730940562555682	60.917905448741905	SERPINB2;SERPINF2;PLAT;SERPINB8
NF-kB Is Activated and Signals Survival	4/13	0.001910810303626873	0.016810293177476923	0	0	9.730940562555682	60.917905448741905	IKBKB;NFKBIA;NGFR;NFKB1
FGFR1 Mutant Receptor Activation	6/31	0.002007528339902646	0.017550090518645776	0	0	5.262365097588978	32.683765503626624	GRB2;LRRFIP1;GAB2;FGF1;FGF2;FGF4
Nuclear Receptor Transcription Pathway	8/53	0.0020358760270037645	0.017686672984595204	0	0	3.9029280143204192	24.185777787473768	MED1;AR;PGR;PPARG;NR3C1;PPARA;ESR1;PPARD
Response to Elevated Platelet Cytosolic Ca2+	14/133	0.002125716760839608	0.018352461475571773	0	0	2.5906891145797832	15.942184314071506	FGB;APP;FGA;HSPA5;ITGB3;SERPINF2;FGG;VEGFC;PPBP;ORM2;ALB;HABP4;SERPING1;PF4
Toll Like Receptor 3 (TLR3) Cascade	12/106	0.0023451942877138867	0.020122346048903103	0	0	2.8083630549747878	17.005725214728475	NFKBIA;IKBKB;IKBIP;APP;RPS6KA3;MAPK11;MAPK14;TP53;NFKB1;SKP1;NFKB2;MAPK3
DEx H-box Helicases Activate Type I IFN and Inflammatory Cytokines Production	3/7	0.0025754034881784464	0.021556674887656457	0	0	16.40646453089245	97.81122453932623	MYD88;NFKB1;NFKB2
Highly Sodium Permeable Postsynaptic Acetylcholine Nicotinic Receptors	3/7	0.0025754034881784464	0.021556674887656457	0	0	16.40646453089245	97.81122453932623	CHRNA3;CHRNB4;CHRNG
Phase 1 - Inactivation of Fast Na+ Channels	3/7	0.0025754034881784464	0.021556674887656457	0	0	16.40646453089245	97.81122453932623	KCND1;KCND2;KCND3
RSK Activation	3/7	0.0025754034881784464	0.021556674887656457	0	0	16.40646453089245	97.81122453932623	RPS6KA3;PDPK1;MAPK3
Intrinsic Pathway for Apoptosis	8/55	0.0025899026663587254	0.021556674887656457	0	0	3.7364542271625494	22.254825740510324	C1QBP;BCL2;XIAP;TP53;TP63;MAPK3;BCL2L1;TP73
Synthesis of Bile Acids and Bile Salts via 7Alpha-Hydroxycholesterol	5/23	0.0027885852458846318	0.023056113136517186	0	0	6.085945463812436	35.79887555533146	AKR1C1;AKR1D1;AKR1C3;AKR1C2;AKR1C4
Activation of Matrix Metalloproteinases	6/33	0.00280322526623842	0.023056113136517186	0	0	4.872050006378364	28.632963071833725	MMP11;CTSK;CTRB2;CTRB1;CTSV;ELANE
Regulation of IGF Transport and Uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)	13/124	0.0031240451271800623	0.025543663098707568	0	0	2.577118785452119	14.866435981729014	APP;FGA;IGFBP4;SERPINC1;IGFBP3;IGFBP2;FGG;IL6;VCAN;ALB;IGFBP7;IGFBP6;PAPPA2
TAK1-dependent IKK and NF-kappa-B Activation	7/45	0.0032192565618267277	0.02616822585344533	0	0	4.040986085904416	23.189622260444786	IKBKB;IKBIP;NFKBIA;APP;TP53;NFKB1;NFKB2
Neurexins and Neuroligins	8/57	0.0032552528369503547	0.026306985135819725	0	0	3.5835701369155255	20.524845387693095	GRIN2A;NLGN4X;NRXN1;NRXN2;GRIN2C;GRIN2B;GRIN1;GRIN2D
Signalling to ERKs	6/34	0.0032797224321246213	0.026351527055798983	0	0	4.697802197802198	26.871412056395034	NTRK1;MAPK11;GRB2;MAPK14;MAPK3;MAPK13
RAS Processing	5/24	0.0033969661456385	0.02701442871229745	0	0	5.76533075808788	32.77517060183253	ICMT;ABHD17B;ABHD17C;GOLGA7;BCL2L1
Synthesis of Prostaglandins (PG) and Thromboxanes (TX)	4/15	0.0034010971400374487	0.02701442871229745	0	0	7.960845569092991	45.2467173257572	AKR1C3;PTGS2;PTGR2;PTGS1
Erythrocytes Take up Oxygen and Release Carbon Dioxide	3/8	0.003986793410814983	0.030786904672404594	0	0	13.124485125858124	72.50973580235025	CA1;CA2;HBB
Interleukin-18 Signaling	3/8	0.003986793410814983	0.030786904672404594	0	0	13.124485125858124	72.50973580235025	IL18RAP;ALOX5;IL18R1
Noncanonical Activation of NOTCH3	3/8	0.003986793410814983	0.030786904672404594	0	0	13.124485125858124	72.50973580235025	NCSTN;PSEN2;PSEN1
RUNX1 Regulates Transcription of Genes Involved in Differentiation of Keratinocytes	3/8	0.003986793410814983	0.030786904672404594	0	0	13.124485125858124	72.50973580235025	CTSL;CTSK;CTSV
Synthesis of UDP-N-acetyl-glucosamine	3/8	0.003986793410814983	0.030786904672404594	0	0	13.124485125858124	72.50973580235025	GFPT2;GFPT1;RENBP
Defective Intrinsic Pathway for Apoptosis	5/25	0.0040951550821957585	0.03110527630738855	0	0	5.47677752293578	30.11105276823411	APP;CAPNS1;C1QBP;CAPN1;TP53
NOTCH3 Activation and Transmission of Signal to the Nucleus	5/25	0.0040951550821957585	0.03110527630738855	0	0	5.47677752293578	30.11105276823411	NCSTN;PSEN2;TACC3;PSEN1;EGFR
TRAF6 Mediated NF-kB Activation	5/25	0.0040951550821957585	0.03110527630738855	0	0	5.47677752293578	30.11105276823411	IKBKB;NFKBIA;APP;NFKB1;NFKB2
Signal Regulatory Protein Family Interactions	4/16	0.004379075017459274	0.03308105583841517	0	0	7.297059946544483	39.62973246038212	SFTPA2;GRB2;CD47;SFTPA1
Developmental Biology	81/1385	0.00476877856836223	0.03583028221634324	0	0	1.3905214338563985	7.433261861118672	ITGB1;NCAN;ITGB3;KRT24;FGF2;TNF;FGF4;RPS6KA3;CAPNS1;RPS19;KRT27;MPZ;SCN9A;TUBB1;ITGAV;CAPN1;IL6R;SCN1A;HOXA4;EPHA4;MED1;CELA2A;TRPC6;EPHA8;ADIPOQ;KRT7;KAZN;MITF;KRT77;GAB2;KRT75;RBX1;CACNB1;TIAM1;SCN10A;CEACAM1;SCN8A;KCNQ2;KCNQ3;PPARG;SCN4A;ITGA5;HOXB1;ANGPTL4;PPARA;TP53;SCN4B;EPHA3;HOXD1;PSEN2;CXCR4;CACNA1D;PSEN1;KLK8;EGFR;NCSTN;TGS1;SMYD1;SCN7A;CACNA1S;NKX6-1;CACNG2;MAPK3;CNTN6;L1CAM;MAPK14;GRIN2B;NFKB1;GRIN1;POMC;MAPK11;NFASC;RPS28;LHX3;LEP;CNTN1;BCL2;CNTN2;GRB2;HOXD3;SCN2A
The NLRP3 Inflammasome	4/17	0.005530159186991375	0.04132753370923662	0	0	6.7353951890034365	35.00747700503133	APP;NLRP3;NFKB1;NFKB2
Activation of PUMA and Translocation to Mitochondria	3/9	0.005786379667959162	0.042463442760377855	0	0	10.93649885583524	56.347559346197365	TP53;TP63;TP73
Interleukin-1 Processing	3/9	0.005786379667959162	0.042463442760377855	0	0	10.93649885583524	56.347559346197365	IL1B;NFKB1;NFKB2
Malate-aspartate Shuttle	3/9	0.005786379667959162	0.042463442760377855	0	0	10.93649885583524	56.347559346197365	SLC25A18;SLC25A12;SLC25A13
Signaling by FGFR1 in Disease	6/38	0.005804355485231505	0.042463442760377855	0	0	4.109715843857635	21.161529765140475	GRB2;LRRFIP1;GAB2;FGF1;FGF2;FGF4
EPH-ephrin Mediated Repulsion of Cells	7/51	0.006549259426381052	0.04766214975219719	0	0	3.4888453500522467	17.543321472794602	EPHA4;TIAM1;NCSTN;EPHA8;PSEN2;PSEN1;EPHA3
Cytosolic Sensors of Pathogen-Associated DNA	8/64	0.006671412802439612	0.048298248934328436	0	0	3.134473121814894	15.703470951256525	IKBKB;NFKBIA;NLRP4;POLR3F;LRRFIP1;NFKB1;MYD88;NFKB2
Gastrin-CREB Signalling Pathway via PKC and MAPK	4/18	0.006866841935443888	0.04845132127039088	0	0	6.253968253968254	31.151334622776073	RPS6KA3;GRB2;EGFR;MAPK3
MECP2 Regulates Neuronal Receptors and Channels	4/18	0.006866841935443888	0.04845132127039088	0	0	6.253968253968254	31.151334622776073	GRIN2A;OPRK1;OPRM1;GRIN2B
PI-3K Cascade FGFR3	4/18	0.006866841935443888	0.04845132127039088	0	0	6.253968253968254	31.151334622776073	GRB2;FGF1;FGF2;FGF4
SHC-mediated Cascade FGFR3	4/18	0.006866841935443888	0.04845132127039088	0	0	6.253968253968254	31.151334622776073	GRB2;FGF1;FGF2;FGF4
Tie2 Signaling	4/18	0.006866841935443888	0.04845132127039088	0	0	6.253968253968254	31.151334622776073	ANGPT4;ANGPT2;ANGPT1;GRB2
Regulation of TP53 Activity Through Phosphorylation	10/92	0.006996959652613823	0.04912007028855158	0	0	2.6782850873491433	13.290399343784028	MAPK11;PRKAB2;PRKAA1;PRKAA2;PRKAG1;PRKAG2;MAPK14;PRKAB1;TP53;PRKAG3
Stimuli-sensing Channels	11/107	0.0072766201028689045	0.05082664292958682	0	0	2.5175255003849113	12.394001585004403	ANO1;TRPC6;TRPA1;CLCNKA;TRPV3;TRPM8;TRPV1;TRPM5;ASIC3;CLCA4;TRPM4
Negative Regulation of FGFR3 Signaling	5/29	0.007922398599263336	0.05397369805498571	0	0	4.5630256116207955	22.076197465360462	GRB2;FGF1;FGF2;FGF4;MAPK3
Activation of the AP-1 Family of Transcription Factors	3/10	0.007998979711746084	0.05397369805498571	0	0	9.373651520104609	45.26012595776322	MAPK11;MAPK14;MAPK3
MAPK3 (ERK1) Activation	3/10	0.007998979711746084	0.05397369805498571	0	0	9.373651520104609	45.26012595776322	IL6;IL6R;MAPK3
Protein Lipoylation	3/10	0.007998979711746084	0.05397369805498571	0	0	9.373651520104609	45.26012595776322	GCSH;LIPT2;LIPT1
STAT5 Activation Downstream of FLT3 ITD Mutants	3/10	0.007998979711746084	0.05397369805498571	0	0	9.373651520104609	45.26012595776322	GRB2;GAB2;BCL2L1
Thyroxine Biosynthesis	3/10	0.007998979711746084	0.05397369805498571	0	0	9.373651520104609	45.26012595776322	TPO;CGA;DUOX2
Urea Cycle	3/10	0.007998979711746084	0.05397369805498571	0	0	9.373651520104609	45.26012595776322	SLC25A15;SLC25A2;CPS1
Complement Cascade	13/139	0.008167457233223019	0.054844278039516886	0	0	2.2685277042915932	10.906168461737904	FCN1;FCN2;COLEC11;FCN3;COLEC10;CPN2;CD19;C3AR1;SERPING1;MASP2;CD59;ELANE;C1QC
Sensory Perception of Sweet, Bitter, and Umami (Glutamate) Taste	6/41	0.008461863980101462	0.056548033328562654	0	0	3.756864031490897	17.92845318742707	SCN9A;TAS1R2;TRPM5;SCN2A;SCN4B;TRPM4
Insulin Receptor Signalling Cascade	7/54	0.008949992328328894	0.059523872422857234	0	0	3.265639520665199	15.40109104669587	PDPK1;GRB2;GAB2;FGF1;FGF2;FGF4;MAPK3
Surfactant Metabolism	5/30	0.009170789167102265	0.06070189020129594	0	0	4.380275229357798	20.551077185352604	SFTPA2;CSF2RB;SFTPA1;CSF2RA;PGA5
Cellular Responses to Stimuli	54/887	0.00936812131270608	0.06169893557670037	0	0	1.4406637503117894	6.728537500234819	ITGB1;CXCL8;EPO;ITGB3;HBB;NR3C1;IKBKB;CDH5;RPS6KA3;CAPNS1;C19ORF10;RPS19;TUBB1;ITGAV;GATSL2;SKP1;MED1;NUP210;PDPK1;RBX1;AR;AKT1S1;PGR;ITGA5;PPARA;TP53;PRKAA2;GSTP1;HM13;LY96;ANAPC11;TGS1;E2F2;NLRP3;E2F3;IGFBP7;MAPK3;EGLN1;GATSL3;HSPA5;GFPT1;ASNS;MAPK14;ESR1;NFKB1;NFKBIA;MAPK11;IL6;GCLC;RPS28;ALB;GNAS;BCL2;BCL2L1
MHC Class II Antigen Presentation	12/126	0.009410197368532719	0.06169893557670037	0	0	2.3132339519318528	10.79346021614922	KLC3;CTSO;KLC2;CTSL;CTSK;TUBB1;CTSV;CTSF;CTSD;RILP;CTSS;CTSB
Signaling by Insulin Receptor	9/82	0.00963739956057653	0.06289195018404402	0	0	2.7057950886938955	12.560582101253416	PDPK1;ATP6V0A2;GRB2;GAB2;FGF1;FGF2;CTSD;FGF4;MAPK3
Autophagy	14/158	0.009803765288906842	0.06367866239056313	0	0	2.13810029612463	9.888689824378236	PRKAB2;PRKAA1;PRKAA2;PRKAG1;HBB;PRKAG2;PRKAB1;PRKAG3;TUBB1;PLIN3;PLIN2;CFTR;TOMM5;ATG5
Sensory Perception	41/640	0.010034179142046643	0.06467169240924844	0	0	1.5166505579474563	6.979258989262218	OR5M9;CHRNA9;OR10T2;OR4M2;CACNA1D;OR4M1;OR4K17;HSD17B6;OR2T12;OR6S1;OR5H15;OR2W3;SCN9A;RDH16;OR13F1;CHRNA10;TAS1R2;TRPM5;TRPM4;OR2D3;OR5F1;OR6C76;OR10G4;AKR1C1;AKR1C3;CACNA2D2;AKR1C4;OR10Q1;OR10AD1;OR5T1;OR2T2;AKR1B10;OR10V1;KCNMA1;KCNQ4;OR2A12;OR10G8;OR5A2;SCN2A;SCN4B;OR4C3
FRS-mediated FGFR3 Signaling	4/20	0.010142754636846158	0.06467169240924844	0	0	5.471649484536083	25.1203190216287	GRB2;FGF1;FGF2;FGF4
PI-3K Cascade FGFR4	4/20	0.010142754636846158	0.06467169240924844	0	0	5.471649484536083	25.1203190216287	GRB2;FGF1;FGF2;FGF4
SHC-mediated Cascade FGFR4	4/20	0.010142754636846158	0.06467169240924844	0	0	5.471649484536083	25.1203190216287	GRB2;FGF1;FGF2;FGF4
Macroautophagy	13/143	0.010250349592140672	0.0650592964980618	0	0	2.198263888888889	10.069023469546238	PRKAB2;PRKAA1;PRKAA2;PRKAG1;PRKAG2;PRKAB1;PRKAG3;TUBB1;PLIN3;PLIN2;CFTR;TOMM5;ATG5
Negative Regulation of FGFR4 Signaling	5/31	0.010548342521085824	0.06555089278261882	0	0	4.21158256880734	19.170224842094164	GRB2;FGF1;FGF2;FGF4;MAPK3
NOTCH4 Activation and Transmission of Signal to the Nucleus	3/11	0.010643808778273216	0.06555089278261882	0	0	8.201516018306636	37.25765744110656	NCSTN;PSEN2;PSEN1
Purine Ribonucleoside Monophosphate Biosynthesis	3/11	0.010643808778273216	0.06555089278261882	0	0	8.201516018306636	37.25765744110656	PPAT;GMPS;PAICS
Signaling by Activated Point Mutants of FGFR1	3/11	0.010643808778273216	0.06555089278261882	0	0	8.201516018306636	37.25765744110656	FGF1;FGF2;FGF4
TGFBR3 PTM Regulation	3/11	0.010643808778273216	0.06555089278261882	0	0	8.201516018306636	37.25765744110656	NCSTN;PSEN2;PSEN1
Activation of GABAB Receptors	6/43	0.010657914941634426	0.06555089278261882	0	0	3.553417941477643	16.137678708037424	GABBR2;KCNJ5;GABBR1;KCNJ6;KCNJ9;KCNJ3
GABA B Receptor Activation	6/43	0.010657914941634426	0.06555089278261882	0	0	3.553417941477643	16.137678708037424	GABBR2;KCNJ5;GABBR1;KCNJ6;KCNJ9;KCNJ3
Regulation of TP53 Activity	14/160	0.010880954893636668	0.06662787357777519	0	0	2.1085890252226225	9.532385439276977	PRKAB2;PRKAA1;PRKAA2;PDPK1;PRKAG1;PRKAG2;MAPK14;PRKAB1;PRKAG3;MAPK11;SMYD2;TP53;TP63;TP73
Transcriptional Regulation of White Adipocyte Differentiation	9/84	0.011210777939668484	0.06834640936903155	0	0	2.633364055299539	11.826121040056488	MED1;TGS1;LEP;ADIPOQ;PPARG;ANGPTL4;PPARA;TNF;NFKB1
Interferon Gamma Signaling	10/99	0.011519327623599107	0.06992080959302516	0	0	2.466726280730402	11.010797613205705	VCAM1;HLA-B;HLA-C;HLA-A;HLA-F;HLA-G;CD44;ICAM1;HLA-E;MAPK3
Bile Acid and Bile Salt Metabolism	6/44	0.011894959188619129	0.07157572845099822	0	0	3.4597256631820654	15.332260596889453	AKR1C1;AKR1D1;ALB;AKR1C3;AKR1C2;AKR1C4
PI3K Cascade	6/44	0.011894959188619129	0.07157572845099822	0	0	3.4597256631820654	15.332260596889453	PDPK1;GRB2;GAB2;FGF1;FGF2;FGF4
Nuclear Signaling by ERBB4	5/32	0.01206091220806575	0.07189144335287362	0	0	4.055385660890248	17.91582377249912	NCSTN;PSEN2;PGR;PSEN1;ESR1
PI-3K Cascade FGFR1	4/21	0.01210258830544779	0.07189144335287362	0	0	5.1495182265346005	22.73170337960237	GRB2;FGF1;FGF2;FGF4
SHC-mediated Cascade FGFR1	4/21	0.01210258830544779	0.07189144335287362	0	0	5.1495182265346005	22.73170337960237	GRB2;FGF1;FGF2;FGF4
TP53 Regulates Metabolic Genes	9/86	0.012968908048205961	0.07670971143406931	0	0	2.564695672990604	11.144116855934234	PRKAB2;PRKAA1;PRKAA2;PRKAG1;PRKAG2;PRKAB1;TP53;PRKAG3;TP63
Negative Regulation of FGFR1 Signaling	5/33	0.013714074023679572	0.07856668564453112	0	0	3.9103456749672345	16.772773464257867	GRB2;FGF1;FGF2;FGF4;MAPK3
Synthesis of Bile Acids and Bile Salts	5/33	0.013714074023679572	0.07856668564453112	0	0	3.9103456749672345	16.772773464257867	AKR1C1;AKR1D1;AKR1C3;AKR1C2;AKR1C4
Erythrocytes Take up Carbon Dioxide and Release Oxygen	3/12	0.013735039288936017	0.07856668564453112	0	0	7.2898550724637685	31.257477750253123	CA1;CA2;HBB
FGFR3 Mutant Receptor Activation	3/12	0.013735039288936017	0.07856668564453112	0	0	7.2898550724637685	31.257477750253123	FGF1;FGF2;FGF4
Hyaluronan Uptake and Degradation	3/12	0.013735039288936017	0.07856668564453112	0	0	7.2898550724637685	31.257477750253123	STAB2;HMMR;CD44
O2 CO2 Exchange in Erythrocytes	3/12	0.013735039288936017	0.07856668564453112	0	0	7.2898550724637685	31.257477750253123	CA1;CA2;HBB
Signaling by Activated Point Mutants of FGFR3	3/12	0.013735039288936017	0.07856668564453112	0	0	7.2898550724637685	31.257477750253123	FGF1;FGF2;FGF4
TP53 Regulates Transcription of Caspase Activators and Caspases	3/12	0.013735039288936017	0.07856668564453112	0	0	7.2898550724637685	31.257477750253123	TP53;TP63;TP73
Chaperone Mediated Autophagy	4/22	0.014289152681477	0.07916759491433568	0	0	4.863179330533282	20.660023880379978	HBB;PLIN3;PLIN2;CFTR
ERK MAPK Targets	4/22	0.014289152681477	0.07916759491433568	0	0	4.863179330533282	20.660023880379978	MAPK11;RPS6KA3;MAPK14;MAPK3
FRS-mediated FGFR4 Signaling	4/22	0.014289152681477	0.07916759491433568	0	0	4.863179330533282	20.660023880379978	GRB2;FGF1;FGF2;FGF4
SHC1 Events in ERBB2 Signaling	4/22	0.014289152681477	0.07916759491433568	0	0	4.863179330533282	20.660023880379978	ERBB3;GRB2;PTPN12;EGFR
Signaling by FGFR3 in Disease	4/22	0.014289152681477	0.07916759491433568	0	0	4.863179330533282	20.660023880379978	GRB2;FGF1;FGF2;FGF4
Arachidonate Metabolism	7/59	0.014295731167984356	0.07916759491433568	0	0	2.950862068965517	12.534655094353521	FAAH;ALOX5;CYP1A2;AKR1C3;PTGS2;PTGR2;PTGS1
Cytoprotection by HMOX1	7/59	0.014295731167984356	0.07916759491433568	0	0	2.950862068965517	12.534655094353521	MED1;HM13;TGS1;ALB;HBB;NLRP3;PPARA
Non-integrin membrane-ECM Interactions	7/59	0.014295731167984356	0.07916759491433568	0	0	2.950862068965517	12.534655094353521	ITGB1;ITGB5;ITGB3;NRXN1;ITGAV;ITGA6;FGF2
Signaling by NTRKs	12/134	0.01487060345106206	0.08202436030546137	0	0	2.1606367857481286	9.092756734478794	NTRK1;RPS6KA3;TIAM1;NTRK2;MAPK11;NTRK3;GRB2;MAPK14;GRIN2B;PCSK5;MAPK3;MAPK13
Negative Regulation of FGFR2 Signaling	5/34	0.01551310369414655	0.0852300953947182	0	0	3.7753084466940843	15.728200063087346	GRB2;FGF1;FGF2;FGF4;MAPK3
Metabolism	116/2181	0.015593295296582764	0.08533338764665371	0	0	1.2591613558049337	5.239262423120606	CHRM3;FAAH;HNMT;NADSYN1;GCSH;RPS19;PPAT;FPGS;CHAC2;MED1;PRKAB2;NUP210;PHYKPL;CTRB2;ADIPOQ;CTRB1;CACNA2D2;CMBL;KMO;BTD;SUCLG2;SUCLG1;CES1;COX15;GLO1;GMPS;CACNA1D;HMMR;PLA2G6;TPO;SGPL1;CGA;HMGCLL1;AGXT2;HBG1;ASNS;PYCR1;PAICS;AZIN1;COQ6;SQLE;BHMT;GCLC;GLUD2;RPS28;AKR1B10;CPS1;VNN2;CYP1A2;ALB;GNAS;ACY3;SLC25A2;NCAN;STAB2;PRKAG2;AKR1B1;ECSIT;OPLAH;FTCD;PIK3C2B;CA1;CA3;CA2;AASS;PLA2G12A;BHMT2;AKR1A1;CTPS2;CTPS1;PTGR2;SUMF2;SUMF1;SLC25A15;SLC25A18;VCAN;PLIN3;PPARG;PLIN2;ANGPTL4;PPARA;BCAT1;SLC25A12;ASPA;CD44;MGLL;PPARD;BCAT2;SLC25A13;OAT;PRKAA2;GSTP1;ODC1;AKR1D1;NDUFB2;PTGS2;PTGS1;TGS1;ALOX5;OXCT2;SLC36A4;DUOX2;CA12;PLA2G2E;PLEKHA1;AKR1C1;GCGR;PLA2G2A;AKR1C3;BBOX1;AKR1C2;AKR1C4;ETNPPL;POMC;SUCLA2;THRSP
Sensory Perception of Taste	6/47	0.01620653666977382	0.08799642957416254	0	0	3.206070958528185	13.216516542920926	SCN9A;TAS1R2;TRPM5;SCN2A;SCN4B;TRPM4
TGF-beta Receptor Signaling Activates SMADs	6/47	0.01620653666977382	0.08799642957416254	0	0	3.206070958528185	13.216516542920926	ITGB1;ITGB5;ITGB3;ITGB8;ITGAV;ITGB6
FRS-mediated FGFR1 Signaling	4/23	0.016710329986692148	0.08933599492885416	0	0	4.606981370953156	18.850515540403407	GRB2;FGF1;FGF2;FGF4
Intrinsic Pathway of Fibrin Clot Formation	4/23	0.016710329986692148	0.08933599492885416	0	0	4.606981370953156	18.850515540403407	SERPINC1;C1QBP;SERPING1;GP1BA
PI-3K Cascade FGFR2	4/23	0.016710329986692148	0.08933599492885416	0	0	4.606981370953156	18.850515540403407	GRB2;FGF1;FGF2;FGF4
SHC-mediated Cascade FGFR2	4/23	0.016710329986692148	0.08933599492885416	0	0	4.606981370953156	18.850515540403407	GRB2;FGF1;FGF2;FGF4
p38MAPK Events	3/13	0.017282316987165966	0.08963589780656975	0	0	6.560526315789474	26.623084471435767	MAPK11;MAPK14;MAPK13
p75NTR Recruits Signalling Complexes	3/13	0.017282316987165966	0.08963589780656975	0	0	6.560526315789474	26.623084471435767	IKBKB;NGFR;MYD88
FGFR2c Ligand Binding and Activation	3/13	0.017282316987165966	0.08963589780656975	0	0	6.560526315789474	26.623084471435767	FGF1;FGF2;FGF4
FGFR3 Ligand Binding and Activation	3/13	0.017282316987165966	0.08963589780656975	0	0	6.560526315789474	26.623084471435767	FGF1;FGF2;FGF4
FGFR3c Ligand Binding and Activation	3/13	0.017282316987165966	0.08963589780656975	0	0	6.560526315789474	26.623084471435767	FGF1;FGF2;FGF4
Glutathione Synthesis and Recycling	3/13	0.017282316987165966	0.08963589780656975	0	0	6.560526315789474	26.623084471435767	GCLC;CHAC2;OPLAH
Phospholipase C-mediated Cascade; FGFR3	3/13	0.017282316987165966	0.08963589780656975	0	0	6.560526315789474	26.623084471435767	FGF1;FGF2;FGF4
TFAP2 (AP-2) Family Regulates Transcription of Growth Factors and Their Receptors	3/13	0.017282316987165966	0.08963589780656975	0	0	6.560526315789474	26.623084471435767	CGA;ESR1;EGFR
Arachidonate Production From DAG	2/5	0.0175807585282584	0.08984284689073227	0	0	14.567619047619047	58.867023692946695	ABHD12;MGLL
FBXW7 Mutants and NOTCH1 in Cancer	2/5	0.0175807585282584	0.08984284689073227	0	0	14.567619047619047	58.867023692946695	RBX1;SKP1
Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling	2/5	0.0175807585282584	0.08984284689073227	0	0	14.567619047619047	58.867023692946695	RBX1;SKP1
NGF-independant TRKA Activation	2/5	0.0175807585282584	0.08984284689073227	0	0	14.567619047619047	58.867023692946695	NTRK1;NTRK2
IRS-mediated Signalling	6/48	0.0178555253297739	0.0909127480160649	0	0	3.1295719206166965	12.597911116192678	PDPK1;GRB2;GAB2;FGF1;FGF2;FGF4
Metabolism of Steroids	13/155	0.01903167648654607	0.09638019127231029	0	0	2.011223591549296	7.9677649561657455	MED1;AKR1C1;AKR1D1;AKR1C3;AKR1B1;AKR1C2;AKR1C4;POMC;SQLE;TGS1;ALB;CGA;PPARA
Post-translational Protein Phosphorylation	10/107	0.019068023453154913	0.09638019127231029	0	0	2.2623336781650196	8.958258841003179	APP;FGA;IL6;VCAN;IGFBP4;SERPINC1;IGFBP3;ALB;FGG;IGFBP7
EPH-Ephrin Signaling	9/92	0.019471833525697556	0.09806466884318696	0	0	2.3785464438398756	9.368586128341665	EPHA4;TIAM1;NCSTN;EPHA8;PSEN2;PSEN1;GRIN2B;EPHA3;GRIN1
Signaling by High-Kinase Activity BRAF Mutants	5/36	0.019568254230094423	0.09819448873585289	0	0	3.5313702278780705	13.89186914562104	FGB;FGA;ITGB3;FGG;MAPK3
MAP Kinase Activation	7/63	0.019970478827961238	0.09949450025400043	0	0	2.7395114942528735	10.721078655952214	IKBKB;RPS6KA3;MAPK11;MAPK14;NFKB1;SKP1;MAPK3
NCAM Signaling for Neurite Out-Growth	7/63	0.019970478827961238	0.09949450025400043	0	0	2.7395114942528735	10.721078655952214	CACNB1;NCAN;CNTN2;CACNA1D;GRB2;CACNA1S;MAPK3
Signaling by VEGF	10/108	0.020218789946223795	0.10037185009018242	0	0	2.2391309464962457	8.735169820025407	CDH5;MAPK11;FLT1;PDPK1;ITGB3;VEGFC;ITGAV;MAPK14;BCAR1;MAPK13
FGFR1c Ligand Binding and Activation	3/14	0.021291236765287578	0.10347838847464941	0	0	5.963802787601415	22.957418551601318	FGF1;FGF2;FGF4
FGFR4 Ligand Binding and Activation	3/14	0.021291236765287578	0.10347838847464941	0	0	5.963802787601415	22.957418551601318	FGF1;FGF2;FGF4
Glutamate and Glutamine Metabolism	3/14	0.021291236765287578	0.10347838847464941	0	0	5.963802787601415	22.957418551601318	GLUD2;OAT;PYCR1
Nucleotide Biosynthesis	3/14	0.021291236765287578	0.10347838847464941	0	0	5.963802787601415	22.957418551601318	PPAT;GMPS;PAICS
Regulation of TP53 Activity Through Association With Co-factors	3/14	0.021291236765287578	0.10347838847464941	0	0	5.963802787601415	22.957418551601318	TP53;TP63;TP73
TP53 Regulates Transcription of Cell Death Genes With Uncertain Role in P53-Dependent Apoptosis	3/14	0.021291236765287578	0.10347838847464941	0	0	5.963802787601415	22.957418551601318	TP53;TP63;TP73
Collagen Degradation	7/64	0.021603699763256993	0.10463115913215058	0	0	2.6913087315991127	10.320874808477653	MMP11;CTSL;PHYKPL;CTSK;CTSD;ELANE;CTSB
Glutathione Conjugation	5/37	0.021833262998410014	0.1050111957362973	0	0	3.4208357224770642	13.082372681620708	GCLC;GSTP1;AKR1A1;CHAC2;OPLAH
NOD1 2 Signaling Pathway	5/37	0.021833262998410014	0.1050111957362973	0	0	3.4208357224770642	13.082372681620708	IKBKB;CYLD;MAPK11;MAPK14;MAPK13
Basigin Interactions	4/25	0.022283080770247907	0.10535198051239657	0	0	4.167784868815796	15.853951886417276	ITGB1;PPIL2;ITGA6;L1CAM
Downstream Signaling of Activated FGFR3	4/25	0.022283080770247907	0.10535198051239657	0	0	4.167784868815796	15.853951886417276	GRB2;FGF1;FGF2;FGF4
FRS-mediated FGFR2 Signaling	4/25	0.022283080770247907	0.10535198051239657	0	0	4.167784868815796	15.853951886417276	GRB2;FGF1;FGF2;FGF4
NOTCH2 Activation and Transmission of Signal to the Nucleus	4/25	0.022283080770247907	0.10535198051239657	0	0	4.167784868815796	15.853951886417276	NCSTN;PSEN2;CNTN1;PSEN1
Signaling by NTRK2 (TRKB)	4/25	0.022283080770247907	0.10535198051239657	0	0	4.167784868815796	15.853951886417276	NTRK2;TIAM1;GRB2;GRIN2B
PIP3 Activates AKT Signaling	20/281	0.0233122618405201	0.10984421680787436	0	0	1.6865390719653786	6.3393222453875095	NTRK2;PDPK1;NTRK3;XIAP;GAB2;IL1RAP;FGF1;FGF2;ESR1;EGFR;FGF4;IL1RL1;ERBB3;CD19;AKT1S1;GRB2;PPARG;TP53;MYD88;MAPK3
Signaling by TGFB Family Members	13/161	0.025123546963296974	0.11741526369291964	0	0	1.929077515015015	7.106624622576286	ITGB1;ITGB5;ITGB3;PSEN2;PSEN1;FGF2;SMAD5;NCSTN;ITGB8;ITGAV;ITGB6;E2F4;MAPK3
Signaling by ERBB2 in Cancer	4/26	0.0254454558192595	0.11741526369291964	0	0	3.9781318338019367	14.60458961312171	ERBB3;GRB2;PTPN12;EGFR
IRS-related Events Triggered by IGF1R	6/52	0.02559523937396629	0.11741526369291964	0	0	2.8568362202366098	10.471301516591291	PDPK1;GRB2;GAB2;FGF1;FGF2;FGF4
Activated NTRK2 Signals Through CDK5	2/6	0.025610568130125834	0.11741526369291964	0	0	10.925142857142857	40.037919417202176	NTRK2;TIAM1
Activation of TRKA Receptors	2/6	0.025610568130125834	0.11741526369291964	0	0	10.925142857142857	40.037919417202176	NTRK1;NTRK2
Biosynthesis of EPA-derived SPMs	2/6	0.025610568130125834	0.11741526369291964	0	0	10.925142857142857	40.037919417202176	ALOX5;PTGS2
CLEC7A Inflammasome Pathway	2/6	0.025610568130125834	0.11741526369291964	0	0	10.925142857142857	40.037919417202176	IL1B;NFKB1
RUNX1 Regulates Transcription of Genes Involved in WNT Signaling	2/6	0.025610568130125834	0.11741526369291964	0	0	10.925142857142857	40.037919417202176	RSPO3;ESR1
Phospholipase C-mediated Cascade; FGFR4	3/15	0.025763780882259345	0.11741526369291964	0	0	5.466533180778032	20.00087296649709	FGF1;FGF2;FGF4
Prolactin Receptor Signaling	3/15	0.025763780882259345	0.11741526369291964	0	0	5.466533180778032	20.00087296649709	PRLR;RBX1;SKP1
Transport of Small Molecules	43/724	0.027298623546010477	0.1240035514018123	0	0	1.3962504005606087	5.027784592816564	SLC22A6;SLC1A1;SLC1A2;CLCNKA;HBB;SLC1A4;SLC6A2;PCSK5;SLC2A6;SLC6A3;CA1;MB;CA2;ATP6V0A2;CSN1S1;TRPM8;TRPM5;SLC36A4;ASIC3;CLCA4;SKP1;TRPM4;SLC12A2;SLC35A1;SLC15A1;TRPC6;TRPA1;SLC32A1;NIPA1;NGB;TRPV3;TRPV1;SLC2A9;ANO1;SLC25A18;FXYD3;ALB;ANGPTL3;GNAS;ANGPTL4;SLC29A1;CFTR;SLC29A2
IGF1R Signaling Cascade	6/53	0.02783021752666029	0.12600652235197982	0	0	2.7959059041942496	10.013908536005877	PDPK1;GRB2;GAB2;FGF1;FGF2;FGF4
Acyl Chain Remodelling of PC	4/27	0.02886407000404393	0.1285931323898111	0	0	3.804970367050152	13.489220032302542	PLA2G12A;PLA2G2E;PLA2G2A;PLA2G6
Downstream Signaling of Activated FGFR4	4/27	0.02886407000404393	0.1285931323898111	0	0	3.804970367050152	13.489220032302542	GRB2;FGF1;FGF2;FGF4
Effects of PIP2 Hydrolysis	4/27	0.02886407000404393	0.1285931323898111	0	0	3.804970367050152	13.489220032302542	ABHD12;DGKE;TRPC6;MGLL
Interleukin Receptor SHC Signaling	4/27	0.02886407000404393	0.1285931323898111	0	0	3.804970367050152	13.489220032302542	CSF2RB;GRB2;GAB2;CSF2RA
Pyroptosis	4/27	0.02886407000404393	0.1285931323898111	0	0	3.804970367050152	13.489220032302542	IL1B;TP53;ELANE;TP63
MAP2K and MAPK Activation	5/40	0.029623747140394317	0.13113696982531242	0	0	3.127129750982962	11.004929259375032	FGB;FGA;ITGB3;FGG;MAPK3
Signaling by FGFR3	5/40	0.029623747140394317	0.13113696982531242	0	0	3.127129750982962	11.004929259375032	GRB2;FGF1;FGF2;FGF4;MAPK3
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)	6/54	0.030190248683921766	0.13322046244651192	0	0	2.7375143513203213	9.581947098794949	PDPK1;GRB2;GAB2;FGF1;FGF2;FGF4
MAP3K8 (TPL2)-dependent MAPK1 3 Activation	3/16	0.03069872219525532	0.13376559201067365	0	0	5.045766590389016	17.577100722812194	IKBKB;NFKB1;SKP1
PI3K Events in ERBB2 Signaling	3/16	0.03069872219525532	0.13376559201067365	0	0	5.045766590389016	17.577100722812194	ERBB3;GRB2;EGFR
Phospholipase C-mediated Cascade FGFR1	3/16	0.03069872219525532	0.13376559201067365	0	0	5.045766590389016	17.577100722812194	FGF1;FGF2;FGF4
Signaling by FLT3 ITD and TKD Mutants	3/16	0.03069872219525532	0.13376559201067365	0	0	5.045766590389016	17.577100722812194	GRB2;GAB2;BCL2L1
Signaling by FGFR4	5/41	0.03256290151750098	0.14100446451503537	0	0	3.040105759429154	10.411090333571346	GRB2;FGF1;FGF2;FGF4;MAPK3
Signaling by RAF1 Mutants	5/41	0.03256290151750098	0.14100446451503537	0	0	3.040105759429154	10.411090333571346	FGB;FGA;ITGB3;FGG;MAPK3
Cellular Response to Chemical Stress	15/202	0.03291979343763164	0.14210718285188814	0	0	1.7621003263148753	6.015248717459675	MED1;PRKAA2;GSTP1;HM13;HBB;NFKB1;RBX1;GCLC;TGS1;ALB;BCL2;NLRP3;PPARA;SKP1;BCL2L1
Activated NTRK2 Signals Through FYN	2/7	0.03482465522185528	0.1480314090470301	0	0	8.739657142857142	29.342784106783547	NTRK2;GRIN2B
Activated NTRK2 Signals Through PI3K	2/7	0.03482465522185528	0.1480314090470301	0	0	8.739657142857142	29.342784106783547	NTRK2;GRB2
Interleukin-36 Pathway	2/7	0.03482465522185528	0.1480314090470301	0	0	8.739657142857142	29.342784106783547	IL1RL2;IL1RAP
Neurofascin Interactions	2/7	0.03482465522185528	0.1480314090470301	0	0	8.739657142857142	29.342784106783547	NFASC;CNTN1
STAT5 Activation	2/7	0.03482465522185528	0.1480314090470301	0	0	8.739657142857142	29.342784106783547	GRB2;GAB2
Translocation of SLC2A4 (GLUT4) to the Plasma Membrane	7/71	0.03567568493149395	0.15020321187614838	0	0	2.3960668103448275	7.986775754161297	PRKAB2;PRKAA2;TUBB1;PRKAG1;PRKAG2;PRKAB1;PRKAG3
tRNA Aminoacylation	5/42	0.03567751046239574	0.15020321187614838	0	0	2.957785767418795	9.858994296333053	PARS2;NARS2;TARS2;EARS2;WARS2
NCAM1 Interactions	5/42	0.03567751046239574	0.15020321187614838	0	0	2.957785767418795	9.858994296333053	CACNB1;NCAN;CNTN2;CACNA1D;CACNA1S
Activated Point Mutants of FGFR2	3/17	0.03609199479613925	0.15020321187614838	0	0	4.6851095129127165	15.562454192930797	FGF1;FGF2;FGF4
Acyl Chain Remodelling of PI	3/17	0.03609199479613925	0.15020321187614838	0	0	4.6851095129127165	15.562454192930797	PLA2G12A;PLA2G2E;PLA2G2A
Biosynthesis of DHA-derived SPMs	3/17	0.03609199479613925	0.15020321187614838	0	0	4.6851095129127165	15.562454192930797	ALOX5;CYP1A2;PTGS2
Hyaluronan Metabolism	3/17	0.03609199479613925	0.15020321187614838	0	0	4.6851095129127165	15.562454192930797	STAB2;HMMR;CD44
Acyl Chain Remodelling of PE	4/29	0.0364810371795026	0.15136907964032423	0	0	3.50020618556701	11.58905206225387	PLA2G12A;PLA2G2E;PLA2G2A;PLA2G6
Interleukin-17 Signaling	7/72	0.03808464774040182	0.15755256059273373	0	0	2.359080459770115	7.709342891821314	IKBKB;RPS6KA3;MAPK11;MAPK14;NFKB1;SKP1;MAPK3
Activation of BH3-only Proteins	4/30	0.04068261934383693	0.16730426298205128	0	0	3.3654066437571593	10.775878344535032	BCL2;TP53;TP63;TP73
Downstream Signaling of Activated FGFR2	4/30	0.04068261934383693	0.16730426298205128	0	0	3.3654066437571593	10.775878344535032	GRB2;FGF1;FGF2;FGF4
Diseases of Signal Transduction by Growth Factor Receptors and Second Messengers	28/451	0.04144211378026029	0.16847536909931954	0	0	1.4579800460561305	4.641417766332488	ITGB3;PSEN2;PSEN1;FGF1;FGF2;EGFR;FGF4;NCSTN;ERBB3;CD19;LRRFIP1;SKP1;MAPK3;FGB;NTRK2;FGA;PDPK1;NTRK3;FGG;PTPN12;GAB2;KREMEN2;ESR1;RBX1;AKT1S1;GRB2;TP53;BCL2L1
Acyl Chain Remodelling of PG	3/18	0.041937034322564425	0.16847536909931954	0	0	4.37254004576659	13.86788665539334	PLA2G12A;PLA2G2E;PLA2G2A
FGFR1 Ligand Binding and Activation	3/18	0.041937034322564425	0.16847536909931954	0	0	4.37254004576659	13.86788665539334	FGF1;FGF2;FGF4
Metabolism of Amine-Derived Hormones	3/18	0.041937034322564425	0.16847536909931954	0	0	4.37254004576659	13.86788665539334	TPO;CGA;DUOX2
Phospholipase C-mediated Cascade; FGFR2	3/18	0.041937034322564425	0.16847536909931954	0	0	4.37254004576659	13.86788665539334	FGF1;FGF2;FGF4
RORA Activates Gene Expression	3/18	0.041937034322564425	0.16847536909931954	0	0	4.37254004576659	13.86788665539334	MED1;TGS1;PPARA
Regulation of NF-kappa B Signaling	3/18	0.041937034322564425	0.16847536909931954	0	0	4.37254004576659	13.86788665539334	IKBIP;IKBKB;TP53
Signaling by Cytosolic FGFR1 Fusion Mutants	3/18	0.041937034322564425	0.16847536909931954	0	0	4.37254004576659	13.86788665539334	GRB2;GAB2;LRRFIP1
TP53 Regulates Transcription of Cell Death Genes	5/44	0.042440673916399024	0.1700073105008491	0	0	2.805810397553517	8.865373452556293	IGFBP3;TNFRSF10A;TP53;TP63;TP73
Activated NTRK3 Signals Through RAS	2/8	0.04510396228058065	0.17431743718995169	0	0	7.282666666666667	22.567419544008725	NTRK3;GRB2
Biosynthesis of Maresins	2/8	0.04510396228058065	0.17431743718995169	0	0	7.282666666666667	22.567419544008725	ALOX5;CYP1A2
Cross-presentation of Particulate Exogenous Antigens (Phagosomes)	2/8	0.04510396228058065	0.17431743718995169	0	0	7.282666666666667	22.567419544008725	ITGB5;ITGAV
Defective CHST14 Causes EDS, Musculocontractural Type	2/8	0.04510396228058065	0.17431743718995169	0	0	7.282666666666667	22.567419544008725	VCAN;NCAN
Defective CHST3 Causes SEDCJD	2/8	0.04510396228058065	0.17431743718995169	0	0	7.282666666666667	22.567419544008725	VCAN;NCAN
Defective CHSY1 Causes TPBS	2/8	0.04510396228058065	0.17431743718995169	0	0	7.282666666666667	22.567419544008725	VCAN;NCAN
FGFR1b Ligand Binding and Activation	2/8	0.04510396228058065	0.17431743718995169	0	0	7.282666666666667	22.567419544008725	FGF1;FGF2
Histidine Catabolism	2/8	0.04510396228058065	0.17431743718995169	0	0	7.282666666666667	22.567419544008725	HNMT;FTCD
VEGF Binds to VEGFR Leading to Receptor Dimerization	2/8	0.04510396228058065	0.17431743718995169	0	0	7.282666666666667	22.567419544008725	FLT1;VEGFC
VEGF Ligand-Receptor Interactions	2/8	0.04510396228058065	0.17431743718995169	0	0	7.282666666666667	22.567419544008725	FLT1;VEGFC
Activated NOTCH1 Transmits Signal to the Nucleus	4/31	0.045146962149915544	0.17431743718995169	0	0	3.2405922531924825	10.038811304084968	NCSTN;PSEN2;CNTN1;PSEN1
Downstream Signaling of Activated FGFR1	4/31	0.045146962149915544	0.17431743718995169	0	0	3.2405922531924825	10.038811304084968	GRB2;FGF1;FGF2;FGF4
MAPK Targets Nuclear Events Mediated by MAP Kinases	4/31	0.045146962149915544	0.17431743718995169	0	0	3.2405922531924825	10.038811304084968	RPS6KA3;MAPK11;MAPK14;MAPK3
DAP12 Interactions	5/45	0.04609205143534893	0.17552863423324663	0	0	2.735521788990826	8.41751448388226	HLA-B;HLA-C;GRB2;TREM1;HLA-E
Paradoxical Activation of RAF Signaling by Kinase Inactive BRAF	5/45	0.04609205143534893	0.17552863423324663	0	0	2.735521788990826	8.41751448388226	FGB;FGA;ITGB3;FGG;MAPK3
Signaling by RAS Mutants	5/45	0.04609205143534893	0.17552863423324663	0	0	2.735521788990826	8.41751448388226	FGB;FGA;ITGB3;FGG;MAPK3
Signaling by Moderate Kinase Activity BRAF Mutants	5/45	0.04609205143534893	0.17552863423324663	0	0	2.735521788990826	8.41751448388226	FGB;FGA;ITGB3;FGG;MAPK3
Signaling Downstream of RAS Mutants	5/45	0.04609205143534893	0.17552863423324663	0	0	2.735521788990826	8.41751448388226	FGB;FGA;ITGB3;FGG;MAPK3
Fatty Acid Metabolism	13/176	0.046459375837659404	0.1764440776348267	0	0	1.7501704158145877	5.371582762028301	FAAH;PRKAB2;PRKAA2;HBG1;AKR1C3;PRKAG2;PTGS2;PTGR2;PTGS1;ALOX5;CYP1A2;THRSP;PPARD
Integration of Energy Metabolism	9/108	0.047734551708193185	0.18079298875855185	0	0	1.9924591537494762	6.06125957088656	CHRM3;PRKAB2;PRKAA2;GCGR;ADIPOQ;GNAS;CACNA2D2;PRKAG2;CACNA1D
Assembly of Active LPL and LIPC Lipase Complexes	3/19	0.048225090029953274	0.18116993281522986	0	0	4.09904176201373	12.42778573999571	ANGPTL3;ANGPTL4;PCSK5
Biosynthesis of Specialized Proresolving Mediators (SPMs)	3/19	0.048225090029953274	0.18116993281522986	0	0	4.09904176201373	12.42778573999571	ALOX5;CYP1A2;PTGS2
GABA Synthesis, Release, Reuptake and Degradation	3/19	0.048225090029953274	0.18116993281522986	0	0	4.09904176201373	12.42778573999571	SLC32A1;GAD1;ABAT
Cell Death Signalling via NRAGE, NRIF and NADE	7/76	0.04877503066788097	0.1827420286478559	0	0	2.221855738797268	6.711196942699111	NET1;TIAM1;NGFR;NCSTN;PSEN2;PSEN1;ITGB3BP
SARS-CoV Infections	30/498	0.049707861576478746	0.1857363644927566	0	0	1.4118457300275482	4.2377850994764765	ITGB1;NR3C1;IKBKB;GJA1;RPS19;CTSL;NLRP3;GOLGA7;IL6R;NUP210;ITGA4;IL1R1;PDPK1;SIGMAR1;HLA-B;HLA-C;HLA-A;HLA-F;HLA-G;NFKB1;RBX1;HLA-E;NFKBIA;ACE2;ANO1;RPS28;FXYD3;GRB2;MASP2;BCL2L1
Assembly of Collagen Fibrils and Other Multimeric Structures	6/61	0.05037143325305475	0.18720933749129975	0	0	2.38822669867446	7.136812034225546	CTSL;PXDN;ITGA6;CTSV;CTSS;CTSB
Regulated Necrosis	6/61	0.05037143325305475	0.18720933749129975	0	0	2.38822669867446	7.136812034225546	IL1B;XIAP;TNFRSF10A;TP53;TP63;ELANE
Adipogenesis	9/110	0.052547329553790705	0.1947754348793842	0	0	1.9527991969703882	5.753026499422875	MED1;TGS1;LEP;ADIPOQ;PPARG;ANGPTL4;PPARA;TNF;NFKB1
Cyclin D Associated Events in G1	5/47	0.05393858715700488	0.19775058088127398	0	0	2.6049858016601135	7.606321889547215	E2F2;E2F3;E2F4;CKS1B;SKP1
G1 Phase	5/47	0.05393858715700488	0.19775058088127398	0	0	2.6049858016601135	7.606321889547215	E2F2;E2F3;E2F4;CKS1B;SKP1
Heme Signaling	5/47	0.05393858715700488	0.19775058088127398	0	0	2.6049858016601135	7.606321889547215	MED1;TGS1;HBB;LY96;PPARA
Signaling by TGF-beta Receptor Complex	8/94	0.05411902290916793	0.19775058088127398	0	0	2.0378408756389326	5.943504604870617	ITGB1;ITGB5;ITGB3;ITGB8;ITGAV;ITGB6;E2F4;MAPK3
Cargo Concentration in the ER	4/33	0.05486106488737924	0.19775058088127398	0	0	3.0167871390765097	8.75758639658073	GRIA1;LMAN2L;CTSZ;CD59
TNFR1-induced NF-kappa-B Signaling Pathway	4/33	0.05486106488737924	0.19775058088127398	0	0	3.0167871390765097	8.75758639658073	IKBKB;CYLD;XIAP;TNF
Apoptotic Factor-Mediated Response	3/20	0.0549455106433379	0.19775058088127398	0	0	3.8577197469376765	11.192839383013073	C1QBP;XIAP;MAPK3
FGFR2 Ligand Binding and Activation	3/20	0.0549455106433379	0.19775058088127398	0	0	3.8577197469376765	11.192839383013073	FGF1;FGF2;FGF4
Ras Activation Upon Ca2+ Influx Through NMDA Receptor	3/20	0.0549455106433379	0.19775058088127398	0	0	3.8577197469376765	11.192839383013073	GRIN2B;GRIN1;GRIN2D
TP53 Regulates Transcription of Genes Involved in Cytochrome C Release	3/20	0.0549455106433379	0.19775058088127398	0	0	3.8577197469376765	11.192839383013073	TP53;TP63;TP73
RHO GTPase Effectors	19/291	0.05521161119828093	0.19775058088127398	0	0	1.5347293637734813	4.445469450014764	ITGB1;PDPK1;IQGAP2;MAPK14;MYLK;AR;MAPK11;KLC3;APITD1;KLC2;FMNL2;TUBB1;CENPL;GRB2;PPP1R12B;BUB1;CFTR;ITGB3BP;MAPK3
Activated NTRK2 Signals Through RAS	2/9	0.0563375755604205	0.19775058088127398	0	0	6.24195918367347	17.954331133760043	NTRK2;GRB2
Axonal Growth Inhibition (RHOA Activation)	2/9	0.0563375755604205	0.19775058088127398	0	0	6.24195918367347	17.954331133760043	RTN4R;NGFR
BH3-only Proteins Associate With and Inactivate Anti-Apoptotic BCL-2 Members	2/9	0.0563375755604205	0.19775058088127398	0	0	6.24195918367347	17.954331133760043	BCL2;BCL2L1
CD163 Mediating an Anti-Inflammatory Response	2/9	0.0563375755604205	0.19775058088127398	0	0	6.24195918367347	17.954331133760043	IL6;MAPK14
CHL1 Interactions	2/9	0.0563375755604205	0.19775058088127398	0	0	6.24195918367347	17.954331133760043	ITGB1;CNTN6
Ca2+ Activated K+ Channels	2/9	0.0563375755604205	0.19775058088127398	0	0	6.24195918367347	17.954331133760043	KCNMA1;KCNN3
EGFR Transactivation by Gastrin	2/9	0.0563375755604205	0.19775058088127398	0	0	6.24195918367347	17.954331133760043	GRB2;EGFR
Formyl Peptide Receptors Bind Formyl Peptides and Many Other Ligands	2/9	0.0563375755604205	0.19775058088127398	0	0	6.24195918367347	17.954331133760043	APP;ANXA1
MAPK1 (ERK2) Activation	2/9	0.0563375755604205	0.19775058088127398	0	0	6.24195918367347	17.954331133760043	IL6;IL6R
Small Interfering RNA (siRNA) Biogenesis	2/9	0.0563375755604205	0.19775058088127398	0	0	6.24195918367347	17.954331133760043	PRKRA;TARBP2
Signaling by FGFR in Disease	6/63	0.05735462541246759	0.20014530981069642	0	0	2.304187564203275	6.586524268258169	GRB2;LRRFIP1;GAB2;FGF1;FGF2;FGF4
Transcriptional Regulation by MECP2	6/63	0.05735462541246759	0.20014530981069642	0	0	2.304187564203275	6.586524268258169	GRIN2A;GAD1;OPRK1;PPARG;OPRM1;GRIN2B
Formation of the Cornified Envelope	10/129	0.05745178317587617	0.20014530981069642	0	0	1.8419547749895806	5.262113414266414	CELA2A;CAPNS1;KRT27;KRT24;KAZN;KRT7;KRT77;CAPN1;KRT75;KLK8
Cellular Responses to Stress	44/787	0.05899091159520222	0.20499341779332772	0	0	1.3066653310045417	3.698348819509036	PRKAA2;CXCL8;EPO;GSTP1;HM13;LY96;HBB;NR3C1;ANAPC11;RPS6KA3;C19ORF10;RPS19;TGS1;TUBB1;E2F2;NLRP3;E2F3;IGFBP7;GATSL2;SKP1;MAPK3;EGLN1;MED1;GATSL3;NUP210;HSPA5;GFPT1;ASNS;MAPK14;ESR1;NFKB1;RBX1;AR;MAPK11;GCLC;IL6;RPS28;ALB;AKT1S1;BCL2;PGR;PPARA;TP53;BCL2L1
Late Endosomal Microautophagy	4/34	0.06010746495566497	0.20783426937406546	0	0	2.9160748377243224	8.198897940214808	HBB;PLIN3;PLIN2;CFTR
Plasma Lipoprotein Remodeling	4/34	0.06010746495566497	0.20783426937406546	0	0	2.9160748377243224	8.198897940214808	ALB;ANGPTL3;ANGPTL4;PCSK5
Ion Channel Transport	13/184	0.061900155295202826	0.21350177632836706	0	0	1.667587177821096	4.639615393611983	TRPC6;TRPA1;CLCNKA;TRPV3;TRPV1;ANO1;FXYD3;ATP6V0A2;TRPM8;TRPM5;ASIC3;CLCA4;TRPM4
Signaling by NOTCH3	5/49	0.06251138995811395	0.21507631693509502	0	0	2.486316722268557	6.8930806406665175	NCSTN;PSEN2;TACC3;PSEN1;EGFR
Cellular Senescence	12/167	0.06408951898358613	0.21996155898070302	0	0	1.697676673503636	4.664323265834358	RPS6KA3;MAPK11;IL6;CXCL8;E2F2;IGFBP7;E2F3;MAPK14;TP53;NFKB1;ANAPC11;MAPK3
Senescence-Associated Secretory Phenotype (SASP)	7/81	0.06458115364730165	0.22110296445751057	0	0	2.0711867039453247	5.67470495563989	RPS6KA3;IL6;CXCL8;IGFBP7;NFKB1;ANAPC11;MAPK3
Mitochondrial Protein Import	6/65	0.06488952200201079	0.22161286383979115	0	0	2.225845998170815	6.087842648032514	DNAJC19;GRPEL1;PAM16;SLC25A12;TOMM5;SLC25A13
Oncogene Induced Senescence	4/35	0.06560998719858929	0.2235242210932331	0	0	2.821860104201308	7.6868241038038025	E2F2;E2F3;TP53;MAPK3
Regulation of TNFR1 Signaling	5/50	0.06706924439370762	0.2279370408490308	0	0	2.4309378185524975	6.568466172109958	IKBKB;CYLD;SPPL2B;XIAP;TNF
p75NTR Regulates Axonogenesis	2/10	0.06842224122790065	0.2280741374263355	0	0	5.461428571428572	14.647864603583724	RTN4R;NGFR
FGFR2b Ligand Binding and Activation	2/10	0.06842224122790065	0.2280741374263355	0	0	5.461428571428572	14.647864603583724	FGF1;FGF2
Ketone Body Metabolism	2/10	0.06842224122790065	0.2280741374263355	0	0	5.461428571428572	14.647864603583724	OXCT2;HMGCLL1
Neurotransmitter Clearance	2/10	0.06842224122790065	0.2280741374263355	0	0	5.461428571428572	14.647864603583724	SLC6A3;SLC6A4
Prednisone ADME	2/10	0.06842224122790065	0.2280741374263355	0	0	5.461428571428572	14.647864603583724	AKR1C1;ALB
RHOBTB3 ATPase Cycle	2/10	0.06842224122790065	0.2280741374263355	0	0	5.461428571428572	14.647864603583724	HTR7;PLIN3
Signal Attenuation	2/10	0.06842224122790065	0.2280741374263355	0	0	5.461428571428572	14.647864603583724	GRB2;MAPK3
Uptake of Dietary Cobalamins Into Enterocytes	2/10	0.06842224122790065	0.2280741374263355	0	0	5.461428571428572	14.647864603583724	CTRB2;CTRB1
VEGFA-VEGFR2 Pathway	8/99	0.06912045395051396	0.2293595038639237	0	0	1.9253657734670393	5.144393641657722	CDH5;MAPK11;PDPK1;ITGB3;ITGAV;MAPK14;BCAR1;MAPK13
Acyl Chain Remodelling of PS	3/22	0.06963288534573799	0.2293595038639237	0	0	3.45128266891485	9.196005942413933	PLA2G12A;PLA2G2E;PLA2G2A
Deregulated CDK5 Triggers Multiple Neurodegenerative Pathways in Alzheimer's Disease Models	3/22	0.06963288534573799	0.2293595038639237	0	0	3.45128266891485	9.196005942413933	APP;CAPNS1;CAPN1
Neurodegenerative Diseases	3/22	0.06963288534573799	0.2293595038639237	0	0	3.45128266891485	9.196005942413933	APP;CAPNS1;CAPN1
Signaling by ERBB2 TMD JMD Mutants	3/22	0.06963288534573799	0.2293595038639237	0	0	3.45128266891485	9.196005942413933	ERBB3;GRB2;EGFR
Metabolism of Lipids	42/758	0.07118655570224547	0.23340621230661052	0	0	1.293102064028368	3.416959233745705	FAAH;PRKAA2;AKR1D1;PRKAG2;AKR1B1;PLA2G6;PTGS2;PTGS1;PIK3C2B;SGPL1;ALOX5;TGS1;OXCT2;CGA;HMGCLL1;MED1;PRKAB2;PLA2G12A;PLA2G2E;PLEKHA1;HBG1;AKR1C1;PLA2G2A;AKR1C3;AKR1C2;AKR1C4;PTGR2;SUMF2;SUMF1;ETNPPL;POMC;SQLE;CYP1A2;ALB;PLIN3;PLIN2;PPARG;THRSP;ANGPTL4;PPARA;MGLL;PPARD
SUMO E3 Ligases SUMOylate Target Proteins	12/170	0.071214665591111	0.23340621230661052	0	0	1.6651788980756568	4.399496738602782	NFKBIA;AR;NSMCE4A;NUP210;MITF;PGR;PPARG;NR3C1;PPARA;TP53;ESR1;NFKB2
Signaling by NOTCH2	4/36	0.07136520879878379	0.23340621230661052	0	0	2.7335337915234823	7.216378318878608	NCSTN;PSEN2;CNTN1;PSEN1
Neurotransmitter Release Cycle	5/51	0.07180689058965346	0.23429947868455	0	0	2.377966693258875	6.263028843062245	SLC32A1;GAD1;SLC1A1;SLC1A2;ABAT
Intracellular Signaling by Second Messengers	20/321	0.07339545556135081	0.23892197477816776	0	0	1.459312986272906	3.8115697510503788	NTRK2;PDPK1;NTRK3;XIAP;GAB2;IL1RAP;FGF1;FGF2;ESR1;EGFR;FGF4;IL1RL1;ERBB3;CD19;AKT1S1;GRB2;PPARG;TP53;MYD88;MAPK3
Signaling by FGFR1	5/52	0.0767230272275279	0.24917057908005558	0	0	2.327249658403279	5.975337752272114	GRB2;FGF1;FGF2;FGF4;MAPK3
Azathioprine ADME	3/23	0.07757127616828757	0.2507536601719063	0	0	3.2785469107551486	8.381795571701366	GMPS;SLC29A1;SLC29A2
RAF-independent MAPK1 3 Activation	3/23	0.07757127616828757	0.2507536601719063	0	0	3.2785469107551486	8.381795571701366	IL6;IL6R;MAPK3
Activated NTRK2 Signals Through FRS2 and FRS3	2/11	0.0812619080348648	0.2567137549283229	0	0	4.854349206349206	12.184794700973093	NTRK2;GRB2
Androgen Biosynthesis	2/11	0.0812619080348648	0.2567137549283229	0	0	4.854349206349206	12.184794700973093	POMC;CGA
Attachment and Entry 9678110	2/11	0.0812619080348648	0.2567137549283229	0	0	4.854349206349206	12.184794700973093	ACE2;CTSL
Constitutive Signaling by Overexpressed ERBB2	2/11	0.0812619080348648	0.2567137549283229	0	0	4.854349206349206	12.184794700973093	GRB2;PTPN12
Dermatan Sulfate Biosynthesis	2/11	0.0812619080348648	0.2567137549283229	0	0	4.854349206349206	12.184794700973093	VCAN;NCAN
Formation of Apoptosome	2/11	0.0812619080348648	0.2567137549283229	0	0	4.854349206349206	12.184794700973093	XIAP;MAPK3
Interleukin-6 Signaling	2/11	0.0812619080348648	0.2567137549283229	0	0	4.854349206349206	12.184794700973093	IL6;IL6R
NFE2L2 Regulating Tumorigenic Genes	2/11	0.0812619080348648	0.2567137549283229	0	0	4.854349206349206	12.184794700973093	BCL2;BCL2L1
RHO GTPases Activate KTN1	2/11	0.0812619080348648	0.2567137549283229	0	0	4.854349206349206	12.184794700973093	KLC3;KLC2
Regulation of the Apoptosome Activity	2/11	0.0812619080348648	0.2567137549283229	0	0	4.854349206349206	12.184794700973093	XIAP;MAPK3
SARS-CoV-2 Activates Modulates Innate and Adaptive Immune Responses	10/138	0.0821154143568197	0.25879210651692924	0	0	1.711631343713956	4.278444249766408	IKBKB;NUP210;HLA-B;HLA-C;NLRP3;MASP2;HLA-A;HLA-F;HLA-G;HLA-E
SLC-mediated Transmembrane Transport	16/249	0.0822921662449516	0.25879210651692924	0	0	1.5065823251733437	3.7626582630518968	SLC12A2;SLC35A1;SLC22A6;SLC15A1;SLC32A1;SLC1A1;SLC1A2;SLC1A4;SLC6A2;SLC2A6;SLC6A3;SLC2A9;SLC25A18;SLC29A1;SLC36A4;SLC29A2
DDX58 IFIH1-mediated Induction of Interferon-Alpha Beta	7/86	0.08315657241951656	0.2609201707971287	0	0	1.9395896988214754	4.823817833710488	IKBKB;NFKBIA;APP;CYLD;NFKB1;ATG5;NFKB2
Cell-Cell Communication	11/157	0.08498547480203278	0.26605813057393146	0	0	1.6510092062387294	4.0701915917620335	ITGB1;CLDN22;CDH5;SFTPA2;GRB2;CLDN17;ITGA6;RSU1;ANGPTL4;CD47;SFTPA1
Estrogen-dependent Nuclear Events Downstream of ESR-membrane Signaling	3/24	0.08588532160278935	0.2676695000625049	0	0	3.1222621771820855	7.664349170170459	BCL2;EGFR;MAPK3
RHO GTPases Activate NADPH Oxidases	3/24	0.08588532160278935	0.2676695000625049	0	0	3.1222621771820855	7.664349170170459	MAPK11;MAPK14;MAPK3
SUMOylation	12/176	0.08694793754050346	0.26996315173582697	0	0	1.603750176230086	3.9170728156691164	NFKBIA;AR;NSMCE4A;NUP210;MITF;PGR;PPARG;NR3C1;PPARA;TP53;ESR1;NFKB2
CLEC7A (Dectin-1) Signaling	7/87	0.08720392455351533	0.26996315173582697	0	0	1.9152442528735631	4.672249736668952	IKBKB;NFKBIA;PDPK1;IL1B;NFKB1;SKP1;NFKB2
Nuclear Events Mediated by NFE2L2	7/87	0.08720392455351533	0.26996315173582697	0	0	1.9152442528735631	4.672249736668952	GCLC;PRKAA2;BCL2;NFKB1;SKP1;RBX1;BCL2L1
Signaling by ERBB2 KD Mutants	3/25	0.09455836117932316	0.2882418831833233	0	0	2.9801851466611193	7.028880083781888	ERBB3;GRB2;EGFR
Binding and Entry of HIV Virion	2/12	0.09476729540631565	0.2882418831833233	0	0	4.368685714285714	10.294069203902625	CD4;CXCR4
Frs2-mediated Activation	2/12	0.09476729540631565	0.2882418831833233	0	0	4.368685714285714	10.294069203902625	NTRK1;MAPK3
Lysine Catabolism	2/12	0.09476729540631565	0.2882418831833233	0	0	4.368685714285714	10.294069203902625	PHYKPL;AASS
PECAM1 Interactions	2/12	0.09476729540631565	0.2882418831833233	0	0	4.368685714285714	10.294069203902625	ITGB3;ITGAV
Peptide Hormone Biosynthesis	2/12	0.09476729540631565	0.2882418831833233	0	0	4.368685714285714	10.294069203902625	POMC;CGA
SUMOylation of Immune Response Proteins	2/12	0.09476729540631565	0.2882418831833233	0	0	4.368685714285714	10.294069203902625	NFKBIA;NFKB2
Transport of Nucleosides and Free Purine and Pyrimidine Bases Across the Plasma Membrane	2/12	0.09476729540631565	0.2882418831833233	0	0	4.368685714285714	10.294069203902625	SLC29A1;SLC29A2
Signaling by NOTCH4	6/72	0.09558606689151736	0.29009745191967057	0	0	1.9890408099363324	4.66972722701001	NCSTN;PSEN2;TACC3;PSEN1;SKP1;RBX1
Class C 3 (Metabotropic Glutamate Pheromone Receptors)	4/40	0.09682378914728208	0.2932136534089806	0	0	2.429298714522082	5.6720786137446515	GPRC6A;GABBR2;GABBR1;TAS1R2
Transport of Inorganic Cations Anions and Amino Acids Oligopeptides	8/107	0.09793218664614244	0.2959255205176913	0	0	1.7690367425695388	4.110321513329165	SLC12A2;SLC15A1;SLC25A18;SLC32A1;SLC1A1;SLC1A2;SLC1A4;SLC36A4
Class I MHC Mediated Antigen Processing & Presentation	22/373	0.09825528248558277	0.29625779317778755	0	0	1.3761316872427984	3.192881838087893	FGB;FGA;HSPA5;ITGB5;FGG;HLA-B;HLA-C;LY96;HLA-A;CTSV;HLA-F;HLA-G;CTSS;FBXO41;HLA-E;ANAPC11;RBX1;IKBKB;CTSL;ITGAV;MYD88;SKP1
SARS-CoV-2-host Interactions	14/218	0.09950512751753617	0.2993768988081716	0	0	1.504475950287415	3.4716476166030175	NUP210;PDPK1;HLA-B;HLA-C;HLA-A;HLA-F;HLA-G;HLA-E;IKBKB;GJA1;RPS28;RPS19;NLRP3;MASP2
TNFR1-induced Proapoptotic Signaling	3/26	0.10357309430308241	0.31086546029770296	0	0	2.8504626405332805	6.463360444687388	CYLD;XIAP;TNF
Transcriptional Regulation by VENTX	4/41	0.103770916243262	0.31086546029770296	0	0	2.3635181573325905	5.354714739397816	IL6;TP53;NFKB1;ANAPC11
Signaling by NOTCH1	6/74	0.10556571903246607	0.3155620418389846	0	0	1.9303370027689606	4.340211394523106	NCSTN;PSEN2;CNTN1;PSEN1;SKP1;RBX1
Advanced Glycosylation Endproduct Receptor Signaling	2/13	0.1088554854513916	0.32012647623271484	0	0	3.9713246753246754	8.807342146612372	APP;MAPK3
Cytochrome C-Mediated Apoptotic Response	2/13	0.1088554854513916	0.32012647623271484	0	0	3.9713246753246754	8.807342146612372	XIAP;MAPK3
ERBB2 Activates PTK6 Signaling	2/13	0.1088554854513916	0.32012647623271484	0	0	3.9713246753246754	8.807342146612372	ERBB3;EGFR
FGFRL1 Modulation of FGFR1 Signaling	2/13	0.1088554854513916	0.32012647623271484	0	0	3.9713246753246754	8.807342146612372	FGF2;FGF4
GRB2 Events in EGFR Signaling	2/13	0.1088554854513916	0.32012647623271484	0	0	3.9713246753246754	8.807342146612372	GRB2;EGFR
Hormone Ligand-Binding Receptors	2/13	0.1088554854513916	0.32012647623271484	0	0	3.9713246753246754	8.807342146612372	GNRH1;CGA
The Activation of Arylsulfatases	2/13	0.1088554854513916	0.32012647623271484	0	0	3.9713246753246754	8.807342146612372	SUMF2;SUMF1
Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants	5/58	0.10985635191583092	0.32012647623271484	0	0	2.0631383070797993	4.556609423518683	NCSTN;PSEN2;PSEN1;SKP1;RBX1
Constitutive Signaling by NOTCH1 PEST Domain Mutants	5/58	0.10985635191583092	0.32012647623271484	0	0	2.0631383070797993	4.556609423518683	NCSTN;PSEN2;PSEN1;SKP1;RBX1
Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer	5/58	0.10985635191583092	0.32012647623271484	0	0	2.0631383070797993	4.556609423518683	NCSTN;PSEN2;PSEN1;SKP1;RBX1
Signaling by NOTCH1 PEST Domain Mutants in Cancer	5/58	0.10985635191583092	0.32012647623271484	0	0	2.0631383070797993	4.556609423518683	NCSTN;PSEN2;PSEN1;SKP1;RBX1
Signaling by NOTCH1 in Cancer	5/58	0.10985635191583092	0.32012647623271484	0	0	2.0631383070797993	4.556609423518683	NCSTN;PSEN2;PSEN1;SKP1;RBX1
Interferon Signaling	17/280	0.11056394994093557	0.32151441510021017	0	0	1.4175435493854451	3.1216593937423878	VCAM1;NUP210;HLA-B;HLA-C;HLA-A;HLA-F;HLA-G;TARBP2;ICAM1;HLA-E;IKBKB;APITD1;PRKRA;TUBB1;TP53;CD44;MAPK3
TNF Signaling	5/59	0.11596007869351938	0.3365021072734696	0	0	2.0248258579680596	4.3625061343858595	IKBKB;CYLD;SPPL2B;XIAP;TNF
Activation of Gene Expression by SREBF (SREBP)	4/43	0.11832009493663882	0.3419229354717837	0	0	2.2420771286750667	4.785403458189263	MED1;SQLE;TGS1;PPARA
Signaling by FGFR2 in Disease	4/43	0.11832009493663882	0.3419229354717837	0	0	2.2420771286750667	4.785403458189263	GRB2;FGF1;FGF2;FGF4
Sensory Processing of Sound	6/77	0.1215002595725236	0.3480625908245146	0	0	1.8484823984088226	3.8963030680002864	KCNMA1;CHRNA9;CACNA2D2;KCNQ4;CHRNA10;CACNA1D
BMAL1 CLOCK,NPAS2 Activates Circadian Gene Expression	3/28	0.12255611192358327	0.3480625908245146	0	0	2.622151029748284	5.504383511240726	MED1;TGS1;PPARA
FLT3 Signaling in Disease	3/28	0.12255611192358327	0.3480625908245146	0	0	2.622151029748284	5.504383511240726	GRB2;GAB2;BCL2L1
CS DS Degradation	2/14	0.1234495376089825	0.3480625908245146	0	0	3.640190476190476	7.6149974854145945	VCAN;NCAN
Erythropoietin Activates RAS	2/14	0.1234495376089825	0.3480625908245146	0	0	3.640190476190476	7.6149974854145945	EPO;GRB2
Heme Biosynthesis	2/14	0.1234495376089825	0.3480625908245146	0	0	3.640190476190476	7.6149974854145945	COX15;ALB
Interleukin-15 Signaling	2/14	0.1234495376089825	0.3480625908245146	0	0	3.640190476190476	7.6149974854145945	GRB2;GAB2
Physiological Factors	2/14	0.1234495376089825	0.3480625908245146	0	0	3.640190476190476	7.6149974854145945	MME;CES1
Prolonged ERK Activation Events	2/14	0.1234495376089825	0.3480625908245146	0	0	3.640190476190476	7.6149974854145945	NTRK1;MAPK3
SHC1 Events in EGFR Signaling	2/14	0.1234495376089825	0.3480625908245146	0	0	3.640190476190476	7.6149974854145945	GRB2;EGFR
TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest	2/14	0.1234495376089825	0.3480625908245146	0	0	3.640190476190476	7.6149974854145945	TP53;E2F8
Tryptophan Catabolism	2/14	0.1234495376089825	0.3480625908245146	0	0	3.640190476190476	7.6149974854145945	KMO;SLC36A4
Interleukin-2 Family Signaling	4/44	0.1259080405337443	0.35355995220586783	0	0	2.185910652920962	4.529651652170243	CSF2RB;GRB2;GAB2;CSF2RA
Retinoid Metabolism and Transport	4/44	0.1259080405337443	0.35355995220586783	0	0	2.185910652920962	4.529651652170243	AKR1B10;AKR1C1;AKR1C3;AKR1C4
Interferon Alpha Beta Signaling	6/78	0.1270613334053263	0.3560791399867007	0	0	1.8227133562954458	3.7604132570757796	HLA-B;HLA-C;HLA-A;HLA-F;HLA-G;HLA-E
Creation of C4 and C2 Activators	7/96	0.12847634666968935	0.3593201647301171	0	0	1.7207542296267597	3.531005685510049	FCN1;FCN2;COLEC11;FCN3;COLEC10;MASP2;C1QC
Downregulation of ERBB2 Signaling	3/29	0.13248785635893778	0.36851274141317886	0	0	2.5211670480549198	5.095944918006224	ERBB3;PTPN12;EGFR
EPHA-mediated Growth Cone Collapse	3/29	0.13248785635893778	0.36851274141317886	0	0	2.5211670480549198	5.095944918006224	EPHA4;EPHA8;EPHA3
Signaling by NTRK1 (TRKA)	8/115	0.13255854007668305	0.36851274141317886	0	0	1.636084015357646	3.306085556285448	NTRK1;RPS6KA3;NTRK2;MAPK11;GRB2;MAPK14;MAPK3;MAPK13
Constitutive Signaling by EGFRvIII	2/15	0.13847812493420694	0.3813400470608416	0	0	3.36	6.642864172702178	GRB2;EGFR
ERBB2 Regulates Cell Motility	2/15	0.13847812493420694	0.3813400470608416	0	0	3.36	6.642864172702178	ERBB3;EGFR
Phase 2 - Plateau Phase	2/15	0.13847812493420694	0.3813400470608416	0	0	3.36	6.642864172702178	CACNB1;CACNA2D2
Signaling by EGFRvIII in Cancer	2/15	0.13847812493420694	0.3813400470608416	0	0	3.36	6.642864172702178	GRB2;EGFR
PKR-mediated Signaling	6/80	0.13854440558685255	0.3813400470608416	0	0	1.7732646538616688	3.504971763169525	IKBKB;APITD1;PRKRA;TUBB1;TP53;TARBP2
PKMTs Methylate Histone Lysines	4/46	0.14167310915866083	0.38918107061371254	0	0	2.081601483663339	4.0679341526603086	SETD6;SMYD2;NFKB1;NFKB2
Laminin Interactions	3/30	0.14268844284716964	0.3911971115533842	0	0	2.4276633613018053	4.726883295132158	ITGB1;ITGAV;ITGA6
Expression and Translocation of Olfactory Receptors	23/414	0.14629756477311237	0.40030239180044525	0	0	1.2902603664416585	2.4800257289433807	OR2D3;OR5M9;OR5F1;OR6C76;OR10G4;OR10T2;OR4M2;OR4M1;OR4K17;OR10Q1;OR2T12;OR10AD1;OR6S1;OR5T1;OR5H15;OR2T2;OR2W3;OR10V1;OR13F1;OR2A12;OR10G8;OR5A2;OR4C3
SARS-CoV-2 Infection	18/313	0.14708384004227992	0.4016631388187998	0	0	1.3374006037765631	2.5634659699980005	NUP210;PDPK1;HLA-B;HLA-C;HLA-A;HLA-F;HLA-G;HLA-E;IKBKB;ACE2;ANO1;GJA1;RPS28;RPS19;CTSL;NLRP3;MASP2;GOLGA7
Synthesis of Substrates in N-glycan Biosythesis	5/64	0.1487651597077629	0.4054579843015499	0	0	1.852744518737366	3.5301940711058273	SLC35A1;GFPT2;GFPT1;NPL;RENBP
EGFR Downregulation	3/31	0.1531393199298586	0.4121127453393761	0	0	2.3408385093167703	4.392366195808519	GRB2;PTPN12;EGFR
Glutamate Binding, Activation of AMPA Receptors and Synaptic Plasticity	3/31	0.1531393199298586	0.4121127453393761	0	0	2.3408385093167703	4.392366195808519	GRIA1;CACNG2;GRIA4
Trafficking of AMPA Receptors	3/31	0.1531393199298586	0.4121127453393761	0	0	2.3408385093167703	4.392366195808519	GRIA1;CACNG2;GRIA4
Defects of Contact Activation System (CAS) and Kallikrein Kinin System (KKS)	2/16	0.15387519052599727	0.4121127453393761	0	0	3.1198367346938776	5.839128414085483	SERPING1;GP1BA
GRB2 Events in ERBB2 Signaling	2/16	0.15387519052599727	0.4121127453393761	0	0	3.1198367346938776	5.839128414085483	GRB2;EGFR
Platelet Adhesion to Exposed Collagen	2/16	0.15387519052599727	0.4121127453393761	0	0	3.1198367346938776	5.839128414085483	ITGB1;GP1BA
Regulation of BACH1 Activity	2/16	0.15387519052599727	0.4121127453393761	0	0	3.1198367346938776	5.839128414085483	RBX1;SKP1
Signaling by ERBB2 ECD Mutants	2/16	0.15387519052599727	0.4121127453393761	0	0	3.1198367346938776	5.839128414085483	GRB2;EGFR
Spry Regulation of FGF Signaling	2/16	0.15387519052599727	0.4121127453393761	0	0	3.1198367346938776	5.839128414085483	GRB2;MAPK3
Signaling by BRAF and RAF1 Fusions	5/65	0.15575479813981336	0.4163445565660395	0	0	1.821769877675841	3.38753065204488	FGB;FGA;ITGB3;FGG;MAPK3
Factors Involved in Megakaryocyte Development and Platelet Production	10/158	0.15681385733081996	0.41837094374249467	0	0	1.4787711587019545	2.739713113611226	KLC3;KLC2;HBG2;HBG1;TUBB1;HBE1;HBB;CABLES1;HBD;TP53
Interleukin-3, Interleukin-5 and GM-CSF Signaling	4/48	0.15817084424294933	0.4203775783894829	0	0	1.9867749661564094	3.6637710606151566	CSF2RB;GRB2;GAB2;CSF2RA
Metabolism of Fat-Soluble Vitamins	4/48	0.15817084424294933	0.4203775783894829	0	0	1.9867749661564094	3.6637710606151566	AKR1B10;AKR1C1;AKR1C3;AKR1C4
Organelle Biogenesis and Maintenance	17/297	0.15969822460035332	0.4236269698368151	0	0	1.3302782392026578	2.4403546447040725	MED1;PRKAB2;PRKAA2;ODF2;PRKAG1;PRKAG2;MAPK14;PRKAB1;PRKAG3;AHI1;IFT52;MAPK11;GLUD2;TGS1;TUBB1;PPARA;RAB11FIP3
Metabolism of Vitamins and Cofactors	12/198	0.16153133694386354	0.42767344447994343	0	0	1.4124184225247063	2.5749180468370048	BTD;AKR1B10;VNN2;CTRB2;AKR1C1;CTRB1;FPGS;AKR1C3;AKR1C4;NADSYN1;PTGS2;COQ6
Epigenetic Regulation of Adipogenesis Genes by MLL3 and MLL4 Complexes	7/103	0.1662214292405535	0.4371259127964879	0	0	1.5946958812260537	2.861577255898637	MED1;ADIPOQ;PLIN2;PPARG;THRSP;ANGPTL4;MGLL
Epigenetic Regulation of Gene Expression by MLL3 and MLL4 Complexes	7/103	0.1662214292405535	0.4371259127964879	0	0	1.5946958812260537	2.861577255898637	MED1;ADIPOQ;PLIN2;PPARG;THRSP;ANGPTL4;MGLL
MLL4 and MLL3 Complexes Regulate Expression of PPARG Targets in Adipogenesis and Hepatic Steatosis	7/103	0.1662214292405535	0.4371259127964879	0	0	1.5946958812260537	2.861577255898637	MED1;ADIPOQ;PLIN2;PPARG;THRSP;ANGPTL4;MGLL
Signaling by TGFBR3	4/49	0.16667390919578315	0.4371259127964879	0	0	1.9425225913198423	3.4804488363622146	NCSTN;PSEN2;PSEN1;FGF2
TP53 Regulates Transcription of Cell Cycle Genes	4/49	0.16667390919578315	0.4371259127964879	0	0	1.9425225913198423	3.4804488363622146	BTG2;E2F4;TP53;E2F8
Olfactory Signaling Pathway	23/422	0.16745782803270248	0.43835476641328897	0	0	1.2638504927423946	2.2585308246807783	OR2D3;OR5M9;OR5F1;OR6C76;OR10G4;OR10T2;OR4M2;OR4M1;OR4K17;OR10Q1;OR2T12;OR10AD1;OR6S1;OR5T1;OR5H15;OR2T2;OR2W3;OR10V1;OR13F1;OR2A12;OR10G8;OR5A2;OR4C3
Aberrant Regulation of Mitotic G1 S Transition in Cancer Due to RB1 Defects	2/17	0.16957962345748226	0.4389491184467418	0	0	2.911695238095238	5.166607264895316	E2F2;E2F3
Defective Binding of RB1 Mutants to E2F1,(E2F2, E2F3)	2/17	0.16957962345748226	0.4389491184467418	0	0	2.911695238095238	5.166607264895316	E2F2;E2F3
GAB1 Signalosome	2/17	0.16957962345748226	0.4389491184467418	0	0	2.911695238095238	5.166607264895316	GRB2;EGFR
KSRP (KHSRP) Binds and Destabilizes mRNA	2/17	0.16957962345748226	0.4389491184467418	0	0	2.911695238095238	5.166607264895316	MAPK11;MAPK14
Signaling by NTRK3 (TRKC)	2/17	0.16957962345748226	0.4389491184467418	0	0	2.911695238095238	5.166607264895316	NTRK3;GRB2
Trafficking of GluR2-containing AMPA Receptors	2/17	0.16957962345748226	0.4389491184467418	0	0	2.911695238095238	5.166607264895316	GRIA1;GRIA4
Initial Triggering of Complement	7/104	0.17197927105735147	0.44433306091025754	0	0	1.5781727692854604	2.7781858731038485	FCN1;FCN2;COLEC11;FCN3;COLEC10;MASP2;C1QC
FGFR2 Mutant Receptor Activation	3/33	0.17471808568220681	0.4489059872426386	0	0	2.1845537757437072	3.811132196798427	FGF1;FGF2;FGF4
Glucagon-type Ligand Receptors	3/33	0.17471808568220681	0.4489059872426386	0	0	2.1845537757437072	3.811132196798427	VIPR2;GCGR;GNAS
PERK Regulates Gene Expression	3/33	0.17471808568220681	0.4489059872426386	0	0	2.1845537757437072	3.811132196798427	CXCL8;HSPA5;ASNS
Signaling by ERBB2	4/50	0.17533518652261415	0.44966034920006215	0	0	1.900194232780517	3.3083441624570264	ERBB3;GRB2;PTPN12;EGFR
Programmed Cell Death	12/202	0.1778016747083491	0.4551460917948531	0	0	1.3823912382111347	2.3875092962286093	C1QBP;IL1B;BCL2;XIAP;LY96;TNFRSF10A;TP53;TP63;ELANE;TP73;BCL2L1;MAPK3
Transcriptional Regulation by RUNX2	7/106	0.1837487430837106	0.46950506045286344	0	0	1.546127946127946	2.619428291584916	AR;ITGA5;NR3C1;ESR1;SKP1;RBX1;MAPK3
Potential Therapeutics for SARS	10/164	0.18422796279918824	0.46986581337774613	0	0	1.4207073203612997	2.4032420210747905	ITGB1;ACE2;ITGA4;IL1R1;FXYD3;SIGMAR1;GRB2;NR3C1;IL6R;RBX1
Caspase Activation via Death Receptors in the Presence of Ligand	2/18	0.18553495278922608	0.47044648469989303	0	0	2.7295714285714285	4.59799579883877	LY96;TNFRSF10A
Cell-extracellular Matrix Interactions	2/18	0.18553495278922608	0.47044648469989303	0	0	2.7295714285714285	4.59799579883877	ITGB1;RSU1
TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest	2/18	0.18553495278922608	0.47044648469989303	0	0	2.7295714285714285	4.59799579883877	E2F4;TP53
Citric Acid Cycle (TCA Cycle)	3/34	0.1858094389210369	0.47044648469989303	0	0	2.1139735734849046	3.5578886644174683	SUCLA2;SUCLG2;SUCLG1
Circadian Clock	5/70	0.192595409573656	0.4799740267376268	0	0	1.6811926605504588	2.7691993784001108	MED1;TGS1;NR3C1;PPARA;SKP1
Nuclear Events Stimulated by ALK Signaling in Cancer	3/35	0.19707813995666248	0.4799740267376268	0	0	2.047804633867277	3.3259520928572845	MAPK3;SKP1;RBX1
Activation of NOXA and Translocation to Mitochondria	1/5	0.2008645309373201	0.4799740267376268	0	0	5.4563356164383565	8.7580983796604	TP53
Biosynthesis of E-series 18(S)-resolvins	1/5	0.2008645309373201	0.4799740267376268	0	0	5.4563356164383565	8.7580983796604	ALOX5
Ciprofloxacin ADME	1/5	0.2008645309373201	0.4799740267376268	0	0	5.4563356164383565	8.7580983796604	ALB
Dopamine Receptors	1/5	0.2008645309373201	0.4799740267376268	0	0	5.4563356164383565	8.7580983796604	DRD2
Formation of Xylulose-5-Phosphate	1/5	0.2008645309373201	0.4799740267376268	0	0	5.4563356164383565	8.7580983796604	AKR1A1
G2 Phase	1/5	0.2008645309373201	0.4799740267376268	0	0	5.4563356164383565	8.7580983796604	E2F3
GRB7 Events in ERBB2 Signaling	1/5	0.2008645309373201	0.4799740267376268	0	0	5.4563356164383565	8.7580983796604	ERBB3
IRAK4 Deficiency (TLR5)	1/5	0.2008645309373201	0.4799740267376268	0	0	5.4563356164383565	8.7580983796604	MYD88
IRF3 Mediated Activation of Type 1 IFN	1/5	0.2008645309373201	0.4799740267376268	0	0	5.4563356164383565	8.7580983796604	NLRP4
LRR FLII-interacting Protein 1 (LRRFIP1) Activates Type I IFN Production	1/5	0.2008645309373201	0.4799740267376268	0	0	5.4563356164383565	8.7580983796604	LRRFIP1
MECP2 Regulates Transcription Factors	1/5	0.2008645309373201	0.4799740267376268	0	0	5.4563356164383565	8.7580983796604	PPARG
MET Activates PTPN11	1/5	0.2008645309373201	0.4799740267376268	0	0	5.4563356164383565	8.7580983796604	GRB2
MET Interacts With TNS Proteins	1/5	0.2008645309373201	0.4799740267376268	0	0	5.4563356164383565	8.7580983796604	ITGB1
NTRK2 Activates RAC1	1/5	0.2008645309373201	0.4799740267376268	0	0	5.4563356164383565	8.7580983796604	NTRK2
Organic Anion Transport	1/5	0.2008645309373201	0.4799740267376268	0	0	5.4563356164383565	8.7580983796604	SLC22A6
PTK6 Expression	1/5	0.2008645309373201	0.4799740267376268	0	0	5.4563356164383565	8.7580983796604	NR3C1
Regulation of HMOX1 Expression and Activity	1/5	0.2008645309373201	0.4799740267376268	0	0	5.4563356164383565	8.7580983796604	HM13
Regulation of NPAS4 Gene Transcription	1/5	0.2008645309373201	0.4799740267376268	0	0	5.4563356164383565	8.7580983796604	NR3C1
Signaling by MST1	1/5	0.2008645309373201	0.4799740267376268	0	0	5.4563356164383565	8.7580983796604	MST1
Signalling to P38 via RIT and RIN	1/5	0.2008645309373201	0.4799740267376268	0	0	5.4563356164383565	8.7580983796604	NTRK1
Tachykinin Receptors Bind Tachykinins	1/5	0.2008645309373201	0.4799740267376268	0	0	5.4563356164383565	8.7580983796604	TACR3
Aflatoxin Activation and Detoxification	2/19	0.20168905889280137	0.4799740267376268	0	0	2.568873949579832	4.11283932713285	ACY3;CYP1A2
Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants	2/19	0.20168905889280137	0.4799740267376268	0	0	2.568873949579832	4.11283932713285	GRB2;EGFR
Diseases of Hemostasis	2/19	0.20168905889280137	0.4799740267376268	0	0	2.568873949579832	4.11283932713285	SERPING1;GP1BA
Glyoxylate Metabolism and Glycine Degradation	2/19	0.20168905889280137	0.4799740267376268	0	0	2.568873949579832	4.11283932713285	GCSH;AGXT2
Microtubule-dependent Trafficking of Connexons From Golgi to the Plasma Membrane	2/19	0.20168905889280137	0.4799740267376268	0	0	2.568873949579832	4.11283932713285	GJA1;TUBB1
Na+ Cl- Dependent Neurotransmitter Transporters	2/19	0.20168905889280137	0.4799740267376268	0	0	2.568873949579832	4.11283932713285	SLC6A2;SLC6A3
Regulation of MITF-M-dependent Genes Involved in Apoptosis	2/19	0.20168905889280137	0.4799740267376268	0	0	2.568873949579832	4.11283932713285	BCL2;MITF
Regulation of TP53 Activity Through Methylation	2/19	0.20168905889280137	0.4799740267376268	0	0	2.568873949579832	4.11283932713285	SMYD2;TP53
Signaling by FGFR2 IIIa TM	2/19	0.20168905889280137	0.4799740267376268	0	0	2.568873949579832	4.11283932713285	FGF1;FGF2
Signaling by FLT3 Fusion Proteins	2/19	0.20168905889280137	0.4799740267376268	0	0	2.568873949579832	4.11283932713285	GRB2;GAB2
Signaling by Ligand-Responsive EGFR Variants in Cancer	2/19	0.20168905889280137	0.4799740267376268	0	0	2.568873949579832	4.11283932713285	GRB2;EGFR
Synthesis, Secretion, and Deacylation of Ghrelin	2/19	0.20168905889280137	0.4799740267376268	0	0	2.568873949579832	4.11283932713285	LEP;CRHR2
Drug ADME	7/109	0.20200345729605157	0.4799740267376268	0	0	1.5004169483885508	2.3998725962341148	GSTP1;AKR1C1;ALB;GMPS;SLC29A1;CES1;SLC29A2
Collagen Formation	6/90	0.20247143145350913	0.4802649995228288	0	0	1.5613416434311957	2.4937069258451046	CTSL;PXDN;ITGA6;CTSV;CTSS;CTSB
Apoptosis	10/168	0.20363065070244457	0.4821918304538295	0	0	1.3844480457857007	2.2032763286135313	C1QBP;BCL2;LY96;XIAP;TNFRSF10A;TP53;TP63;BCL2L1;TP73;MAPK3
Aberrant Regulation of Mitotic Cell Cycle Due to RB1 Defects	3/36	0.20850659025260523	0.49039621057719335	0	0	1.985645933014354	3.113065175030642	E2F2;E2F3;ANAPC11
Metabolism of Steroid Hormones	3/36	0.20850659025260523	0.49039621057719335	0	0	1.985645933014354	3.113065175030642	POMC;AKR1B1;CGA
ROS and RNS Production in Phagocytes	3/36	0.20850659025260523	0.49039621057719335	0	0	1.985645933014354	3.113065175030642	ATP6V0A2;LPO;MPO
Transcriptional Regulation by the AP-2 (TFAP2) Family of Transcription Factors	3/36	0.20850659025260523	0.49039621057719335	0	0	1.985645933014354	3.113065175030642	CGA;ESR1;EGFR
Downstream TCR Signaling	6/91	0.20938809776895143	0.49163759442372035	0	0	1.5428918754643075	2.4124130032875164	IKBKB;NFKBIA;CD4;PDPK1;NFKB1;SKP1
Activation of NF-kappaB in B Cells	4/54	0.21139014419137186	0.49550134979090543	0	0	1.747812142038946	2.7161871591386078	IKBKB;NFKBIA;NFKB1;SKP1
Chondroitin Sulfate Biosynthesis	2/20	0.21799390113037376	0.5041789061085183	0	0	2.426031746031746	3.695545514696023	VCAN;NCAN
Defective B3GALT6 Causes EDSP2 and SEMDJL1	2/20	0.21799390113037376	0.5041789061085183	0	0	2.426031746031746	3.695545514696023	VCAN;NCAN
Defective B3GAT3 Causes JDSSDHD	2/20	0.21799390113037376	0.5041789061085183	0	0	2.426031746031746	3.695545514696023	VCAN;NCAN
Defective B4GALT7 Causes EDS, Progeroid Type	2/20	0.21799390113037376	0.5041789061085183	0	0	2.426031746031746	3.695545514696023	VCAN;NCAN
Induction of Cell-Cell Fusion	2/20	0.21799390113037376	0.5041789061085183	0	0	2.426031746031746	3.695545514696023	ACE2;ANO1
Receptor-type Tyrosine-Protein Phosphatases	2/20	0.21799390113037376	0.5041789061085183	0	0	2.426031746031746	3.695545514696023	NTRK3;IL1RAP
SUMOylation of Transcription Factors	2/20	0.21799390113037376	0.5041789061085183	0	0	2.426031746031746	3.695545514696023	MITF;TP53
Transport of Connexons to the Plasma Membrane	2/20	0.21799390113037376	0.5041789061085183	0	0	2.426031746031746	3.695545514696023	GJA1;TUBB1
Sensory Processing of Sound by Outer Hair Cells of the Cochlea	4/55	0.22071293134668993	0.5075717206256265	0	0	1.713451474518788	2.5888407678133505	KCNMA1;CHRNA9;KCNQ4;CHRNA10
Signaling by Non-Receptor Tyrosine Kinases	4/55	0.22071293134668993	0.5075717206256265	0	0	1.713451474518788	2.5888407678133505	ERBB3;NR3C1;EGFR;BCAR1
Signaling by PTK6	4/55	0.22071293134668993	0.5075717206256265	0	0	1.713451474518788	2.5888407678133505	ERBB3;NR3C1;EGFR;BCAR1
SARS-CoV-1-host Interactions	7/112	0.22092150430108207	0.5075717206256265	0	0	1.4573180076628351	2.2004741555888123	NFKBIA;RPS28;RPS19;PDPK1;NLRP3;NFKB1;BCL2L1
Post-translational Modification Synthesis of GPI-anchored Proteins	6/93	0.2234637369160805	0.5091961442791966	0	0	1.5072647373213508	2.258645446942893	OTOA;VNN2;RAET1G;LYPD6B;CNTN3;CNTN4
TCR Signaling	7/113	0.22736330197658197	0.5091961442791966	0	0	1.4434938191281719	2.138111838106624	NFKBIA;IKBKB;CD4;PDPK1;PTPRJ;NFKB1;SKP1
HSP90 Chaperone Cycle for Steroid Hormone Receptors (SHR) in the Presence of Ligand	4/56	0.23014196806170925	0.5091961442791966	0	0	1.6804123711340206	2.468624762992802	AR;TUBB1;PGR;NR3C1
Regulation of Cholesterol Biosynthesis by SREBP (SREBF)	4/56	0.23014196806170925	0.5091961442791966	0	0	1.6804123711340206	2.468624762992802	MED1;SQLE;TGS1;PPARA
Transcriptional Activation of Mitochondrial Biogenesis	4/56	0.23014196806170925	0.5091961442791966	0	0	1.6804123711340206	2.468624762992802	MED1;GLUD2;TGS1;PPARA
Oxidative Stress Induced Senescence	6/94	0.23061563454235937	0.5091961442791966	0	0	1.4900584490136728	2.185920027194121	MAPK11;E2F2;E2F3;MAPK14;TP53;MAPK3
Diseases of Mitotic Cell Cycle	3/38	0.23177416808861634	0.5091961442791966	0	0	1.871984308597581	2.7368256991667663	E2F2;E2F3;ANAPC11
FLT3 Signaling	3/38	0.23177416808861634	0.5091961442791966	0	0	1.871984308597581	2.7368256991667663	PTPRJ;GRB2;GAB2
Extra-nuclear Estrogen Signaling	5/75	0.23213251384752057	0.5091961442791966	0	0	1.5606979030144168	2.2793163986869365	PDPK1;BCL2;ESR1;EGFR;MAPK3
Signaling by FGFR2	5/75	0.23213251384752057	0.5091961442791966	0	0	1.5606979030144168	2.2793163986869365	GRB2;FGF1;FGF2;FGF4;MAPK3
Branched-chain Amino Acid Catabolism	2/21	0.23440526113353885	0.5091961442791966	0	0	2.2982255639097744	3.33404450463398	BCAT1;BCAT2
Interleukin-37 Signaling	2/21	0.23440526113353885	0.5091961442791966	0	0	2.2982255639097744	3.33404450463398	PTPN12;IL18R1
Negative Regulation of MET Activity	2/21	0.23440526113353885	0.5091961442791966	0	0	2.2982255639097744	3.33404450463398	PTPRJ;GRB2
RHO GTPases Activate PAKs	2/21	0.23440526113353885	0.5091961442791966	0	0	2.2982255639097744	3.33404450463398	PPP1R12B;MYLK
Regulation of FZD by Ubiquitination	2/21	0.23440526113353885	0.5091961442791966	0	0	2.2982255639097744	3.33404450463398	RSPO3;RSPO4
TP53 Regulates Transcription of Additional Cell Cycle Genes With Uncertain Roles in the P53 Pathway	2/21	0.23440526113353885	0.5091961442791966	0	0	2.2982255639097744	3.33404450463398	BTG2;TP53
p75NTR Negatively Regulates Cell Cycle via SC1	1/6	0.23591533591064934	0.5091961442791966	0	0	4.364840182648402	6.304061350309737	NGFR
Activated NTRK3 Signals Through PI3K	1/6	0.23591533591064934	0.5091961442791966	0	0	4.364840182648402	6.304061350309737	NTRK3
Activation of Caspases Through Apoptosome-Mediated Cleavage	1/6	0.23591533591064934	0.5091961442791966	0	0	4.364840182648402	6.304061350309737	XIAP
Acyl Chain Remodeling of CL	1/6	0.23591533591064934	0.5091961442791966	0	0	4.364840182648402	6.304061350309737	PLA2G6
Biosynthesis of Lipoxins (LX)	1/6	0.23591533591064934	0.5091961442791966	0	0	4.364840182648402	6.304061350309737	ALOX5
Biosynthesis of Maresin-Like SPMs	1/6	0.23591533591064934	0.5091961442791966	0	0	4.364840182648402	6.304061350309737	CYP1A2
Choline Catabolism	1/6	0.23591533591064934	0.5091961442791966	0	0	4.364840182648402	6.304061350309737	BHMT
Defective F9 Activation	1/6	0.23591533591064934	0.5091961442791966	0	0	4.364840182648402	6.304061350309737	GP1BA
Estrogen-stimulated Signaling Through PRKCZ	1/6	0.23591533591064934	0.5091961442791966	0	0	4.364840182648402	6.304061350309737	PDPK1
MET Activates PI3K AKT Signaling	1/6	0.23591533591064934	0.5091961442791966	0	0	4.364840182648402	6.304061350309737	GRB2
Metal Sequestration by Antimicrobial Proteins	1/6	0.23591533591064934	0.5091961442791966	0	0	4.364840182648402	6.304061350309737	LTF
Mineralocorticoid Biosynthesis	1/6	0.23591533591064934	0.5091961442791966	0	0	4.364840182648402	6.304061350309737	CGA
Mtb Iron Assimilation by Chelation	1/6	0.23591533591064934	0.5091961442791966	0	0	4.364840182648402	6.304061350309737	LTF
NADE Modulates Death Signalling	1/6	0.23591533591064934	0.5091961442791966	0	0	4.364840182648402	6.304061350309737	NGFR
Negative Feedback Regulation of MAPK Pathway	1/6	0.23591533591064934	0.5091961442791966	0	0	4.364840182648402	6.304061350309737	MAPK3
RUNX1 Regulates Estrogen Receptor Mediated Transcription	1/6	0.23591533591064934	0.5091961442791966	0	0	4.364840182648402	6.304061350309737	ESR1
RUNX3 Regulates Immune Response and Cell Migration	1/6	0.23591533591064934	0.5091961442791966	0	0	4.364840182648402	6.304061350309737	ITGA4
SARS-CoV-1-mediated Effects on Programmed Cell Death	1/6	0.23591533591064934	0.5091961442791966	0	0	4.364840182648402	6.304061350309737	BCL2L1
SARS-CoV-2 Targets PDZ Proteins in Cell-Cell Junction	1/6	0.23591533591064934	0.5091961442791966	0	0	4.364840182648402	6.304061350309737	GJA1
SLC15A4 TASL-dependent IRF5 Activation	1/6	0.23591533591064934	0.5091961442791966	0	0	4.364840182648402	6.304061350309737	IKBKB
Signaling by LRP5 Mutants	1/6	0.23591533591064934	0.5091961442791966	0	0	4.364840182648402	6.304061350309737	KREMEN2
Synthesis of 15-Eicosatetraenoic Acid Derivatives	1/6	0.23591533591064934	0.5091961442791966	0	0	4.364840182648402	6.304061350309737	PTGS2
TNFR1-mediated Ceramide Production	1/6	0.23591533591064934	0.5091961442791966	0	0	4.364840182648402	6.304061350309737	TNF
Epigenetic Regulation by WDR5-containing Histone Modifying Complexes	8/135	0.2411743057055496	0.5197399766367657	0	0	1.3769832280746264	1.9583942188208505	MED1;ADIPOQ;TASP1;PLIN2;PPARG;THRSP;ANGPTL4;MGLL
Transcriptional Regulation by TP53	19/362	0.24166151580404513	0.5199837569158247	0	0	1.2124610083793756	1.721958011089811	PRKAB2;BTG2;PRKAA1;PRKAA2;PDPK1;IGFBP3;PRKAG1;PRKAG2;TNFRSF10A;MAPK14;PRKAB1;PRKAG3;MAPK11;SMYD2;E2F4;TP53;TP63;TP73;E2F8
Synthesis of PA	3/39	0.243580034508237	0.5233017742912666	0	0	1.81988939740656	2.5702474609905654	PLA2G12A;PLA2G2E;PLA2G2A
Signaling by PDGF	4/58	0.24928435324384524	0.533221216473567	0	0	1.6180051758516822	2.247669774141081	PLAT;GRB2;PTPN12;BCAR1
Cellular Hexose Transport	2/22	0.250882500412743	0.533221216473567	0	0	2.1832	3.018864719997382	SLC2A9;SLC2A6
Cobalamin (Cbl, Vitamin B12) Transport and Metabolism	2/22	0.250882500412743	0.533221216473567	0	0	2.1832	3.018864719997382	CTRB2;CTRB1
Early Phase of HIV Life Cycle	2/22	0.250882500412743	0.533221216473567	0	0	2.1832	3.018864719997382	CD4;CXCR4
Nef-mediates Down Modulation of Cell Surface Receptors by Recruiting Them to Clathrin Adapters	2/22	0.250882500412743	0.533221216473567	0	0	2.1832	3.018864719997382	CD4;HLA-A
RA Biosynthesis Pathway	2/22	0.250882500412743	0.533221216473567	0	0	2.1832	3.018864719997382	AKR1C3;RDH16
The Canonical Retinoid Cycle in Rods (Twilight Vision)	2/22	0.250882500412743	0.533221216473567	0	0	2.1832	3.018864719997382	RDH16;HSD17B6
SARS-CoV-1 Infection	9/157	0.25211573629848544	0.5350242342822821	0	0	1.3293607547639805	1.8316823494850945	NFKBIA;ACE2;RPS28;RPS19;CTSL;PDPK1;NLRP3;NFKB1;BCL2L1
Diseases of Programmed Cell Death	5/78	0.25687849722535266	0.5443004743037199	0	0	1.4963239914540656	2.0337318643237765	APP;CAPNS1;C1QBP;CAPN1;TP53
Regulation of RUNX2 Expression and Activity	4/59	0.25898066414511123	0.5459305154527588	0	0	1.588503592627304	2.1460713334813915	NR3C1;ESR1;SKP1;RBX1
Metabolism of Nucleotides	6/98	0.25989969927713796	0.5459305154527588	0	0	1.4249737932411521	1.9200944669836368	AGXT2;PPAT;GMPS;CTPS2;CTPS1;PAICS
Biosynthesis of the N-glycan Precursor (Dolichol LLO) and Transfer to a Nascent Protein	5/79	0.2652659956712236	0.5459305154527588	0	0	1.4760259112323333	1.9587191507605584	SLC35A1;GFPT2;GFPT1;NPL;RENBP
Cell Junction Organization	7/119	0.2672574334051018	0.5459305154527588	0	0	1.3657327586206895	1.8021429854742168	ITGB1;CLDN22;CDH5;CLDN17;ITGA6;RSU1;ANGPTL4
KEAP1-NFE2L2 Pathway	7/119	0.2672574334051018	0.5459305154527588	0	0	1.3657327586206895	1.8021429854742168	GCLC;PRKAA2;BCL2;NFKB1;SKP1;RBX1;BCL2L1
SLC Transporter Disorders	6/99	0.2673716084446943	0.5459305154527588	0	0	1.4095774230584053	1.8593958448625587	SLC2A9;SLC35A1;NUP210;SLC1A1;SLC6A2;SLC6A3
Visual Phototransduction	6/99	0.2673716084446943	0.5459305154527588	0	0	1.4095774230584053	1.8593958448625587	AKR1B10;AKR1C1;RDH16;AKR1C3;HSD17B6;AKR1C4
Activated TAK1 Mediates P38 MAPK Activation	2/23	0.267388332136999	0.5459305154527588	0	0	2.0791292517006803	2.7424821961220958	MAPK11;MAPK14
IKK Complex Recruitment Mediated by RIP1	2/23	0.267388332136999	0.5459305154527588	0	0	2.0791292517006803	2.7424821961220958	IKBKB;LY96
Signaling by Retinoic Acid	3/41	0.26745615897076175	0.5459305154527588	0	0	1.723925087317837	2.273511746229005	RDH16;AKR1C3;PPARD
ARMS-mediated Activation	1/7	0.2694304558277644	0.5459305154527588	0	0	3.6371765601217656	4.769956907719688	NTRK1
Acyl Chain Remodeling of DAG and TAG	1/7	0.2694304558277644	0.5459305154527588	0	0	3.6371765601217656	4.769956907719688	MGLL
CREB Phosphorylation	1/7	0.2694304558277644	0.5459305154527588	0	0	3.6371765601217656	4.769956907719688	RPS6KA3
Cation-coupled Chloride Cotransporters	1/7	0.2694304558277644	0.5459305154527588	0	0	3.6371765601217656	4.769956907719688	SLC12A2
Defective Binding of VWF Variant to GPIb IX V	1/7	0.2694304558277644	0.5459305154527588	0	0	3.6371765601217656	4.769956907719688	GP1BA
Enhanced Binding of GP1BA Variant to VWF Multimer Collagen	1/7	0.2694304558277644	0.5459305154527588	0	0	3.6371765601217656	4.769956907719688	GP1BA
Erythropoietin Activates Phospholipase C Gamma (PLCG)	1/7	0.2694304558277644	0.5459305154527588	0	0	3.6371765601217656	4.769956907719688	EPO
Erythropoietin Activates STAT5	1/7	0.2694304558277644	0.5459305154527588	0	0	3.6371765601217656	4.769956907719688	EPO
FGFR3b Ligand Binding and Activation	1/7	0.2694304558277644	0.5459305154527588	0	0	3.6371765601217656	4.769956907719688	FGF1
Fructose Metabolism	1/7	0.2694304558277644	0.5459305154527588	0	0	3.6371765601217656	4.769956907719688	AKR1B1
Glycine Degradation	1/7	0.2694304558277644	0.5459305154527588	0	0	3.6371765601217656	4.769956907719688	GCSH
NrCAM Interactions	1/7	0.2694304558277644	0.5459305154527588	0	0	3.6371765601217656	4.769956907719688	CNTN2
PTK6 Promotes HIF1A Stabilization	1/7	0.2694304558277644	0.5459305154527588	0	0	3.6371765601217656	4.769956907719688	EGFR
RUNX3 Regulates CDKN1A Transcription	1/7	0.2694304558277644	0.5459305154527588	0	0	3.6371765601217656	4.769956907719688	TP53
Reversal of Alkylation Damage by DNA Dioxygenases	1/7	0.2694304558277644	0.5459305154527588	0	0	3.6371765601217656	4.769956907719688	ALKBH5
SMAC (DIABLO) Binds to IAPs	1/7	0.2694304558277644	0.5459305154527588	0	0	3.6371765601217656	4.769956907719688	XIAP
SMAC(DIABLO)-mediated Dissociation of IAP Caspase Complexes	1/7	0.2694304558277644	0.5459305154527588	0	0	3.6371765601217656	4.769956907719688	XIAP
SOS-mediated Signalling	1/7	0.2694304558277644	0.5459305154527588	0	0	3.6371765601217656	4.769956907719688	GRB2
Signaling by LTK in Cancer	1/7	0.2694304558277644	0.5459305154527588	0	0	3.6371765601217656	4.769956907719688	MAPK3
TYSND1 Cleaves Peroxisomal Proteins	1/7	0.2694304558277644	0.5459305154527588	0	0	3.6371765601217656	4.769956907719688	TYSND1
Amyloid Fiber Formation	5/80	0.27371410134399177	0.5529979663781228	0	0	1.456269113149847	1.8868458664866787	BACE1;APP;FGA;NCSTN;LTF
G Alpha (12 13) Signalling Events	5/80	0.27371410134399177	0.5529979663781228	0	0	1.456269113149847	1.8868458664866787	NET1;TIAM1;ADRA1D;ADRA1B;ADRA1A
Gamma Carboxylation, Hypusinylation, Hydroxylation, and Arylsulfatase Activation	4/61	0.27858164714353206	0.5612007094630573	0	0	1.53260585599164	1.9587378643638393	ICMT;PROZ;SUMF2;SUMF1
Nuclear Events (Kinase and Transcription Factor Activation)	4/61	0.27858164714353206	0.5612007094630573	0	0	1.53260585599164	1.9587378643638393	RPS6KA3;MAPK11;MAPK14;MAPK3
EPHB-mediated Forward Signaling	3/42	0.27949596729028153	0.5622277779066445	0	0	1.6796338672768878	2.1411425227832983	TIAM1;GRIN2B;GRIN1
G-protein Activation	2/24	0.28388860589094594	0.5661480088786439	0	0	1.9845194805194806	2.498854043502947	POMC;OPRM1
Glutamate Neurotransmitter Release Cycle	2/24	0.28388860589094594	0.5661480088786439	0	0	1.9845194805194806	2.498854043502947	SLC1A1;SLC1A2
Growth Hormone Receptor Signaling	2/24	0.28388860589094594	0.5661480088786439	0	0	1.9845194805194806	2.498854043502947	PRLR;MAPK3
Other Interleukin Signaling	2/24	0.28388860589094594	0.5661480088786439	0	0	1.9845194805194806	2.498854043502947	CD4;PRTN3
RUNX2 Regulates Osteoblast Differentiation	2/24	0.28388860589094594	0.5661480088786439	0	0	1.9845194805194806	2.498854043502947	AR;MAPK3
Triglyceride Catabolism	2/24	0.28388860589094594	0.5661480088786439	0	0	1.9845194805194806	2.498854043502947	PLIN3;MGLL
Oncogenic MAPK Signaling	5/82	0.2907711675560675	0.579042869488444	0	0	1.418295007744549	1.7519044971670317	FGB;FGA;ITGB3;FGG;MAPK3
Transport of Vitamins, Nucleosides, and Related Molecules	3/43	0.29158415703153423	0.579831156328802	0	0	1.6375572082379863	2.0181690812717368	SLC35A1;SLC29A1;SLC29A2
Protein Localization	9/164	0.29322930383482176	0.5822696176148604	0	0	1.2688568455477924	1.5566340464498185	DNAJC19;APP;GRPEL1;PAM16;TYSND1;PXMP4;SLC25A12;TOMM5;SLC25A13
Signaling by EGFR in Cancer	2/25	0.3003521047487544	0.5828277732490137	0	0	1.898136645962733	2.283078397226082	GRB2;EGFR
Signaling by Erythropoietin	2/25	0.3003521047487544	0.5828277732490137	0	0	1.898136645962733	2.283078397226082	EPO;GRB2
DNA Damage Reversal	1/8	0.30147709997556893	0.5828277732490137	0	0	3.117416829745597	3.7379736250846807	ALKBH5
Defects in Biotin (Btn) Metabolism	1/8	0.30147709997556893	0.5828277732490137	0	0	3.117416829745597	3.7379736250846807	BTD
Defects of Platelet Adhesion to Exposed Collagen	1/8	0.30147709997556893	0.5828277732490137	0	0	3.117416829745597	3.7379736250846807	GP1BA
Formation of Intermediate Mesoderm	1/8	0.30147709997556893	0.5828277732490137	0	0	3.117416829745597	3.7379736250846807	FGF2
IFNG Signaling Activates MAPKs	1/8	0.30147709997556893	0.5828277732490137	0	0	3.117416829745597	3.7379736250846807	MAPK3
Inhibition of Signaling by Overexpressed EGFR	1/8	0.30147709997556893	0.5828277732490137	0	0	3.117416829745597	3.7379736250846807	EGFR
Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs IMPs VICKZs) Bind RNA	1/8	0.30147709997556893	0.5828277732490137	0	0	3.117416829745597	3.7379736250846807	CD44
Metabolism of Ingested SeMet, Sec, MeSec Into H2Se	1/8	0.30147709997556893	0.5828277732490137	0	0	3.117416829745597	3.7379736250846807	HNMT
RUNX2 Regulates Genes Involved in Cell Migration	1/8	0.30147709997556893	0.5828277732490137	0	0	3.117416829745597	3.7379736250846807	ITGA5
Regulation of NFE2L2 Gene Expression	1/8	0.30147709997556893	0.5828277732490137	0	0	3.117416829745597	3.7379736250846807	NFKB1
Regulation of Cytoskeletal Remodeling and Cell Spreading by IPP Complex Components	1/8	0.30147709997556893	0.5828277732490137	0	0	3.117416829745597	3.7379736250846807	RSU1
Regulation of Gene Expression in Early Pancreatic Precursor Cells	1/8	0.30147709997556893	0.5828277732490137	0	0	3.117416829745597	3.7379736250846807	NKX6-1
SMAC, XIAP-regulated Apoptotic Response	1/8	0.30147709997556893	0.5828277732490137	0	0	3.117416829745597	3.7379736250846807	XIAP
Signaling by Overexpressed Wild-Type EGFR in Cancer	1/8	0.30147709997556893	0.5828277732490137	0	0	3.117416829745597	3.7379736250846807	EGFR
Synthesis of Ketone Bodies	1/8	0.30147709997556893	0.5828277732490137	0	0	3.117416829745597	3.7379736250846807	HMGCLL1
Synthesis of Epoxy (EET) and Dihydroxyeicosatrienoic Acids (DHET)	1/8	0.30147709997556893	0.5828277732490137	0	0	3.117416829745597	3.7379736250846807	CYP1A2
TRAIL Signaling	1/8	0.30147709997556893	0.5828277732490137	0	0	3.117416829745597	3.7379736250846807	TNFRSF10A
Negative Regulation of NOTCH4 Signaling	3/44	0.3037067987346522	0.5855096397242254	0	0	1.5975330691522018	1.9037682102880524	TACC3;SKP1;RBX1
Smooth Muscle Contraction	3/44	0.3037067987346522	0.5855096397242254	0	0	1.5975330691522018	1.9037682102880524	ANXA1;ITGB5;MYLK
Cargo Recognition for Clathrin-Mediated Endocytosis	6/105	0.31318846992796384	0.6029528714679636	0	0	1.3237309953727865	1.5367856702507616	CHRM2;CD4;GRB2;TOR1B;CFTR;EGFR
GPER1 Signaling	3/45	0.3158504995103682	0.604784330306117	0	0	1.5594148414514548	1.7972042098490655	ITGB1;GNAS;ITGA5
A Tetrasaccharide Linker Sequence Is Required for GAG Synthesis	2/26	0.3167503542898224	0.604784330306117	0	0	1.8189523809523809	2.091142854936888	VCAN;NCAN
Attachment and Entry 9694614	2/26	0.3167503542898224	0.604784330306117	0	0	1.8189523809523809	2.091142854936888	ACE2;CTSL
Constitutive Signaling by AKT1 E17K in Cancer	2/26	0.3167503542898224	0.604784330306117	0	0	1.8189523809523809	2.091142854936888	PDPK1;AKT1S1
MicroRNA (miRNA) Biogenesis	2/26	0.3167503542898224	0.604784330306117	0	0	1.8189523809523809	2.091142854936888	PRKRA;TARBP2
Miscellaneous Transport and Binding Events	2/26	0.3167503542898224	0.604784330306117	0	0	1.8189523809523809	2.091142854936888	NIPA1;CSN1S1
Metabolism of Water-Soluble Vitamins and Cofactors	7/127	0.32301072668661024	0.6158915090458	0	0	1.2741475095785442	1.4398755534777314	BTD;VNN2;CTRB2;FPGS;CTRB1;NADSYN1;PTGS2
Regulation of Complement Cascade	7/128	0.3301244411261545	0.6188286323095648	0	0	1.2635508691935025	1.4003752348146727	CD19;C3AR1;SERPING1;CD59;ELANE;CPN2;C1QC
tRNA Modification in the Mitochondrion	1/9	0.33211953935462973	0.6188286323095648	0	0	2.7275970319634704	3.0065219679383697	TRMU
Defective Factor IX Causes Hemophilia B	1/9	0.33211953935462973	0.6188286323095648	0	0	2.7275970319634704	3.0065219679383697	GP1BA
Digestion of Dietary Carbohydrate	1/9	0.33211953935462973	0.6188286323095648	0	0	2.7275970319634704	3.0065219679383697	SI
EGFR Interacts With Phospholipase C-gamma	1/9	0.33211953935462973	0.6188286323095648	0	0	2.7275970319634704	3.0065219679383697	EGFR
NR1H2 & NR1H3 Regulate Gene Expression Linked to Lipogenesis	1/9	0.33211953935462973	0.6188286323095648	0	0	2.7275970319634704	3.0065219679383697	ANGPTL3
PI3K AKT Activation	1/9	0.33211953935462973	0.6188286323095648	0	0	2.7275970319634704	3.0065219679383697	NTRK1
PI5P Regulates TP53 Acetylation	1/9	0.33211953935462973	0.6188286323095648	0	0	2.7275970319634704	3.0065219679383697	TP53
Phase 3 - Rapid Repolarisation	1/9	0.33211953935462973	0.6188286323095648	0	0	2.7275970319634704	3.0065219679383697	KCNH2
Regulation of PTEN Localization	1/9	0.33211953935462973	0.6188286323095648	0	0	2.7275970319634704	3.0065219679383697	XIAP
SHC-related Events Triggered by IGF1R	1/9	0.33211953935462973	0.6188286323095648	0	0	2.7275970319634704	3.0065219679383697	GRB2
Sperm Motility And Taxes	1/9	0.33211953935462973	0.6188286323095648	0	0	2.7275970319634704	3.0065219679383697	CATSPER1
Synthesis of (16-20)-Hydroxyeicosatetraenoic Acids (HETE)	1/9	0.33211953935462973	0.6188286323095648	0	0	2.7275970319634704	3.0065219679383697	CYP1A2
Synthesis of 5-Eicosatetraenoic Acids	1/9	0.33211953935462973	0.6188286323095648	0	0	2.7275970319634704	3.0065219679383697	ALOX5
TRIF-mediated Programmed Cell Death	1/9	0.33211953935462973	0.6188286323095648	0	0	2.7275970319634704	3.0065219679383697	LY96
Gamma-carboxylated Protein Precursors Transport From the Endoplasmic Reticulum to Golgi Apparatus	1/9	0.33211953935462973	0.6188286323095648	0	0	2.7275970319634704	3.0065219679383697	PROZ
Transport of Nucleotide Sugars	1/9	0.33211953935462973	0.6188286323095648	0	0	2.7275970319634704	3.0065219679383697	SLC35A1
Downstream Signaling Events of B Cell Receptor (BCR)	4/68	0.3485349734794397	0.6455549084905441	0	0	1.3644759450171822	1.4381804321139027	IKBKB;NFKBIA;NFKB1;SKP1
ATF4 Activates Genes in Response to Endoplasmic Reticulum Stress	2/28	0.34924984977330154	0.6455549084905441	0	0	1.6788571428571428	1.7661035056439702	CXCL8;ASNS
Adrenaline,noradrenaline Inhibits Insulin Secretion	2/28	0.34924984977330154	0.6455549084905441	0	0	1.6788571428571428	1.7661035056439702	CACNA2D2;CACNA1D
Caspase Activation via Extrinsic Apoptotic Signalling Pathway	2/28	0.34924984977330154	0.6455549084905441	0	0	1.6788571428571428	1.7661035056439702	LY96;TNFRSF10A
Metabolism of Porphyrins	2/28	0.34924984977330154	0.6455549084905441	0	0	1.6788571428571428	1.7661035056439702	COX15;ALB
Sulfur Amino Acid Metabolism	2/28	0.34924984977330154	0.6455549084905441	0	0	1.6788571428571428	1.7661035056439702	BHMT;BHMT2
C-type Lectin Receptors (CLRs)	7/131	0.3515935138219413	0.6490238834163325	0	0	1.2327864293659623	1.2886064576286715	NFKBIA;IKBKB;PDPK1;IL1B;NFKB1;SKP1;NFKB2
Recycling Pathway of L1	3/48	0.35228217758465363	0.6494326615950511	0	0	1.4552250190694127	1.5182694177485871	RPS6KA3;TUBB1;L1CAM
COPII-mediated Vesicle Transport	4/69	0.3585992041772868	0.6507418877271222	0	0	1.3434135166093928	1.3777376474078464	GRIA1;LMAN2L;CTSZ;CD59
High Laminar Flow Shear Stress Activates Signaling by PIEZO1 and PECAM1 CDH5 KDR in Endothelial Cell	4/69	0.3585992041772868	0.6507418877271222	0	0	1.3434135166093928	1.3777376474078464	CDH5;CAPNS1;PDPK1;GNAS
Sensory Processing of Sound by Inner Hair Cells of the Cochlea	4/69	0.3585992041772868	0.6507418877271222	0	0	1.3434135166093928	1.3777376474078464	KCNMA1;CACNA2D2;KCNQ4;CACNA1D
Phase II - Conjugation of Compounds	6/111	0.36013077788250064	0.6507418877271222	0	0	1.2476955879940954	1.2742565835796995	GCLC;GSTP1;CYP1A2;AKR1A1;CHAC2;OPLAH
ATF6 (ATF6-alpha) Activates Chaperone Genes	1/10	0.3614192354858549	0.6507418877271222	0	0	2.4244038559107053	2.4673562367217836	HSPA5
Acetylcholine Regulates Insulin Secretion	1/10	0.3614192354858549	0.6507418877271222	0	0	2.4244038559107053	2.4673562367217836	CHRM3
Activation of Ca-permeable Kainate Receptor	1/10	0.3614192354858549	0.6507418877271222	0	0	2.4244038559107053	2.4673562367217836	GRIK2
Alpha-defensins	1/10	0.3614192354858549	0.6507418877271222	0	0	2.4244038559107053	2.4673562367217836	CD4
Gamma-carboxylation of Protein Precursors	1/10	0.3614192354858549	0.6507418877271222	0	0	2.4244038559107053	2.4673562367217836	PROZ
Glucocorticoid Biosynthesis	1/10	0.3614192354858549	0.6507418877271222	0	0	2.4244038559107053	2.4673562367217836	POMC
Glycoprotein Hormones	1/10	0.3614192354858549	0.6507418877271222	0	0	2.4244038559107053	2.4673562367217836	CGA
HDL Remodeling	1/10	0.3614192354858549	0.6507418877271222	0	0	2.4244038559107053	2.4673562367217836	ALB
Ionotropic Activity of Kainate Receptors	1/10	0.3614192354858549	0.6507418877271222	0	0	2.4244038559107053	2.4673562367217836	GRIK2
MET Receptor Recycling	1/10	0.3614192354858549	0.6507418877271222	0	0	2.4244038559107053	2.4673562367217836	GRB2
Nef Mediated CD4 Down-regulation	1/10	0.3614192354858549	0.6507418877271222	0	0	2.4244038559107053	2.4673562367217836	CD4
Reactions Specific to the Complex N-glycan Synthesis Pathway	1/10	0.3614192354858549	0.6507418877271222	0	0	2.4244038559107053	2.4673562367217836	CGA
Removal of Aminoterminal Propeptides From Gamma-Carboxylated Proteins	1/10	0.3614192354858549	0.6507418877271222	0	0	2.4244038559107053	2.4673562367217836	PROZ
Role of Second Messengers in Netrin-1 Signaling	1/10	0.3614192354858549	0.6507418877271222	0	0	2.4244038559107053	2.4673562367217836	TRPC6
DAP12 Signaling	2/29	0.3653062905703109	0.6518302232255868	0	0	1.6165925925925926	1.6279396581445884	GRB2;HLA-E
Downstream Signal Transduction	2/29	0.3653062905703109	0.6518302232255868	0	0	1.6165925925925926	1.6279396581445884	GRB2;BCAR1
G1 S-Specific Transcription	2/29	0.3653062905703109	0.6518302232255868	0	0	1.6165925925925926	1.6279396581445884	E2F4;E2F6
Myogenesis	2/29	0.3653062905703109	0.6518302232255868	0	0	1.6165925925925926	1.6279396581445884	MAPK11;MAPK14
Phosphorylation of CD3 and TCR Zeta Chains	2/29	0.3653062905703109	0.6518302232255868	0	0	1.6165925925925926	1.6279396581445884	CD4;PTPRJ
The Role of Nef in HIV-1 Replication and Disease Pathogenesis	2/29	0.3653062905703109	0.6518302232255868	0	0	1.6165925925925926	1.6279396581445884	CD4;HLA-A
VEGFR2 Mediated Vascular Permeability	2/29	0.3653062905703109	0.6518302232255868	0	0	1.6165925925925926	1.6279396581445884	CDH5;PDPK1
Signaling by FGFR	5/91	0.3691763776253332	0.6578912370502733	0	0	1.269268721997013	1.2648018620052977	GRB2;FGF1;FGF2;FGF4;MAPK3
Insulin Receptor Recycling	2/30	0.3812075616816714	0.6732768631438807	0	0	1.5587755102040817	1.5033006708097052	ATP6V0A2;CTSD
Interconversion of Nucleotide Di- and Triphosphates	2/30	0.3812075616816714	0.6732768631438807	0	0	1.5587755102040817	1.5033006708097052	CTPS2;CTPS1
Signaling by CSF3 (G-CSF)	2/30	0.3812075616816714	0.6732768631438807	0	0	1.5587755102040817	1.5033006708097052	GRB2;GAB2
Biological Oxidations	11/222	0.38281346164323843	0.6732768631438807	0	0	1.1384915118811774	1.093188035755924	POMC;ACY3;GCLC;GSTP1;CYP1A2;AKR1A1;CHAC2;CMBL;OPLAH;CES1;PTGS1
Signaling by ALK Fusions and Activated Point Mutants	5/93	0.3867354375119881	0.6732768631438807	0	0	1.2402913886572144	1.178294733658073	GRB2;TP53;SKP1;RBX1;MAPK3
Signaling by ALK in Cancer	5/93	0.3867354375119881	0.6732768631438807	0	0	1.2402913886572144	1.178294733658073	GRB2;TP53;SKP1;RBX1;MAPK3
IRE1alpha Activates Chaperones	3/51	0.3884734530271281	0.6732768631438807	0	0	1.3640589244851258	1.2897592398090139	C19ORF10;HSPA5;GFPT1
Transcriptional and Post-Translational Regulation of MITF-M Expression and Activity	3/51	0.3884734530271281	0.6732768631438807	0	0	1.3640589244851258	1.2897592398090139	POMC;MITF;MAPK3
Biotin Transport and Metabolism	1/11	0.3894349625666763	0.6732768631438807	0	0	2.1818493150684932	2.0576113335695814	BTD
CASP8 Activity Is Inhibited	1/11	0.3894349625666763	0.6732768631438807	0	0	2.1818493150684932	2.0576113335695814	TNFRSF10A
Dimerization of Procaspase-8	1/11	0.3894349625666763	0.6732768631438807	0	0	2.1818493150684932	2.0576113335695814	TNFRSF10A
Formation of Annular Gap Junctions	1/11	0.3894349625666763	0.6732768631438807	0	0	2.1818493150684932	2.0576113335695814	GJA1
Gamma-carboxylation, Transport, and Amino-Terminal Cleavage of Proteins	1/11	0.3894349625666763	0.6732768631438807	0	0	2.1818493150684932	2.0576113335695814	PROZ
MET Activates RAP1 and RAC1	1/11	0.3894349625666763	0.6732768631438807	0	0	2.1818493150684932	2.0576113335695814	GRB2
MET Activates RAS Signaling	1/11	0.3894349625666763	0.6732768631438807	0	0	2.1818493150684932	2.0576113335695814	GRB2
Nef Mediated Downregulation of MHC Class I Complex Cell Surface Expression	1/11	0.3894349625666763	0.6732768631438807	0	0	2.1818493150684932	2.0576113335695814	HLA-A
Receptor Mediated Mitophagy	1/11	0.3894349625666763	0.6732768631438807	0	0	2.1818493150684932	2.0576113335695814	ATG5
Regulation by c-FLIP	1/11	0.3894349625666763	0.6732768631438807	0	0	2.1818493150684932	2.0576113335695814	TNFRSF10A
Regulation of CDH11 Function	1/11	0.3894349625666763	0.6732768631438807	0	0	2.1818493150684932	2.0576113335695814	ANGPTL4
Regulation of Gene Expression by Hypoxia-inducible Factor	1/11	0.3894349625666763	0.6732768631438807	0	0	2.1818493150684932	2.0576113335695814	EPO
Ribavirin ADME	1/11	0.3894349625666763	0.6732768631438807	0	0	2.1818493150684932	2.0576113335695814	SLC29A1
Signaling by FGFR4 in Disease	1/11	0.3894349625666763	0.6732768631438807	0	0	2.1818493150684932	2.0576113335695814	GRB2
Signaling by Leptin	1/11	0.3894349625666763	0.6732768631438807	0	0	2.1818493150684932	2.0576113335695814	LEP
Type I Hemidesmosome Assembly	1/11	0.3894349625666763	0.6732768631438807	0	0	2.1818493150684932	2.0576113335695814	ITGA6
Antiviral Mechanism by IFN-stimulated Genes	8/158	0.3902645759078392	0.673872994424716	0	0	1.1644342155734562	1.095651517421124	IKBKB;APITD1;NUP210;PRKRA;TUBB1;TP53;TARBP2;MAPK3
Class B 2 (Secretin Family Receptors)	5/94	0.39550621062861047	0.6778152315055612	0	0	1.2262911040098958	1.1374938797189924	FZD3;VIPR2;GCGR;GNAS;CRHR2
FOXO-mediated Transcription of Oxidative Stress, Metabolic and Neuronal Genes	2/31	0.3969364017593718	0.6778152315055612	0	0	1.5049458128078819	1.3905386405134754	POMC;NR3C1
Nicotinate Metabolism	2/31	0.3969364017593718	0.6778152315055612	0	0	1.5049458128078819	1.3905386405134754	NADSYN1;PTGS2
RHO GTPases Activate IQGAPs	2/31	0.3969364017593718	0.6778152315055612	0	0	1.5049458128078819	1.3905386405134754	TUBB1;IQGAP2
RUNX2 Regulates Bone Development	2/31	0.3969364017593718	0.6778152315055612	0	0	1.5049458128078819	1.3905386405134754	AR;MAPK3
Signaling by CSF1 (M-CSF) in Myeloid Cells	2/31	0.3969364017593718	0.6778152315055612	0	0	1.5049458128078819	1.3905386405134754	GRB2;GAB2
Tight Junction Interactions	2/31	0.3969364017593718	0.6778152315055612	0	0	1.5049458128078819	1.3905386405134754	CLDN22;CLDN17
Transcriptional Regulation of Brown and Beige Adipocyte Differentiation	2/31	0.3969364017593718	0.6778152315055612	0	0	1.5049458128078819	1.3905386405134754	PPARG;PPARA
Transcriptional Regulation of Brown and Beige Adipocyte Differentiation by EBF2	2/31	0.3969364017593718	0.6778152315055612	0	0	1.5049458128078819	1.3905386405134754	PPARG;PPARA
Cyclin E Associated Events During G1 S Transition	4/73	0.398757710495997	0.6800898375330501	0	0	1.2652688546906385	1.1632898151787063	CABLES1;E2F4;CKS1B;SKP1
Antimicrobial Peptides	5/95	0.40426550833518377	0.6877956628958452	0	0	1.2126019367991845	1.098233466832649	CD4;PLA2G2A;PRTN3;ELANE;LTF
Unfolded Protein Response (UPR)	5/95	0.40426550833518377	0.6877956628958452	0	0	1.2126019367991845	1.098233466832649	CXCL8;C19ORF10;HSPA5;GFPT1;ASNS
PPARA Activates Gene Expression	6/117	0.4074495793230191	0.6879308748608789	0	0	1.179880224656344	1.0593414022362828	MED1;TGS1;PLIN2;PPARG;ANGPTL4;PPARA
Mitotic G1 Phase and G1 S Transition	7/139	0.40932394288548907	0.6879308748608789	0	0	1.157584465343086	1.0340104715786385	E2F2;CABLES1;E2F3;E2F4;E2F6;SKP1;CKS1B
RHO GTPases Activate Formins	7/139	0.40932394288548907	0.6879308748608789	0	0	1.157584465343086	1.0340104715786385	ITGB1;APITD1;FMNL2;TUBB1;CENPL;BUB1;ITGB3BP
Deposition of New CENPA-containing Nucleosomes at the Centromere	3/53	0.4123303823991518	0.6879308748608789	0	0	1.3093592677345538	1.1600011168993345	APITD1;CENPL;ITGB3BP
Nucleosome Assembly	3/53	0.4123303823991518	0.6879308748608789	0	0	1.3093592677345538	1.1600011168993345	APITD1;CENPL;ITGB3BP
Signaling by EGFR	3/53	0.4123303823991518	0.6879308748608789	0	0	1.3093592677345538	1.1600011168993345	GRB2;PTPN12;EGFR
PINK1-PRKN Mediated Mitophagy	2/32	0.4124773578755928	0.6879308748608789	0	0	1.454704761904762	1.2882486634861177	TOMM5;ATG5
Regulation of Necroptotic Cell Death	2/32	0.4124773578755928	0.6879308748608789	0	0	1.454704761904762	1.2882486634861177	XIAP;TNFRSF10A
Respiratory Syncytial Virus (RSV) Attachment and Entry	2/32	0.4124773578755928	0.6879308748608789	0	0	1.454704761904762	1.2882486634861177	LY96;EGFR
ATF6 (ATF6-alpha) Activates Chaperones	1/12	0.4162229250057548	0.6879308748608789	0	0	1.983395599833956	1.7385142436438012	HSPA5
Butyrophilin (BTN) Family Interactions	1/12	0.4162229250057548	0.6879308748608789	0	0	1.983395599833956	1.7385142436438012	BTNL8
CD28 Dependent Vav1 Pathway	1/12	0.4162229250057548	0.6879308748608789	0	0	1.983395599833956	1.7385142436438012	GRB2
Erythropoietin Activates Phosphoinositide-3-kinase (PI3K)	1/12	0.4162229250057548	0.6879308748608789	0	0	1.983395599833956	1.7385142436438012	EPO
GP1b-IX-V Activation Signalling	1/12	0.4162229250057548	0.6879308748608789	0	0	1.983395599833956	1.7385142436438012	GP1BA
Gap Junction Degradation	1/12	0.4162229250057548	0.6879308748608789	0	0	1.983395599833956	1.7385142436438012	GJA1
Organic Anion Transporters	1/12	0.4162229250057548	0.6879308748608789	0	0	1.983395599833956	1.7385142436438012	SLC25A18
Pregnenolone Biosynthesis	1/12	0.4162229250057548	0.6879308748608789	0	0	1.983395599833956	1.7385142436438012	AKR1B1
Pyrimidine Catabolism	1/12	0.4162229250057548	0.6879308748608789	0	0	1.983395599833956	1.7385142436438012	AGXT2
Signaling by LTK	1/12	0.4162229250057548	0.6879308748608789	0	0	1.983395599833956	1.7385142436438012	GRB2
Signaling by PDGFRA Extracellular Domain Mutants	1/12	0.4162229250057548	0.6879308748608789	0	0	1.983395599833956	1.7385142436438012	GRB2
Signaling by PDGFRA Transmembrane, Juxtamembrane and Kinase Domain Mutants	1/12	0.4162229250057548	0.6879308748608789	0	0	1.983395599833956	1.7385142436438012	GRB2
Specification of Primordial Germ Cells	1/12	0.4162229250057548	0.6879308748608789	0	0	1.983395599833956	1.7385142436438012	CXCR4
Sphingolipid Catabolism	1/12	0.4162229250057548	0.6879308748608789	0	0	1.983395599833956	1.7385142436438012	SGPL1
Suppression of Apoptosis	1/12	0.4162229250057548	0.6879308748608789	0	0	1.983395599833956	1.7385142436438012	MAPK3
Cyclin A Cdk2-associated Events at S Phase Entry	4/75	0.4186913575691189	0.6903689051258307	0	0	1.2294984108545892	1.0704274399815779	CABLES1;E2F4;CKS1B;SKP1
Plasma Lipoprotein Assembly, Remodeling, and Clearance	4/75	0.4186913575691189	0.6903689051258307	0	0	1.2294984108545892	1.0704274399815779	ALB;ANGPTL3;ANGPTL4;PCSK5
Regulation of Lipid Metabolism by PPARalpha	6/119	0.4231851852141152	0.6969519045587916	0	0	1.1588754661004033	0.9965696327746496	MED1;TGS1;PLIN2;PPARG;ANGPTL4;PPARA
SARS-CoV-1 Activates Modulates Innate Immune Responses	3/54	0.42415039255294185	0.6977148469214073	0	0	1.2836182527931081	1.1009172563422331	NFKBIA;NLRP3;NFKB1
Amino Acid Transport Across the Plasma Membrane	2/33	0.4278166606898559	0.7012560829704005	0	0	1.407705069124424	1.1952268234038126	SLC1A4;SLC36A4
Glucagon Signaling in Metabolic Regulation	2/33	0.4278166606898559	0.7012560829704005	0	0	1.407705069124424	1.1952268234038126	GCGR;GNAS
Sialic Acid Metabolism	2/33	0.4278166606898559	0.7012560829704005	0	0	1.407705069124424	1.1952268234038126	SLC35A1;NPL
Mitotic G2-G2 M Phases	9/186	0.4297740123067458	0.7036347197954966	0	0	1.109857064750449	0.9372695867427181	PPME1;ODF2;TUBB1;E2F3;HMMR;PPP1R12B;TP53;SKP1;RBX1
Signaling by NOTCH	10/209	0.4348269015384596	0.7110698742805398	0	0	1.0968336492149329	0.9134510201395778	NCSTN;TACC3;PSEN2;CNTN1;E2F3;PSEN1;TP53;EGFR;SKP1;RBX1
Hedgehog 'Off' State	5/99	0.4391076730033202	0.714963037148947	0	0	1.1607578567245755	0.9553160516671991	IFT52;TUBB1;GNAS;SKP1;RBX1
Downregulation of ERBB2 ERBB3 Signaling	1/13	0.44183686972010466	0.714963037148947	0	0	1.8180175038051751	1.4849831275557819	ERBB3
ERKs Are Inactivated	1/13	0.44183686972010466	0.714963037148947	0	0	1.8180175038051751	1.4849831275557819	MAPK3
IRF3-mediated Induction of Type I IFN	1/13	0.44183686972010466	0.714963037148947	0	0	1.8180175038051751	1.4849831275557819	NLRP4
NF-kB Activation Through FADD RIP-1 Pathway Mediated by Caspase-8 and -10	1/13	0.44183686972010466	0.714963037148947	0	0	1.8180175038051751	1.4849831275557819	IKBKB
POU5F1 (OCT4), SOX2, NANOG Activate Genes Related to Proliferation	1/13	0.44183686972010466	0.714963037148947	0	0	1.8180175038051751	1.4849831275557819	FGF2
Synthesis of PE	1/13	0.44183686972010466	0.714963037148947	0	0	1.8180175038051751	1.4849831275557819	ETNPPL
TRAF6 Mediated IRF7 Activation in TLR7 8 or 9 Signaling	1/13	0.44183686972010466	0.714963037148947	0	0	1.8180175038051751	1.4849831275557819	MYD88
Ubiquinol Biosynthesis	1/13	0.44183686972010466	0.714963037148947	0	0	1.8180175038051751	1.4849831275557819	COQ6
Metabolic Disorders of Biological Oxidation Enzymes	2/34	0.4429421065421348	0.7150865599228424	0	0	1.3636428571428572	1.1104364729723195	GCLC;OPLAH
RIPK1-mediated Regulated Necrosis	2/34	0.4429421065421348	0.7150865599228424	0	0	1.3636428571428572	1.1104364729723195	XIAP;TNFRSF10A
Costimulation by the CD28 Family	4/78	0.44828268461753823	0.722031206973787	0	0	1.1794681279217363	0.9463241410779525	CD4;PDPK1;BTLA;GRB2
Regulation of Insulin Secretion	4/78	0.44828268461753823	0.722031206973787	0	0	1.1794681279217363	0.9463241410779525	CHRM3;GNAS;CACNA2D2;CACNA1D
CD28 Co-Stimulation	2/35	0.45784294713077645	0.7340273316168158	0	0	1.3222510822510822	1.0329809751879862	PDPK1;GRB2
Lysosome Vesicle Biogenesis	2/35	0.45784294713077645	0.7340273316168158	0	0	1.3222510822510822	1.0329809751879862	APP;CTSZ
Negative Regulators of DDX58 IFIH1 Signaling	2/35	0.45784294713077645	0.7340273316168158	0	0	1.3222510822510822	1.0329809751879862	CYLD;ATG5
Transcriptional Regulation by NPAS4	2/35	0.45784294713077645	0.7340273316168158	0	0	1.3222510822510822	1.0329809751879862	NR3C1;MAPK3
AKT Phosphorylates Targets in the Cytosol	1/14	0.4663281933561732	0.7382644518964474	0	0	1.678082191780822	1.2801512035138911	AKT1S1
Golgi Cisternae Pericentriolar Stack Reorganization	1/14	0.4663281933561732	0.7382644518964474	0	0	1.678082191780822	1.2801512035138911	MAPK3
IRAK1 Recruits IKK Complex	1/14	0.4663281933561732	0.7382644518964474	0	0	1.678082191780822	1.2801512035138911	IKBKB
IRAK1 Recruits IKK Complex Upon TLR7 8 or 9 Stimulation	1/14	0.4663281933561732	0.7382644518964474	0	0	1.678082191780822	1.2801512035138911	IKBKB
LGI-ADAM Interactions	1/14	0.4663281933561732	0.7382644518964474	0	0	1.678082191780822	1.2801512035138911	CACNG2
Methylation	1/14	0.4663281933561732	0.7382644518964474	0	0	1.678082191780822	1.2801512035138911	CYP1A2
PTK6 Regulates RHO GTPases, RAS GTPase and MAP Kinases	1/14	0.4663281933561732	0.7382644518964474	0	0	1.678082191780822	1.2801512035138911	BCAR1
Regulation of NPAS4 Gene Expression	1/14	0.4663281933561732	0.7382644518964474	0	0	1.678082191780822	1.2801512035138911	NR3C1
Regulation of TBK1, IKK? (IKBKE)-mediated Activation of IRF3, IRF7	1/14	0.4663281933561732	0.7382644518964474	0	0	1.678082191780822	1.2801512035138911	LY96
Retrograde Neurotrophin Signalling	1/14	0.4663281933561732	0.7382644518964474	0	0	1.678082191780822	1.2801512035138911	NTRK1
SHC1 Events in ERBB4 Signaling	1/14	0.4663281933561732	0.7382644518964474	0	0	1.678082191780822	1.2801512035138911	GRB2
RHO GTPases Activate WASPs and WAVEs	2/36	0.47250978542653344	0.7455035207070164	0	0	1.283294117647059	0.9620815221601602	GRB2;MAPK3
Regulation of TP53 Degradation	2/36	0.47250978542653344	0.7455035207070164	0	0	1.283294117647059	0.9620815221601602	PDPK1;TP53
SMAD2 SMAD3 SMAD4 Heterotrimer Regulates Transcription	2/36	0.47250978542653344	0.7455035207070164	0	0	1.283294117647059	0.9620815221601602	E2F4;MAPK3
NRAGE Signals Death Through JNK	3/59	0.4818572996202952	0.7587832220682009	0	0	1.168703007518797	0.853278559507662	NET1;TIAM1;NGFR
Keratinization	10/217	0.48201840653684996	0.7587832220682009	0	0	1.0539981835303034	0.7691793930169294	CELA2A;CAPNS1;KRT27;KRT24;KRT7;KAZN;KRT77;CAPN1;KRT75;KLK8
Gap Junction Assembly	2/37	0.4869344781179637	0.7597622794111945	0	0	1.2465632653061225	0.8970589708710037	GJA1;TUBB1
Gene and Protein Expression by JAK-STAT Signaling After Interleukin-12 Stimulation	2/37	0.4869344781179637	0.7597622794111945	0	0	1.2465632653061225	0.8970589708710037	CA1;SERPINB2
Regulation of TP53 Expression and Degradation	2/37	0.4869344781179637	0.7597622794111945	0	0	1.2465632653061225	0.8970589708710037	PDPK1;TP53
mRNA Decay by 5' to 3' Exoribonuclease	1/15	0.48974604485786344	0.7597622794111945	0	0	1.5581376386170906	1.1123050641746146	DDX6
Activation of BAD and Translocation to Mitochondria	1/15	0.48974604485786344	0.7597622794111945	0	0	1.5581376386170906	1.1123050641746146	BCL2
Diseases Associated With Glycosylation Precursor Biosynthesis	1/15	0.48974604485786344	0.7597622794111945	0	0	1.5581376386170906	1.1123050641746146	GFPT1
IRAK2 Mediated Activation of TAK1 Complex Upon TLR7 8 or 9 Stimulation	1/15	0.48974604485786344	0.7597622794111945	0	0	1.5581376386170906	1.1123050641746146	LY96
Negative Regulation of FLT3	1/15	0.48974604485786344	0.7597622794111945	0	0	1.5581376386170906	1.1123050641746146	PTPRJ
Negative Regulation of TCF-dependent Signaling by WNT Ligand Antagonists	1/15	0.48974604485786344	0.7597622794111945	0	0	1.5581376386170906	1.1123050641746146	KREMEN2
Organic Cation Anion Zwitterion Transport	1/15	0.48974604485786344	0.7597622794111945	0	0	1.5581376386170906	1.1123050641746146	SLC22A6
Regulation of Innate Immune Responses to Cytosolic DNA	1/15	0.48974604485786344	0.7597622794111945	0	0	1.5581376386170906	1.1123050641746146	NLRP4
Response of EIF2AK1 (HRI) to Heme Deficiency	1/15	0.48974604485786344	0.7597622794111945	0	0	1.5581376386170906	1.1123050641746146	ASNS
SARS-CoV-2 Targets Host Intracellular Signalling and Regulatory Pathways	1/15	0.48974604485786344	0.7597622794111945	0	0	1.5581376386170906	1.1123050641746146	PDPK1
Phase I - Functionalization of Compounds	5/105	0.4903814409968121	0.7598998918456731	0	0	1.0907683486238533	0.7772506997879423	POMC;CYP1A2;CMBL;CES1;PTGS1
Diseases of Metabolism	12/264	0.4911485906815636	0.7602411370238011	0	0	1.0388659510046794	0.7386425924701916	POMC;GCLC;VCAN;BTD;SFTPA2;SI;NCAN;GFPT1;CSF2RB;SFTPA1;OPLAH;CSF2RA
Disease	94/2131	0.4921632213358256	0.7609642688062265	0	0	1.0069675248013914	0.7138844577667645	ITGB1;APP;NCAN;ITGB3;NR3C1;FGF1;OPLAH;SLC6A2;FGF2;SLC6A3;FGF4;IKBKB;GJA1;CAPNS1;RPS19;CTSL;C1QBP;TUBB1;C3AR1;CAPN1;LRRFIP1;IL6R;GOLGA7;SKP1;FGB;MED1;FGA;ITGA4;NUP210;PDPK1;IL1R1;SIGMAR1;FGG;HLA-B;HLA-C;GP1BA;GAB2;HLA-A;KREMEN2;HLA-F;HLA-G;RBX1;HLA-E;ACE2;ANO1;VCAN;BTD;IL1B;AKT1S1;SERPING1;MASP2;TP53;CFTR;LTF;SFTPA2;SLC1A1;PSEN2;LY96;CXCR4;CSF2RB;PSEN1;CSF2RA;EGFR;ANAPC11;NCSTN;ERBB3;SI;CD19;E2F2;NLRP3;E2F3;MAPK3;NTRK2;SLC35A1;NTRK3;GFPT1;PTPN12;MAPK14;ESR1;NFKB1;NFKB2;NFKBIA;SLC2A9;POMC;IL6;GCLC;CD4;RPS28;FXYD3;GNAS;GRB2;SFTPA1;MYD88;BCL2L1
Glycerophospholipid Biosynthesis	6/128	0.49295202023520057	0.761337009029921	0	0	1.072876475127515	0.7588921277215694	PLA2G12A;PLA2G2E;PLA2G2A;PLA2G6;MGLL;ETNPPL
Regulation of Ornithine Decarboxylase (ODC)	2/38	0.5011100439859026	0.7722205777609807	0	0	1.2118730158730158	0.8373188815644309	ODC1;AZIN1
Triglyceride Metabolism	2/38	0.5011100439859026	0.7722205777609807	0	0	1.2118730158730158	0.8373188815644309	PLIN3;MGLL
Regulation of PTEN Gene Transcription	3/61	0.504167912515918	0.7760724234741151	0	0	1.1282845419395566	0.7727010500751447	PPARG;TP53;MAPK3
Leishmania Infection	11/245	0.5116977228816987	0.7791496041181843	0	0	1.0253400051321528	0.686999554268455	APP;IL6;IL1B;C3AR1;GNAS;NLRP3;GRB2;MAPK14;NFKB1;NFKB2;MAPK3
Parasitic Infection Pathways	11/245	0.5116977228816987	0.7791496041181843	0	0	1.0253400051321528	0.686999554268455	APP;IL6;IL1B;C3AR1;GNAS;NLRP3;GRB2;MAPK14;NFKB1;NFKB2;MAPK3
cGMP Effects	1/16	0.5121374238263396	0.7791496041181843	0	0	1.454185692541857	0.9730862194486606	KCNMA1
Elevation of Cytosolic Ca2+ Levels	1/16	0.5121374238263396	0.7791496041181843	0	0	1.454185692541857	0.9730862194486606	TRPC6
Heme Degradation	1/16	0.5121374238263396	0.7791496041181843	0	0	1.454185692541857	0.9730862194486606	ALB
InlB-mediated Entry of Listeria Monocytogenes Into Host Cell	1/16	0.5121374238263396	0.7791496041181843	0	0	1.454185692541857	0.9730862194486606	GRB2
Regulation of KIT Signaling	1/16	0.5121374238263396	0.7791496041181843	0	0	1.454185692541857	0.9730862194486606	GRB2
STING Mediated Induction of Host Immune Responses	1/16	0.5121374238263396	0.7791496041181843	0	0	1.454185692541857	0.9730862194486606	NLRP4
TRAF6-mediated Induction of TAK1 Complex Within TLR4 Complex	1/16	0.5121374238263396	0.7791496041181843	0	0	1.454185692541857	0.9730862194486606	LY96
Transcription of E2F Targets Under Neg Control by P107 (RBL1) and P130 (RBL2) in Complex With HDAC1	1/16	0.5121374238263396	0.7791496041181843	0	0	1.454185692541857	0.9730862194486606	E2F4
Glycosphingolipid Catabolism	2/39	0.5150305778767903	0.7791496041181843	0	0	1.179057915057915	0.7823391258795135	SUMF2;SUMF1
Mitophagy	2/39	0.5150305778767903	0.7791496041181843	0	0	1.179057915057915	0.7823391258795135	TOMM5;ATG5
Ovarian Tumor Domain Proteases	2/39	0.5150305778767903	0.7791496041181843	0	0	1.179057915057915	0.7823391258795135	ESR1;TP53
Cellular Response to Hypoxia	3/62	0.5151356015716629	0.7791496041181843	0	0	1.1091028972578831	0.7356958001649765	EGLN1;EPO;RBX1
Kinesins	3/62	0.5151356015716629	0.7791496041181843	0	0	1.1091028972578831	0.7356958001649765	KLC3;KLC2;TUBB1
RHO GTPases Activate PKNs	3/62	0.5151356015716629	0.7791496041181843	0	0	1.1091028972578831	0.7356958001649765	AR;PDPK1;PPP1R12B
Signaling by Nuclear Receptors	12/270	0.5227524185657678	0.7898107193548014	0	0	1.0143836537168975	0.6579772324136746	MED1;PDPK1;RDH16;ANGPTL3;AKR1C3;BCL2;PGR;CTSD;ESR1;EGFR;PPARD;MAPK3
Vpu Mediated Degradation of CD4	2/40	0.5286911697333185	0.7967487230211943	0	0	1.14796992481203	0.7316595703055657	CD4;SKP1
Formation of Senescence-Associated Heterochromatin Foci (SAHF)	1/17	0.5335472744512968	0.7967487230211943	0	0	1.3632277397260273	0.8563900269827475	TP53
Metabolism of Folate and Pterines	1/17	0.5335472744512968	0.7967487230211943	0	0	1.3632277397260273	0.8563900269827475	FPGS
PKA Activation in Glucagon Signalling	1/17	0.5335472744512968	0.7967487230211943	0	0	1.3632277397260273	0.8563900269827475	GNAS
Platelet Sensitization by LDL	1/17	0.5335472744512968	0.7967487230211943	0	0	1.3632277397260273	0.8563900269827475	MAPK14
Protein Methylation	1/17	0.5335472744512968	0.7967487230211943	0	0	1.3632277397260273	0.8563900269827475	METTL10
Regulation of MITF-M-dependent Genes Involved in Cell Cycle and Proliferation	1/17	0.5335472744512968	0.7967487230211943	0	0	1.3632277397260273	0.8563900269827475	MITF
Regulation of MITF-M-dependent Genes Involved in Lysosome Biogenesis and Autophagy	1/17	0.5335472744512968	0.7967487230211943	0	0	1.3632277397260273	0.8563900269827475	MITF
Signaling by Activin	1/17	0.5335472744512968	0.7967487230211943	0	0	1.3632277397260273	0.8563900269827475	MAPK3
Specification of the Neural Plate Border	1/17	0.5335472744512968	0.7967487230211943	0	0	1.3632277397260273	0.8563900269827475	FGF4
Platelet Homeostasis	4/87	0.5336496842681524	0.7967487230211943	0	0	1.0510771608771856	0.6600929350494883	TRPC6;KCNMA1;GNAS;MAPK14
Mitotic Spindle Checkpoint	5/111	0.5398564684288185	0.8050235924993908	0	0	1.0287021810628354	0.6341454901337371	APITD1;CENPL;BUB1;ITGB3BP;ANAPC11
Diseases Associated With Glycosaminoglycan Metabolism	2/41	0.5420878291938344	0.8050235924993908	0	0	1.1184761904761904	0.6848734434036354	VCAN;NCAN
MET Promotes Cell Motility	2/41	0.5420878291938344	0.8050235924993908	0	0	1.1184761904761904	0.6848734434036354	ITGB1;GRB2
RET Signaling	2/41	0.5420878291938344	0.8050235924993908	0	0	1.1184761904761904	0.6848734434036354	GRB2;GAB2
SARS-CoV-1 Modulates Host Translation Machinery	2/41	0.5420878291938344	0.8050235924993908	0	0	1.1184761904761904	0.6848734434036354	RPS28;RPS19
TNFR2 Non-Canonical NF-kB Pathway	4/88	0.5427348983168763	0.8051243422203395	0	0	1.0385097910871106	0.6346689490187885	TNFRSF25;TNF;SKP1;NFKB2
MITF-M-regulated Melanocyte Development	6/136	0.5524726671322051	0.8132267712503679	0	0	1.0064293915040183	0.5971662059911833	POMC;CEACAM1;BCL2;MITF;MAPK14;MAPK3
Zygotic Genome Activation (ZGA)	1/18	0.5540185751173887	0.8132267712503679	0	0	1.2829707225355895	0.7576674227190496	TP53
Activation of IRF3, IRF7 Mediated by TBK1, IKK? (IKBKE)	1/18	0.5540185751173887	0.8132267712503679	0	0	1.2829707225355895	0.7576674227190496	LY96
Crosslinking of Collagen Fibrils	1/18	0.5540185751173887	0.8132267712503679	0	0	1.2829707225355895	0.7576674227190496	PXDN
Formation of Definitive Endoderm	1/18	0.5540185751173887	0.8132267712503679	0	0	1.2829707225355895	0.7576674227190496	CXCR4
Formation of the Nephric Duct	1/18	0.5540185751173887	0.8132267712503679	0	0	1.2829707225355895	0.7576674227190496	FGF2
Mitochondrial Unfolded Protein Response (UPRmt)	1/18	0.5540185751173887	0.8132267712503679	0	0	1.2829707225355895	0.7576674227190496	ESR1
RNA Polymerase III Chain Elongation	1/18	0.5540185751173887	0.8132267712503679	0	0	1.2829707225355895	0.7576674227190496	POLR3F
Recycling of Bile Acids and Salts	1/18	0.5540185751173887	0.8132267712503679	0	0	1.2829707225355895	0.7576674227190496	ALB
FBXL7 Down-Regulates AURKA During Mitotic Entry and in Early Mitosis	2/42	0.5552174143284886	0.8132267712503679	0	0	1.0904571428571428	0.6416200806154668	SKP1;RBX1
GSK3B and BTRC CUL1-mediated-degradation of NFE2L2	2/42	0.5552174143284886	0.8132267712503679	0	0	1.0904571428571428	0.6416200806154668	SKP1;RBX1
Regulation of MITF-M-dependent Genes Involved in Pigmentation	2/42	0.5552174143284886	0.8132267712503679	0	0	1.0904571428571428	0.6416200806154668	MITF;MAPK14
G2 M Transition	8/184	0.5605385806899984	0.8201564496411556	0	0	0.991055549743697	0.5736796467207804	PPME1;ODF2;TUBB1;HMMR;PPP1R12B;TP53;SKP1;RBX1
ADORA2B Mediated Anti-Inflammatory Cytokines Production	2/43	0.568077564939707	0.8219520307159354	0	0	1.0638048780487805	0.6015787985947618	IL6;GNAS
Aggrephagy	2/43	0.568077564939707	0.8219520307159354	0	0	1.0638048780487805	0.6015787985947618	TUBB1;CFTR
Aspirin ADME	2/43	0.568077564939707	0.8219520307159354	0	0	1.0638048780487805	0.6015787985947618	ALB;CES1
Signaling by SCF-KIT	2/43	0.568077564939707	0.8219520307159354	0	0	1.0638048780487805	0.6015787985947618	GRB2;GAB2
Activation of HOX Genes During Differentiation	4/91	0.5694298706931413	0.8219520307159354	0	0	1.0025411120327579	0.564550595675606	HOXD1;HOXB1;HOXD3;HOXA4
Activation of Anterior HOX Genes in Hindbrain Development During Early Embryogenesis	4/91	0.5694298706931413	0.8219520307159354	0	0	1.0025411120327579	0.564550595675606	HOXD1;HOXB1;HOXD3;HOXA4
Mitochondrial Translation Elongation	4/91	0.5694298706931413	0.8219520307159354	0	0	1.0025411120327579	0.564550595675606	MRPL47;MRPL32;MRPL11;MRPL22
Mitochondrial Translation Initiation	4/91	0.5694298706931413	0.8219520307159354	0	0	1.0025411120327579	0.564550595675606	MRPL47;MRPL32;MRPL11;MRPL22
Mitochondrial Translation Termination	4/91	0.5694298706931413	0.8219520307159354	0	0	1.0025411120327579	0.564550595675606	MRPL47;MRPL32;MRPL11;MRPL22
NFE2L2 Regulating Anti-Oxidant Detoxification Enzymes	1/19	0.5735924243125592	0.8219520307159354	0	0	1.2116311516996447	0.6734684515872618	GCLC
Nicotinamide Salvaging	1/19	0.5735924243125592	0.8219520307159354	0	0	1.2116311516996447	0.6734684515872618	PTGS2
Other Semaphorin Interactions	1/19	0.5735924243125592	0.8219520307159354	0	0	1.2116311516996447	0.6734684515872618	ITGB1
Prostacyclin Signalling Through Prostacyclin Receptor	1/19	0.5735924243125592	0.8219520307159354	0	0	1.2116311516996447	0.6734684515872618	GNAS
RHO GTPases Activate ROCKs	1/19	0.5735924243125592	0.8219520307159354	0	0	1.2116311516996447	0.6734684515872618	PPP1R12B
RHO GTPases Activate CIT	1/19	0.5735924243125592	0.8219520307159354	0	0	1.2116311516996447	0.6734684515872618	PPP1R12B
SARS-CoV-1 Targets Host Intracellular Signalling and Regulatory Pathways	1/19	0.5735924243125592	0.8219520307159354	0	0	1.2116311516996447	0.6734684515872618	PDPK1
Scavenging by Class A Receptors	1/19	0.5735924243125592	0.8219520307159354	0	0	1.2116311516996447	0.6734684515872618	COLEC11
TICAM1, RIP1-mediated IKK Complex Recruitment	1/19	0.5735924243125592	0.8219520307159354	0	0	1.2116311516996447	0.6734684515872618	IKBKB
Transcription of E2F Targets Under Negative Control by DREAM Complex	1/19	0.5735924243125592	0.8219520307159354	0	0	1.2116311516996447	0.6734684515872618	E2F4
VEGFR2 Mediated Cell Proliferation	1/19	0.5735924243125592	0.8219520307159354	0	0	1.2116311516996447	0.6734684515872618	PDPK1
Cell-cell Junction Organization	4/92	0.5781331598284075	0.8276056561910262	0	0	0.9910965323336457	0.543072392002821	CLDN22;CDH5;CLDN17;ANGPTL4
EML4 and NUDC in Mitotic Spindle Formation	5/116	0.5793104288624904	0.8284377532087054	0	0	0.9821059591701794	0.5361481410346716	APITD1;TUBB1;CENPL;BUB1;ITGB3BP
Disorders of Transmembrane Transporters	7/164	0.5829747796941311	0.8328211138487588	0	0	0.9719745222929936	0.5244884871504855	SLC2A9;SLC35A1;NUP210;SLC1A1;SLC6A2;CFTR;SLC6A3
Asparagine N-linked Glycosylation	13/306	0.5865629355030556	0.8366954172469039	0	0	0.9669684616356972	0.5158537995750809	GRIA1;SLC35A1;LMAN2L;COG4;GFPT2;CTSZ;GFPT1;NPL;RENBP;TUBB1;TRIM13;CD59;CGA
Metabolism of Proteins	89/2067	0.5907819660092836	0.8366954172469039	0	0	0.9789826415442969	0.5152466442656028	APP;PARS2;CTSZ;NR3C1;MRPL32;GCSH;RPS19;METTL10;TUBB1;NARS2;CTSD;EARS2;SKP1;FGA;MME;NUP210;IGFBP4;IGFBP3;COG4;IGFBP2;FGG;HLA-B;MRPL47;MITF;HLA-A;RENBP;SUMF2;SUMF1;RBX1;BACE1;ACE2;AR;VCAN;NSMCE4A;TRIM13;SUCLG2;PPARG;TARS2;PGR;PPARA;TP53;CFTR;CES1;LTF;PAPPA2;GRIA1;LIPT2;LIPT1;SFTPA2;LMAN2L;SERPINC1;PROZ;CSF2RB;NPL;CSF2RA;FBXO41;MRPL11;CRHR2;NCSTN;OTOA;NLRP3;CD59;IGFBP7;IGFBP6;CGA;SLC35A1;ACE;ICMT;GFPT2;GFPT1;ESR1;PGA5;MRPL22;NFKB2;WARS2;NFKBIA;POMC;CYLD;IL6;RPS28;VNN2;RAET1G;LYPD6B;LEP;ALB;CNTN3;REN;CNTN4;SFTPA1
Aberrant Regulation of Mitotic Exit in Cancer Due to RB1 Defects	1/20	0.5923081227129161	0.8366954172469039	0	0	1.1478010093727469	0.6011358736083894	ANAPC11
Class I Peroxisomal Membrane Protein Import	1/20	0.5923081227129161	0.8366954172469039	0	0	1.1478010093727469	0.6011358736083894	PXMP4
Conversion From APC C Cdc20 to APC C Cdh1 in Late Anaphase	1/20	0.5923081227129161	0.8366954172469039	0	0	1.1478010093727469	0.6011358736083894	ANAPC11
Phosphorylation of the APC C	1/20	0.5923081227129161	0.8366954172469039	0	0	1.1478010093727469	0.6011358736083894	ANAPC11
Signaling by KIT in Disease	1/20	0.5923081227129161	0.8366954172469039	0	0	1.1478010093727469	0.6011358736083894	GRB2
Signaling by PDGFR in Disease	1/20	0.5923081227129161	0.8366954172469039	0	0	1.1478010093727469	0.6011358736083894	GRB2
Signaling by Phosphorylated Juxtamembrane, Extracellular and Kinase Domain KIT Mutants	1/20	0.5923081227129161	0.8366954172469039	0	0	1.1478010093727469	0.6011358736083894	GRB2
Synthesis of Leukotrienes (LT) and Eoxins (EX)	1/20	0.5923081227129161	0.8366954172469039	0	0	1.1478010093727469	0.6011358736083894	ALOX5
Vitamin B5 (Pantothenate) Metabolism	1/20	0.5923081227129161	0.8366954172469039	0	0	1.1478010093727469	0.6011358736083894	VNN2
Amplification of Signal From Unattached Kinetochores via a MAD2 Inhibitory Signal	4/94	0.5952343641462009	0.8382733193143053	0	0	0.968970344915362	0.5027018746977114	APITD1;CENPL;BUB1;ITGB3BP
Amplification of Signal From the Kinetochores	4/94	0.5952343641462009	0.8382733193143053	0	0	0.968970344915362	0.5027018746977114	APITD1;CENPL;BUB1;ITGB3BP
MITF-M-dependent Gene Expression	4/94	0.5952343641462009	0.8382733193143053	0	0	0.968970344915362	0.5027018746977114	CEACAM1;BCL2;MITF;MAPK14
Early SARS-CoV-2 Infection Events	2/46	0.6050282553315509	0.8464895414767	0	0	0.9911168831168831	0.49801652938584295	ACE2;CTSL
Interleukin-12 Signaling	2/46	0.6050282553315509	0.8464895414767	0	0	0.9911168831168831	0.49801652938584295	CA1;SERPINB2
Kidney Development	2/46	0.6050282553315509	0.8464895414767	0	0	0.9911168831168831	0.49801652938584295	ITGB1;FGF2
Metabolism of Polyamines	2/46	0.6050282553315509	0.8464895414767	0	0	0.9911168831168831	0.49801652938584295	ODC1;AZIN1
NIK-->noncanonical NF-kB Signaling	2/46	0.6050282553315509	0.8464895414767	0	0	0.9911168831168831	0.49801652938584295	SKP1;NFKB2
ESR-mediated Signaling	8/192	0.6089503308030401	0.8464895414767	0	0	0.9475659178466003	0.47001029459650634	MED1;PDPK1;BCL2;PGR;ESR1;CTSD;EGFR;MAPK3
CD209 (DC-SIGN) Signaling	1/21	0.6102032522011894	0.8464895414767	0	0	1.0903538812785387	0.5385946672330333	NFKB1
Digestion	1/21	0.6102032522011894	0.8464895414767	0	0	1.0903538812785387	0.5385946672330333	SI
ER Quality Control Compartment (ERQC)	1/21	0.6102032522011894	0.8464895414767	0	0	1.0903538812785387	0.5385946672330333	TRIM13
Formation of the Ureteric Bud	1/21	0.6102032522011894	0.8464895414767	0	0	1.0903538812785387	0.5385946672330333	ITGB1
Inactivation of APC C via Direct Inhibition of the APC C Complex	1/21	0.6102032522011894	0.8464895414767	0	0	1.0903538812785387	0.5385946672330333	ANAPC11
Inhib of Proteolytic Activity of APC C Required for Onset of Anaphase by Mitotic Spindle Checkpoint	1/21	0.6102032522011894	0.8464895414767	0	0	1.0903538812785387	0.5385946672330333	ANAPC11
Regulation of Gene Expression in Beta Cells	1/21	0.6102032522011894	0.8464895414767	0	0	1.0903538812785387	0.5385946672330333	NKX6-1
Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1)	1/21	0.6102032522011894	0.8464895414767	0	0	1.0903538812785387	0.5385946672330333	LEP
VxPx Cargo-Targeting to Cilium	1/21	0.6102032522011894	0.8464895414767	0	0	1.0903538812785387	0.5385946672330333	RAB11FIP3
Clathrin-mediated Endocytosis	6/145	0.6153335818637987	0.8500250824383402	0	0	0.9408188718829759	0.4568529403810916	CHRM2;CD4;GRB2;TOR1B;CFTR;EGFR
Degradation of GLI1 by the Proteasome	2/47	0.6168006033661028	0.8500250824383402	0	0	0.9690412698412698	0.4682499266580451	SKP1;RBX1
Degradation of GLI2 by the Proteasome	2/47	0.6168006033661028	0.8500250824383402	0	0	0.9690412698412698	0.4682499266580451	SKP1;RBX1
GLI3 Is Processed to GLI3R by the Proteasome	2/47	0.6168006033661028	0.8500250824383402	0	0	0.9690412698412698	0.4682499266580451	SKP1;RBX1
Estrogen-dependent Gene Expression	5/121	0.6168896048439085	0.8500250824383402	0	0	0.9395266529579247	0.45385262444943847	MED1;BCL2;PGR;ESR1;CTSD
G1 S Transition	5/121	0.6168896048439085	0.8500250824383402	0	0	0.9395266529579247	0.45385262444943847	CABLES1;E2F4;E2F6;SKP1;CKS1B
trans-Golgi Network Vesicle Budding	3/72	0.6170325958131548	0.8500250824383402	0	0	0.9478658839916426	0.45766133305979406	TBC1D8B;APP;CTSZ
Mitochondrial Translation	4/97	0.6200962936829515	0.8533998497220817	0	0	0.9375654337410241	0.44804423883160194	MRPL47;MRPL32;MRPL11;MRPL22
Defects in Vitamin and Cofactor Metabolism	1/22	0.627313750293062	0.8578967970351772	0	0	1.038377908240922	0.48420440777112583	BTD
Insertion of Tail-Anchored Proteins Into the Endoplasmic Reticulum Membrane	1/22	0.627313750293062	0.8578967970351772	0	0	1.038377908240922	0.48420440777112583	APP
Listeria Monocytogenes Entry Into Host Cells	1/22	0.627313750293062	0.8578967970351772	0	0	1.038377908240922	0.48420440777112583	GRB2
NPAS4 Regulates Expression of Target Genes	1/22	0.627313750293062	0.8578967970351772	0	0	1.038377908240922	0.48420440777112583	MAPK3
Post-chaperonin Tubulin Folding Pathway	1/22	0.627313750293062	0.8578967970351772	0	0	1.038377908240922	0.48420440777112583	TUBB1
Regulation of Signaling by CBL	1/22	0.627313750293062	0.8578967970351772	0	0	1.038377908240922	0.48420440777112583	GRB2
Gap Junction Trafficking	2/48	0.6283013952387125	0.8578967970351772	0	0	0.9479254658385093	0.44053442471923043	GJA1;TUBB1
NOTCH1 Intracellular Domain Regulates Transcription	2/48	0.6283013952387125	0.8578967970351772	0	0	0.9479254658385093	0.44053442471923043	SKP1;RBX1
Fc Epsilon Receptor (FCERI) Signaling	8/197	0.6377635003657338	0.8698132860440445	0	0	0.9222544918747451	0.4148187760016279	IKBKB;NFKBIA;PDPK1;GRB2;GAB2;NFKB1;SKP1;MAPK3
XBP1(S) Activates Chaperone Genes	2/49	0.6395317829762687	0.8698132860440445	0	0	0.9277082066869301	0.4147031572448763	C19ORF10;GFPT1
Dectin-1 Mediated Noncanonical NF-kB Signaling	2/49	0.6395317829762687	0.8698132860440445	0	0	0.9277082066869301	0.4147031572448763	SKP1;NFKB2
Retrograde Transport at the Trans-Golgi-Network	2/49	0.6395317829762687	0.8698132860440445	0	0	0.9277082066869301	0.4147031572448763	COG4;PLIN3
Nitric Oxide Stimulates Guanylate Cyclase	1/23	0.6436739823653678	0.872884717549133	0	0	0.9911270236612703	0.4366538152613451	KCNMA1
RNA Polymerase III Transcription Termination	1/23	0.6436739823653678	0.872884717549133	0	0	0.9911270236612703	0.4366538152613451	POLR3F
Signaling by NODAL	1/23	0.6436739823653678	0.872884717549133	0	0	0.9911270236612703	0.4366538152613451	MAPK3
S Phase	6/150	0.6480235245598849	0.8779266073472125	0	0	0.9079123612705702	0.3938780580404903	CABLES1;E2F4;SKP1;RBX1;ANAPC11;CKS1B
Chondroitin Sulfate Dermatan Sulfate Metabolism	2/50	0.650493339402924	0.8795581145623195	0	0	0.9083333333333333	0.3906053334192905	VCAN;NCAN
SCF(Skp2)-mediated Degradation of P27 P21	2/50	0.650493339402924	0.8795581145623195	0	0	0.9083333333333333	0.3906053334192905	CKS1B;SKP1
Cellular Response to Heat Stress	4/101	0.6517132517909902	0.8795934955710535	0	0	0.8987139972366883	0.3847849476256489	NUP210;HSPA5;AKT1S1;MAPK3
Host Interactions of HIV Factors	5/126	0.6524179093048605	0.8795934955710535	0	0	0.9004662976723027	0.3845621032019403	CD4;NUP210;HLA-A;SKP1;RBX1
Resolution of Sister Chromatid Cohesion	5/126	0.6524179093048605	0.8795934955710535	0	0	0.9004662976723027	0.3845621032019403	APITD1;TUBB1;CENPL;BUB1;ITGB3BP
Glycosaminoglycan Metabolism	5/127	0.6592662001330544	0.8820504008701547	0	0	0.8930384268311025	0.37206470694890537	VCAN;NCAN;STAB2;HMMR;CD44
Xenobiotics	1/24	0.6593168104345977	0.8820504008701547	0	0	0.9479849116537622	0.39488417270126036	CYP1A2
APC C Cdc20 Mediated Degradation of Cyclin B	1/24	0.6593168104345977	0.8820504008701547	0	0	0.9479849116537622	0.39488417270126036	ANAPC11
mTORC1-mediated Signalling	1/24	0.6593168104345977	0.8820504008701547	0	0	0.9479849116537622	0.39488417270126036	AKT1S1
CD28 Dependent PI3K Akt Signaling	1/24	0.6593168104345977	0.8820504008701547	0	0	0.9479849116537622	0.39488417270126036	PDPK1
DARPP-32 Events	1/24	0.6593168104345977	0.8820504008701547	0	0	0.9479849116537622	0.39488417270126036	PDE4A
Incretin Synthesis, Secretion, and Inactivation	1/24	0.6593168104345977	0.8820504008701547	0	0	0.9479849116537622	0.39488417270126036	LEP
Synthesis of Very Long-Chain Fatty acyl-CoAs	1/24	0.6593168104345977	0.8820504008701547	0	0	0.9479849116537622	0.39488417270126036	HBG1
Gap Junction Trafficking and Regulation	2/51	0.66118801892734	0.8828543192209439	0	0	0.8897492711370263	0.3681044289193076	GJA1;TUBB1
Transcriptional Activity of SMAD2 SMAD3 SMAD4 Heterotrimer	2/51	0.66118801892734	0.8828543192209439	0	0	0.8897492711370263	0.3681044289193076	E2F4;MAPK3
Transcriptional Regulation by RUNX1	8/202	0.6653519049790506	0.8875615623041078	0	0	0.8982477785818515	0.3659813543968092	CTSL;CTSK;RSPO3;GP1BA;CTSV;ESR1;TP73;PF4
Cell Cycle, Mitotic	21/516	0.6693213963008382	0.8920007103146357	0	0	0.9232228830359671	0.37066560579185026	NUP210;ODF2;CABLES1;HMMR;ANAPC11;RBX1;CKS1B;APITD1;PPME1;TUBB1;CENPL;E2F2;E2F3;E2F4;PPP1R12B;E2F6;TP53;BUB1;ITGB3BP;SKP1;MAPK3
COPI-independent Golgi-to-ER Retrograde Traffic	2/52	0.671618121354063	0.8926098907288298	0	0	0.8719085714285715	0.34707660964488585	TUBB1;PLA2G6
ADP Signalling Through P2Y Purinoceptor 1	1/25	0.6742736584642239	0.8926098907288298	0	0	0.9084379756468798	0.358032874568956	MAPK14
Cyclin A B1 B2 Associated Events During G2 M Transition	1/25	0.6742736584642239	0.8926098907288298	0	0	0.9084379756468798	0.358032874568956	PPME1
Formation of Tubulin Folding Intermediates by CCT TriC	1/25	0.6742736584642239	0.8926098907288298	0	0	0.9084379756468798	0.358032874568956	TUBB1
G Beta Gamma Signalling Through PI3Kgamma	1/25	0.6742736584642239	0.8926098907288298	0	0	0.9084379756468798	0.358032874568956	PDPK1
Interleukin-7 Signaling	1/25	0.6742736584642239	0.8926098907288298	0	0	0.9084379756468798	0.358032874568956	RAG1
Metabolism of Cofactors	1/25	0.6742736584642239	0.8926098907288298	0	0	0.9084379756468798	0.358032874568956	COQ6
ER to Golgi Anterograde Transport	6/155	0.6789705607885255	0.8965304006247521	0	0	0.8772143413032926	0.33963766359620273	GRIA1;LMAN2L;COG4;TUBB1;CTSZ;CD59
Signaling by MET	3/79	0.6791701524157294	0.8965304006247521	0	0	0.8602462965193304	0.3328151756167835	ITGB1;PTPRJ;GRB2
Switching of Origins to a Post-Replicative State	3/79	0.6791701524157294	0.8965304006247521	0	0	0.8602462965193304	0.3328151756167835	SKP1;RBX1;ANAPC11
Formation of the Ternary Complex, and Subsequently, the 43S Complex	2/53	0.6817862580002567	0.8965779551753612	0	0	0.8547675070028011	0.32740935518129005	RPS28;RPS19
Intraflagellar Transport	2/53	0.6817862580002567	0.8965779551753612	0	0	0.8547675070028011	0.32740935518129005	IFT52;TUBB1
Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha	2/53	0.6817862580002567	0.8965779551753612	0	0	0.8547675070028011	0.32740935518129005	EGLN1;RBX1
Synthesis of PIPs at the Plasma Membrane	2/53	0.6817862580002567	0.8965779551753612	0	0	0.8547675070028011	0.32740935518129005	PLEKHA1;PIK3C2B
Generic Transcription Pathway	51/1230	0.6840820956257646	0.8970184258920871	0	0	0.9397137558607348	0.35678802455901953	BTG2;PRKAG1;PRKAG2;CTSV;NR3C1;PRKAG3;CTSL;CTSK;RSPO3;TP63;SKP1;MED1;PRKAB2;ITGA4;PDPK1;IGFBP3;GP1BA;OPRM1;PRKAB1;RBX1;AR;PPARG;PGR;ITGA5;PPARA;TP53;PPARD;PRKAA1;PRKAA2;EGFR;ANAPC11;GRIN2A;SMYD2;E2F4;CGA;E2F6;E2F8;MAPK3;GAD1;OPRK1;ZNF77;TNFRSF10A;MAPK14;GRIN2B;ESR1;NFKB1;POMC;MAPK11;IL6;TP73;PF4
Late SARS-CoV-2 Infection Events	3/80	0.6874074835524081	0.8970184258920871	0	0	0.8490296888466224	0.3182401238777021	ACE2;ANO1;GOLGA7
APC-Cdc20 Mediated Degradation of Nek2A	1/26	0.6885745758466597	0.8970184258920871	0	0	0.8720547945205479	0.3253912446067015	ANAPC11
Calnexin Calreticulin Cycle	1/26	0.6885745758466597	0.8970184258920871	0	0	0.8720547945205479	0.3253912446067015	TRIM13
Digestion and Absorption	1/26	0.6885745758466597	0.8970184258920871	0	0	0.8720547945205479	0.3253912446067015	SI
Endogenous Sterols	1/26	0.6885745758466597	0.8970184258920871	0	0	0.8720547945205479	0.3253912446067015	POMC
Fertilization	1/26	0.6885745758466597	0.8970184258920871	0	0	0.8720547945205479	0.3253912446067015	CATSPER1
Interleukin-20 Family Signaling	1/26	0.6885745758466597	0.8970184258920871	0	0	0.8720547945205479	0.3253912446067015	IL22RA2
N-glycan Antennae Elongation in the Medial trans-Golgi	1/26	0.6885745758466597	0.8970184258920871	0	0	0.8720547945205479	0.3253912446067015	CGA
Translocation of ZAP-70 to Immunological Synapse	1/26	0.6885745758466597	0.8970184258920871	0	0	0.8720547945205479	0.3253912446067015	CD4
snRNP Assembly	2/54	0.691695319637894	0.8993980302120418	0	0	0.8382857142857143	0.3090002539234641	NUP210;TGS1
Metabolism of Non-Coding RNA	2/54	0.691695319637894	0.8993980302120418	0	0	0.8382857142857143	0.3090002539234641	NUP210;TGS1
Respiratory Electron Transport	6/158	0.6966711157070954	0.9050213559185631	0	0	0.8597649404797872	0.31075501907055997	SLC25A18;COX15;NDUFB2;ECSIT;SLC25A12;SLC25A13
Amino Acids Regulate mTORC1	2/55	0.7013484473239031	0.9063371703475616	0	0	0.8224258760107817	0.29175594439070174	GATSL3;GATSL2
SARS-CoV-2 Modulates Host Translation Machinery	2/55	0.7013484473239031	0.9063371703475616	0	0	0.8224258760107817	0.29175594439070174	RPS28;RPS19
Cardiogenesis	1/27	0.7022482967369236	0.9063371703475616	0	0	0.8384703196347032	0.2963726268635272	SMYD1
Cholesterol Biosynthesis	1/27	0.7022482967369236	0.9063371703475616	0	0	0.8384703196347032	0.2963726268635272	SQLE
G0 and Early G1	1/27	0.7022482967369236	0.9063371703475616	0	0	0.8384703196347032	0.2963726268635272	E2F4
Prefoldin Mediated Transfer of Substrate to CCT TriC	1/27	0.7022482967369236	0.9063371703475616	0	0	0.8384703196347032	0.2963726268635272	TUBB1
RNA Polymerase III Transcription Initiation From Type 2 Promoter	1/27	0.7022482967369236	0.9063371703475616	0	0	0.8384703196347032	0.2963726268635272	POLR3F
Aerobic Respiration and Respiratory Electron Transport	10/260	0.7083609321156474	0.9133781963272263	0	0	0.870726643598616	0.30022787375590854	SLC25A18;SUCLA2;COX15;GLO1;NDUFB2;SUCLG2;SUCLG1;ECSIT;SLC25A12;SLC25A13
Interleukin-12 Family Signaling	2/56	0.7107490047925125	0.9148952064510802	0	0	0.8071534391534392	0.27559118407943456	CA1;SERPINB2
Regulation of HSF1-mediated Heat Shock Response	3/83	0.7111650505530185	0.9148952064510802	0	0	0.817062356979405	0.2784963069656822	NUP210;HSPA5;MAPK3
Phospholipid Metabolism	8/211	0.7117155991889719	0.9148952064510802	0	0	0.8580158383737607	0.2917913550608494	PLA2G12A;PLA2G2E;PLEKHA1;PLA2G2A;PLA2G6;MGLL;ETNPPL;PIK3C2B
Transport to the Golgi and Subsequent Modification	7/186	0.7121702254532869	0.9148952064510802	0	0	0.8515250754511012	0.28904023717675037	GRIA1;LMAN2L;COG4;TUBB1;CTSZ;CD59;CGA
Platelet Calcium Homeostasis	1/28	0.7153222980973237	0.9164036814334378	0	0	0.8073735836292913	0.2704879702868056	TRPC6
RNA Polymerase III Transcription Initiation From Type 1 Promoter	1/28	0.7153222980973237	0.9164036814334378	0	0	0.8073735836292913	0.2704879702868056	POLR3F
RNA Polymerase III Transcription Initiation From Type 3 Promoter	1/28	0.7153222980973237	0.9164036814334378	0	0	0.8073735836292913	0.2704879702868056	POLR3F
Signaling by Hedgehog	5/136	0.7169057831568706	0.9175865917017035	0	0	0.8312907066321171	0.27666256771964615	IFT52;TUBB1;GNAS;SKP1;RBX1
Transport of Bile Salts and Organic Acids, Metal Ions and Amine Compounds	3/84	0.718768461801923	0.9180383200745629	0	0	0.8069327909144843	0.26646211946517945	SLC22A6;SLC6A2;SLC6A3
Signaling by the B Cell Receptor (BCR)	6/162	0.7192392013354393	0.9180383200745629	0	0	0.8375430539609644	0.2760217696689416	NFKBIA;IKBKB;CD19;GRB2;NFKB1;SKP1
E3 Ubiquitin Ligases Ubiquitinate Target Proteins	2/57	0.7199005531519954	0.9180383200745629	0	0	0.7924363636363636	0.26042802763417044	HLA-B;HLA-A
Heparan Sulfate Heparin (HS-GAG) Metabolism	2/57	0.7199005531519954	0.9180383200745629	0	0	0.7924363636363636	0.26042802763417044	VCAN;NCAN
EGR2 and SOX10-mediated Initiation of Schwann Cell Myelination	1/29	0.727822854507489	0.9259977050507255	0	0	0.7784980430528375	0.2473269537448266	MPZ
TNFs Bind Their Physiological Receptors	1/29	0.727822854507489	0.9259977050507255	0	0	0.7784980430528375	0.2473269537448266	TNFRSF25
Glycosphingolipid Metabolism	2/58	0.7288068268528731	0.9259977050507255	0	0	0.7782448979591837	0.24619510084316368	SUMF2;SUMF1
Orc1 Removal From Chromatin	2/58	0.7288068268528731	0.9259977050507255	0	0	0.7782448979591837	0.24619510084316368	SKP1;RBX1
Membrane Trafficking	25/633	0.7342660752503054	0.9305768107175129	0	0	0.8935534809735607	0.27600420874762316	CHRM2;GRIA1;APP;PRKAA2;LMAN2L;CTSZ;PRKAG1;PRKAG2;PLA2G6;PRKAG3;EGFR;GJA1;KLC3;KLC2;TUBB1;CD59;TBC1D8B;PRKAB2;COG4;TOR1B;PRKAB1;CD4;PLIN3;GRB2;CFTR
Adherens Junctions Interactions	2/59	0.7374717118915531	0.9305768107175129	0	0	0.7645513784461153	0.23282695679777682	CDH5;ANGPTL4
Iron Uptake and Transport	2/59	0.7374717118915531	0.9305768107175129	0	0	0.7645513784461153	0.23282695679777682	ATP6V0A2;SKP1
RHOQ GTPase Cycle	2/59	0.7374717118915531	0.9305768107175129	0	0	0.7645513784461153	0.23282695679777682	GJA1;CFTR
Activation of Kainate Receptors Upon Glutamate Binding	1/30	0.7397750905344257	0.9305768107175129	0	0	0.7516139190678633	0.22654325286448485	GRIK2
MET Activates PTK2 Signaling	1/30	0.7397750905344257	0.9305768107175129	0	0	0.7516139190678633	0.22654325286448485	ITGB1
PD-1 Signaling	1/30	0.7397750905344257	0.9305768107175129	0	0	0.7516139190678633	0.22654325286448485	CD4
Paracetamol ADME	1/30	0.7397750905344257	0.9305768107175129	0	0	0.7516139190678633	0.22654325286448485	GSTP1
Recognition of DNA Damage by PCNA-containing Replication Complex	1/30	0.7397750905344257	0.9305768107175129	0	0	0.7516139190678633	0.22654325286448485	RBX1
Regulation of CDH11 Expression and Function	1/30	0.7397750905344257	0.9305768107175129	0	0	0.7516139190678633	0.22654325286448485	ANGPTL4
Regulation of TP53 Activity Through Acetylation	1/30	0.7397750905344257	0.9305768107175129	0	0	0.7516139190678633	0.22654325286448485	TP53
Regulation of PLK1 Activity at G2 M Transition	3/87	0.7406450742586388	0.930828800379302	0	0	0.7779911735861392	0.23357920793412318	ODF2;PPP1R12B;SKP1
Ribosomal Scanning and Start Codon Recognition	2/60	0.7458992252990224	0.9357400028570769	0	0	0.7513300492610837	0.22026350456733512	RPS28;RPS19
Translation Initiation Complex Formation	2/60	0.7458992252990224	0.9357400028570769	0	0	0.7513300492610837	0.22026350456733512	RPS28;RPS19
Downregulation of SMAD2 3 SMAD4 Transcriptional Activity	1/31	0.7512030313001404	0.9373179654463153	0	0	0.7265220700152207	0.20784293671746576	MAPK3
Metalloprotease DUBs	1/31	0.7512030313001404	0.9373179654463153	0	0	0.7265220700152207	0.20784293671746576	NLRP3
RNA Polymerase I Promoter Opening	1/31	0.7512030313001404	0.9373179654463153	0	0	0.7265220700152207	0.20784293671746576	MAPK3
Sealing of the Nuclear Envelope (NE) by ESCRT-III	1/31	0.7512030313001404	0.9373179654463153	0	0	0.7265220700152207	0.20784293671746576	TUBB1
Signaling by BMP	1/31	0.7512030313001404	0.9373179654463153	0	0	0.7265220700152207	0.20784293671746576	SMAD5
Transferrin Endocytosis and Recycling	1/31	0.7512030313001404	0.9373179654463153	0	0	0.7265220700152207	0.20784293671746576	ATP6V0A2
Signaling by Rho GTPases, Miro GTPases and RHOBTB3	27/688	0.7521272212834822	0.9376294507480182	0	0	0.8872012102874433	0.25271908030344625	ITGB1;IQGAP2;MYLK;GJA1;KLC3;HTR7;KLC2;DDRGK1;C1QBP;TUBB1;BUB1;MAPK3;PDPK1;MAPK14;NISCH;NET1;AR;TIAM1;MAPK11;APITD1;FMNL2;CENPL;PLIN3;GRB2;PPP1R12B;CFTR;ITGB3BP
mRNA Activation Upon Binding of the Cap-Binding Complex and eIFs, and Subsequent Binding to 43S	2/61	0.754093496255203	0.9392383152282546	0	0	0.7385569007263922	0.20844950078109425	RPS28;RPS19
Opioid Signalling	3/90	0.7611479083987804	0.9433305555345434	0	0	0.7510455298666456	0.20498103850780253	POMC;PDE4A;OPRM1
Cooperation of Prefoldin and TriC CCT in Actin and Tubulin Folding	1/32	0.7621296502628002	0.9433305555345434	0	0	0.7030490499337163	0.19097525478081953	TUBB1
Defective TPR May Confer Susceptibility Towards Thyroid Papillary Carcinoma (TPC)	1/32	0.7621296502628002	0.9433305555345434	0	0	0.7030490499337163	0.19097525478081953	NUP210
G-protein Beta Gamma Signalling	1/32	0.7621296502628002	0.9433305555345434	0	0	0.7030490499337163	0.19097525478081953	PDPK1
Regulation of Glucokinase by Glucokinase Regulatory Protein	1/32	0.7621296502628002	0.9433305555345434	0	0	0.7030490499337163	0.19097525478081953	NUP210
Thrombin Signalling Through Proteinase Activated Receptors (PARs)	1/32	0.7621296502628002	0.9433305555345434	0	0	0.7030490499337163	0.19097525478081953	MAPK3
Transcriptional Regulation of Pluripotent Stem Cells	1/32	0.7621296502628002	0.9433305555345434	0	0	0.7030490499337163	0.19097525478081953	FGF2
Regulation of Expression and Function of Type II Classical Cadherins	1/33	0.7725769154496989	0.9537139542407472	0	0	0.681043093607306	0.1757252644848319	ANGPTL4
Regulation of Homotypic Cell-Cell Adhesion	1/33	0.7725769154496989	0.9537139542407472	0	0	0.681043093607306	0.1757252644848319	ANGPTL4
Signal Amplification	1/33	0.7725769154496989	0.9537139542407472	0	0	0.681043093607306	0.1757252644848319	MAPK14
Translation	11/302	0.7764535842406436	0.9572214018254953	0	0	0.82201217431331	0.2079842164589312	RPS28;RPS19;PARS2;NARS2;TARS2;MRPL47;EARS2;MRPL32;MRPL11;MRPL22;WARS2
Gastrulation	4/120	0.7770559825565125	0.9572214018254953	0	0	0.750760358652289	0.18937395624823677	EPHA4;CXCR4;FGF2;FGF4
FCERI Mediated NF-kB Activation	5/147	0.7774841457992693	0.9572214018254953	0	0	0.7664507688331825	0.19290954713703223	NFKBIA;IKBKB;PDPK1;NFKB1;SKP1
Diseases of Carbohydrate Metabolism	1/34	0.7825658332342162	0.9609048171213451	0	0	0.6603708316037084	0.1619078900622047	SI
Signaling by WNT in Cancer	1/34	0.7825658332342162	0.9609048171213451	0	0	0.6603708316037084	0.1619078900622047	KREMEN2
Transcriptional Regulation by E2F6	1/34	0.7825658332342162	0.9609048171213451	0	0	0.6603708316037084	0.1619078900622047	E2F6
Cytochrome P450 - Arranged by Substrate Type	2/65	0.7846237175775013	0.9609048171213451	0	0	0.6915192743764172	0.1677287031269748	POMC;CYP1A2
RUNX1 Regulates Genes Involved in Megakaryocyte Differentiation and Platelet Function	2/65	0.7846237175775013	0.9609048171213451	0	0	0.6915192743764172	0.1677287031269748	GP1BA;PF4
The Role of GTSE1 in G2 M Progression After G2 Checkpoint	2/65	0.7846237175775013	0.9609048171213451	0	0	0.6915192743764172	0.1677287031269748	TUBB1;TP53
Binding and Uptake of Ligands by Scavenger Receptors	4/122	0.7879001432792181	0.961089008006852	0	0	0.7379579474634516	0.1759173074857277	COLEC11;ALB;STAB2;HBB
Vesicle-mediated Transport	29/752	0.7892832178264291	0.961089008006852	0	0	0.870325426028863	0.20594516177669522	CHRM2;GRIA1;APP;COLEC11;PRKAA2;LMAN2L;CTSZ;PRKAG1;STAB2;PRKAG2;HBB;PLA2G6;PRKAG3;EGFR;GJA1;KLC3;KLC2;TUBB1;CD59;TBC1D8B;PRKAB2;COG4;TOR1B;PRKAB1;CD4;ALB;PLIN3;GRB2;CFTR
Activated PKN1 Stimulates Transcription of AR (Androgen Receptor) Regulated Genes KLK2 and KLK3	1/35	0.7921164904916863	0.961089008006852	0	0	0.640914585012087	0.14936310210200734	AR
GPVI-mediated Activation Cascade	1/35	0.7921164904916863	0.961089008006852	0	0	0.640914585012087	0.14936310210200734	PDPK1
Latent Infection - Other Responses of Mtb to Phagocytosis	1/35	0.7921164904916863	0.961089008006852	0	0	0.640914585012087	0.14936310210200734	LTF
N-glycan Trimming in the ER and Calnexin Calreticulin Cycle	1/35	0.7921164904916863	0.961089008006852	0	0	0.640914585012087	0.14936310210200734	TRIM13
Nuclear Import of Rev Protein	1/35	0.7921164904916863	0.961089008006852	0	0	0.640914585012087	0.14936310210200734	NUP210
Nucleotide Catabolism	1/35	0.7921164904916863	0.961089008006852	0	0	0.640914585012087	0.14936310210200734	AGXT2
SUMOylation of SUMOylation Proteins	1/35	0.7921164904916863	0.961089008006852	0	0	0.640914585012087	0.14936310210200734	NUP210
Transport of the SLBP Independent Mature mRNA	1/35	0.7921164904916863	0.961089008006852	0	0	0.640914585012087	0.14936310210200734	NUP210
Role of LAT2 NTAL LAB on Calcium Mobilization	3/95	0.7923798583998939	0.961089008006852	0	0	0.710041289423938	0.16523682054189204	PDPK1;GRB2;GAB2
Separation of Sister Chromatids	6/177	0.7933060839677781	0.9613735455232882	0	0	0.7634700988982215	0.1767785616692658	APITD1;TUBB1;CENPL;BUB1;ITGB3BP;ANAPC11
FOXO-mediated Transcription	2/67	0.7986022405515176	0.9651081902630775	0	0	0.6701714285714285	0.15071637972976937	POMC;NR3C1
Detoxification of Reactive Oxygen Species	1/36	0.8012480946500657	0.9651081902630775	0	0	0.622570123939987	0.13795198221800511	GSTP1
Nuclear Pore Complex (NPC) Disassembly	1/36	0.8012480946500657	0.9651081902630775	0	0	0.622570123939987	0.13795198221800511	NUP210
RNA Polymerase III Transcription Initiation	1/36	0.8012480946500657	0.9651081902630775	0	0	0.622570123939987	0.13795198221800511	POLR3F
Rev-mediated Nuclear Export of HIV RNA	1/36	0.8012480946500657	0.9651081902630775	0	0	0.622570123939987	0.13795198221800511	NUP210
Striated Muscle Contraction	1/36	0.8012480946500657	0.9651081902630775	0	0	0.622570123939987	0.13795198221800511	MYBPC1
Transport of the SLBP Dependant Mature mRNA	1/36	0.8012480946500657	0.9651081902630775	0	0	0.622570123939987	0.13795198221800511	NUP210
Mitochondrial Protein Degradation	3/97	0.803885443610679	0.9674465511851463	0	0	0.6948609961536589	0.15168711527159792	APP;SUCLG2;MRPL32
Complex I Biogenesis	2/68	0.8052854836015899	0.9674561989682021	0	0	0.659982683982684	0.1429248115066647	NDUFB2;ECSIT
Regulation of APC C Activators Between G1 S and Early Anaphase	2/68	0.8052854836015899	0.9674561989682021	0	0	0.659982683982684	0.1429248115066647	SKP1;ANAPC11
Evasion by RSV of Host Interferon Responses	1/37	0.8099790124185933	0.9697423146096853	0	0	0.6052447995941147	0.12755349082455128	RBX1
Fatty acyl-CoA Biosynthesis	1/37	0.8099790124185933	0.9697423146096853	0	0	0.6052447995941147	0.12755349082455128	HBG1
HSF1-dependent Transactivation	1/37	0.8099790124185933	0.9697423146096853	0	0	0.6052447995941147	0.12755349082455128	AKT1S1
Transport of Ribonucleoproteins Into the Host Nucleus	1/37	0.8099790124185933	0.9697423146096853	0	0	0.6052447995941147	0.12755349082455128	NUP210
DNA Damage Recognition in GG-NER	1/38	0.8183268062908121	0.975535386573095	0	0	0.5888559792669382	0.11806179832413997	RBX1
Fanconi Anemia Pathway	1/38	0.8183268062908121	0.975535386573095	0	0	0.5888559792669382	0.11806179832413997	APITD1
Interactions of Rev With Host Cellular Proteins	1/38	0.8183268062908121	0.975535386573095	0	0	0.5888559792669382	0.11806179832413997	NUP210
Maturation of Spike Protein 9694548	1/38	0.8183268062908121	0.975535386573095	0	0	0.5888559792669382	0.11806179832413997	GOLGA7
NEP NS2 Interacts With the Cellular Export Machinery	1/38	0.8183268062908121	0.975535386573095	0	0	0.5888559792669382	0.11806179832413997	NUP210
COPI-dependent Golgi-to-ER Retrograde Traffic	3/101	0.8252907811354909	0.9791717776783846	0	0	0.6663592210339513	0.12795395962233702	KLC3;KLC2;TUBB1
COPI-mediated Anterograde Transport	3/101	0.8252907811354909	0.9791717776783846	0	0	0.6663592210339513	0.12795395962233702	COG4;TUBB1;CD59
Association of TriC CCT With Target Proteins During Biosynthesis	1/39	0.8263082699401044	0.9791717776783846	0	0	0.5733297284306657	0.10938406926772495	TP53
Autodegradation of the E3 Ubiquitin Ligase COP1	1/39	0.8263082699401044	0.9791717776783846	0	0	0.5733297284306657	0.10938406926772495	TP53
Export of Viral Ribonucleoproteins From Nucleus	1/39	0.8263082699401044	0.9791717776783846	0	0	0.5733297284306657	0.10938406926772495	NUP210
Response of Mtb to Phagocytosis	1/39	0.8263082699401044	0.9791717776783846	0	0	0.5733297284306657	0.10938406926772495	MAPK3
SUMOylation of Ubiquitinylation Proteins	1/39	0.8263082699401044	0.9791717776783846	0	0	0.5733297284306657	0.10938406926772495	NUP210
Signaling by Rho GTPases	25/672	0.8289933846160781	0.9811356504864902	0	0	0.8379229524493691	0.15714667127707763	ITGB1;IQGAP2;MYLK;GJA1;KLC3;KLC2;DDRGK1;C1QBP;TUBB1;BUB1;MAPK3;PDPK1;MAPK14;NISCH;NET1;AR;TIAM1;MAPK11;APITD1;FMNL2;CENPL;GRB2;PPP1R12B;CFTR;ITGB3BP
AURKA Activation by TPX2	2/72	0.8300831114907284	0.9811356504864902	0	0	0.6221387755102041	0.11586056128916136	ODF2;HMMR
Degradation of Beta-Catenin by the Destruction Complex	2/72	0.8300831114907284	0.9811356504864902	0	0	0.6221387755102041	0.11586056128916136	SKP1;RBX1
RHOU GTPase Cycle	1/40	0.8339394614443304	0.9820540952936205	0	0	0.558599695585997	0.10143861424006619	GRB2
Vpr-mediated Nuclear Import of PICs	1/40	0.8339394614443304	0.9820540952936205	0	0	0.558599695585997	0.10143861424006619	NUP210
Pre-NOTCH Transcription and Translation	2/73	0.8358210123006967	0.9820540952936205	0	0	0.6133440643863179	0.10999760839804698	E2F3;TP53
Post-translational Protein Modification	57/1457	0.8368629827291072	0.9820540952936205	0	0	0.8799747386759582	0.15671903274228044	APP;CTSZ;NR3C1;GCSH;METTL10;TUBB1;SKP1;FGA;NUP210;IGFBP4;IGFBP3;COG4;FGG;HLA-B;MITF;HLA-A;RENBP;SUMF2;SUMF1;RBX1;AR;VCAN;NSMCE4A;TRIM13;PPARG;PGR;PPARA;TP53;CFTR;GRIA1;LIPT2;LIPT1;LMAN2L;SERPINC1;PROZ;NPL;FBXO41;OTOA;NLRP3;CD59;IGFBP7;CGA;SLC35A1;ICMT;GFPT2;GFPT1;ESR1;NFKB2;NFKBIA;CYLD;IL6;VNN2;RAET1G;LYPD6B;ALB;CNTN3;CNTN4
Cellular Response to Starvation	5/161	0.8395385005586814	0.9820540952936205	0	0	0.6971521406727829	0.12193396057816522	RPS28;GATSL3;RPS19;ASNS;GATSL2
Respiratory Syncytial Virus Infection Pathway	4/133	0.8401775811132937	0.9820540952936205	0	0	0.6746405960023798	0.11748326496325713	MED1;LY96;EGFR;RBX1
Dual Incision in GG-NER	1/41	0.8412357360575012	0.9820540952936205	0	0	0.5446061643835617	0.09415334020926784	RBX1
Generation of Second Messenger Molecules	1/41	0.8412357360575012	0.9820540952936205	0	0	0.5446061643835617	0.09415334020926784	CD4
RNA Polymerase III Abortive And Retractive Initiation	1/41	0.8412357360575012	0.9820540952936205	0	0	0.5446061643835617	0.09415334020926784	POLR3F
RNA Polymerase III Transcription	1/41	0.8412357360575012	0.9820540952936205	0	0	0.5446061643835617	0.09415334020926784	POLR3F
RHOC GTPase Cycle	2/74	0.8413831534404743	0.9820540952936205	0	0	0.6047936507936508	0.10445278051528997	FMNL2;C1QBP
RHOG GTPase Cycle	2/74	0.8413831534404743	0.9820540952936205	0	0	0.6047936507936508	0.10445278051528997	ITGB1;IQGAP2
APC C-mediated Degradation of Cell Cycle Proteins	2/75	0.8467738946639197	0.9820540952936205	0	0	0.596477495107632	0.09920707251108818	SKP1;ANAPC11
Regulation of Mitotic Cell Cycle	2/75	0.8467738946639197	0.9820540952936205	0	0	0.596477495107632	0.09920707251108818	SKP1;ANAPC11
Deactivation of the Beta-Catenin Transactivating Complex	1/42	0.848211776535564	0.9820540952936205	0	0	0.5312952444592939	0.08746444661960918	XIAP
Formation of WDR5-containing Histone-Modifying Complexes	1/42	0.848211776535564	0.9820540952936205	0	0	0.5312952444592939	0.08746444661960918	TASP1
Glucagon-like Peptide-1 (GLP1) Regulates Insulin Secretion	1/42	0.848211776535564	0.9820540952936205	0	0	0.5312952444592939	0.08746444661960918	GNAS
NS1 Mediated Effects on Host Pathways	1/42	0.848211776535564	0.9820540952936205	0	0	0.5312952444592939	0.08746444661960918	NUP210
RND3 GTPase Cycle	1/42	0.848211776535564	0.9820540952936205	0	0	0.5312952444592939	0.08746444661960918	NISCH
Regulation of Beta-Cell Development	1/42	0.848211776535564	0.9820540952936205	0	0	0.5312952444592939	0.08746444661960918	NKX6-1
SCF-beta-TrCP Mediated Degradation of Emi1	1/42	0.848211776535564	0.9820540952936205	0	0	0.5312952444592939	0.08746444661960918	SKP1
Transport of Mature mRNA Derived From an Intronless Transcript	1/42	0.848211776535564	0.9820540952936205	0	0	0.5312952444592939	0.08746444661960918	NUP210
Vif-mediated Degradation of APOBEC3G	1/42	0.848211776535564	0.9820540952936205	0	0	0.5312952444592939	0.08746444661960918	RBX1
Golgi-to-ER Retrograde Transport	4/135	0.8484212144304721	0.9820540952936205	0	0	0.6642707868803721	0.1091915375374398	KLC3;KLC2;TUBB1;PLA2G6
Response of EIF2AK4 (GCN2) to Amino Acid Deficiency	3/106	0.8492095348804191	0.9820540952936205	0	0	0.6338450600964208	0.10360154478203101	RPS28;RPS19;ASNS
ISG15 Antiviral Mechanism	2/76	0.8519975513832986	0.9820540952936205	0	0	0.5883861003861004	0.0942427584853742	NUP210;MAPK3
Regulation of mRNA Stability by Proteins That Bind AU-rich Elements	2/76	0.8519975513832986	0.9820540952936205	0	0	0.5883861003861004	0.0942427584853742	MAPK11;MAPK14
Sphingolipid Metabolism	3/107	0.8536364158010494	0.9820540952936205	0	0	0.6277173913043478	0.09933622599574395	SGPL1;SUMF2;SUMF1
Formation of Incision Complex in GG-NER	1/43	0.8548816225217848	0.9820540952936205	0	0	0.5186181778647532	0.081315322834115	RBX1
Interactions of Vpr With Host Cellular Proteins	1/43	0.8548816225217848	0.9820540952936205	0	0	0.5186181778647532	0.081315322834115	NUP210
Negative Regulation of MAPK Pathway	1/43	0.8548816225217848	0.9820540952936205	0	0	0.5186181778647532	0.081315322834115	MAPK3
RND2 GTPase Cycle	1/43	0.8548816225217848	0.9820540952936205	0	0	0.5186181778647532	0.081315322834115	NISCH
Transport of Mature mRNAs Derived From Intronless Transcripts	1/43	0.8548816225217848	0.9820540952936205	0	0	0.5186181778647532	0.081315322834115	NUP210
Vasopressin Regulates Renal Water Homeostasis via Aquaporins	1/43	0.8548816225217848	0.9820540952936205	0	0	0.5186181778647532	0.081315322834115	GNAS
Protein Ubiquitination	2/77	0.8570583908633974	0.9829300027228733	0	0	0.5805104761904762	0.08954329319056725	HLA-B;HLA-A
SUMOylation of DNA Damage Response and Repair Proteins	2/77	0.8570583908633974	0.9829300027228733	0	0	0.5805104761904762	0.08954329319056725	NSMCE4A;NUP210
Synthesis of DNA	3/108	0.8579494179529878	0.9831407180170264	0	0	0.6217064400130762	0.09525172739758472	SKP1;RBX1;ANAPC11
Degradation of DVL	1/44	0.8612586989657788	0.9836890645541764	0	0	0.5065307422746097	0.07565561214790091	RBX1
Intra-Golgi Traffic	1/44	0.8612586989657788	0.9836890645541764	0	0	0.5065307422746097	0.07565561214790091	COG4
Netrin-1 Signaling	1/44	0.8612586989657788	0.9836890645541764	0	0	0.5065307422746097	0.07565561214790091	TRPC6
Stabilization of P53	1/44	0.8612586989657788	0.9836890645541764	0	0	0.5065307422746097	0.07565561214790091	TP53
RSV-host Interactions	3/109	0.8621507201726657	0.9838994261412195	0	0	0.6158089028971115	0.09133996280509936	MED1;LY96;RBX1
Carboxyterminal Post-Translational Modifications of Tubulin	1/45	0.8673558427254492	0.9882169027773561	0	0	0.49499273557492734	0.07044041469774436	TUBB1
Somitogenesis	1/45	0.8673558427254492	0.9882169027773561	0	0	0.49499273557492734	0.07044041469774436	EPHA4
RNA Polymerase II Transcription	52/1360	0.868918290710105	0.9891862605135511	0	0	0.85847465480493	0.12062099861290045	BTG2;PRKAG1;PRKAG2;CTSV;NR3C1;PRKAG3;CTSL;CTSK;RSPO3;TP63;SKP1;MED1;PRKAB2;ITGA4;PDPK1;IGFBP3;GP1BA;OPRM1;PRKAB1;RBX1;AR;PPARG;PGR;ITGA5;PPARA;TP53;PPARD;PRKAA1;PRKAA2;EGFR;ANAPC11;GRIN2A;SMYD2;E2F4;CGA;E2F6;E2F8;MAPK3;GAD1;OPRK1;ZNF77;TNFRSF10A;MAPK14;GRIN2B;ESR1;NFKB1;POMC;MAPK11;IL6;INTS6;TP73;PF4
SUMOylation of DNA Replication Proteins	1/46	0.8731853285106912	0.9932304473239449	0	0	0.4839675291730086	0.06562960562486171	NUP210
SUMOylation of RNA Binding Proteins	1/47	0.8787588933715644	0.9987529532187037	0	0	0.4734216795711733	0.06118725025397345	NUP210
Infection With Mycobacterium Tuberculosis	2/82	0.8800658164267415	0.9992203422335215	0	0	0.5440857142857143	0.06951161984013114	LTF;MAPK3
Gene Expression (Transcription)	62/1615	0.882632203962341	0.9992203422335215	0	0	0.860665484180628	0.10745124137686829	BTG2;PRKAG1;PRKAG2;CTSV;NR3C1;PRKAG3;CTSL;CTSK;RSPO3;TP63;SKP1;MED1;PRKAB2;ITGA4;NUP210;PDPK1;IGFBP3;ADIPOQ;GP1BA;OPRM1;PRKAB1;RBX1;AR;PPARG;PLIN2;PGR;ITGA5;ANGPTL4;PPARA;TP53;MGLL;PPARD;PRKAA1;PRKAA2;EGFR;ANAPC11;GRIN2A;SMYD2;TASP1;E2F4;CGA;E2F6;E2F8;MAPK3;GAD1;OPRK1;ZNF77;TNFRSF10A;MAPK14;GRIN2B;ESR1;TARBP2;NFKB1;POMC;MAPK11;IL6;PRKRA;POLR3F;THRSP;INTS6;TP73;PF4
Complex IV Assembly	1/48	0.8840877601698846	0.9992203422335215	0	0	0.4633245895268629	0.05708110065088889	COX15
DNA Damage Bypass	1/48	0.8840877601698846	0.9992203422335215	0	0	0.4633245895268629	0.05708110065088889	RBX1
Defective CFTR Causes Cystic Fibrosis	1/48	0.8840877601698846	0.9992203422335215	0	0	0.4633245895268629	0.05708110065088889	CFTR
G Alpha (Z) Signalling Events	1/48	0.8840877601698846	0.9992203422335215	0	0	0.4633245895268629	0.05708110065088889	GNAS
PTEN Regulation	4/145	0.8844244468412601	0.9992203422335215	0	0	0.6168344260031033	0.07575848655379448	XIAP;PPARG;TP53;MAPK3
Mitotic Prometaphase	6/203	0.8849210368988957	0.9992203422335215	0	0	0.6617983879897661	0.08090939405856903	APITD1;ODF2;TUBB1;CENPL;BUB1;ITGB3BP
Intra-Golgi and Retrograde Golgi-to-ER Traffic	6/204	0.8876248179866002	0.9999707910578968	0	0	0.6584211808092405	0.07848783925230562	KLC3;KLC2;COG4;TUBB1;PLIN3;PLA2G6
PI Metabolism	2/84	0.8882719810115256	0.9999707910578968	0	0	0.530759581881533	0.06288296112915208	PLEKHA1;PIK3C2B
Defensins	1/49	0.8891826602500434	0.9999707910578968	0	0	0.4536482115677321	0.0532821607888787	CD4
Pyruvate Metabolism	1/49	0.8891826602500434	0.9999707910578968	0	0	0.4536482115677321	0.0532821607888787	GLO1
Viral Messenger RNA Synthesis	1/49	0.8891826602500434	0.9999707910578968	0	0	0.4536482115677321	0.0532821607888787	NUP210
Transcriptional Regulation by RUNX3	2/86	0.895954781535842	0.9999916093609006	0	0	0.5180680272108844	0.056917717008265735	ITGA4;TP53
RHOA GTPase Cycle	4/149	0.8965973401475498	0.9999916093609006	0	0	0.5996919066240076	0.06545542041506476	NET1;TIAM1;DDRGK1;C1QBP
Chromosome Maintenance	3/119	0.8984940452262112	0.9999916093609006	0	0	0.5624260238301901	0.06019938208173688	APITD1;CENPL;ITGB3BP
Asymmetric Localization of PCP Proteins	1/51	0.898711155532163	0.9999916093609006	0	0	0.4354566210045662	0.04650397646873374	FZD3
Cargo Trafficking to the Periciliary Membrane	1/51	0.898711155532163	0.9999916093609006	0	0	0.4354566210045662	0.04650397646873374	RAB11FIP3
Formation of TC-NER Pre-Incision Complex	1/51	0.898711155532163	0.9999916093609006	0	0	0.4354566210045662	0.04650397646873374	RBX1
RAC2 GTPase Cycle	2/88	0.9031434995785752	0.9999916093609006	0	0	0.5059667774086378	0.05154477039549798	ITGB1;TIAM1
Aquaporin-mediated Transport	1/52	0.9031639440641192	0.9999916093609006	0	0	0.4268958725042528	0.043479851406538886	GNAS
Pre-NOTCH Expression and Processing	2/89	0.9065614098525769	0.9999916093609006	0	0	0.5001247947454844	0.04906049551553259	E2F3;TP53
p53-Dependent G1 DNA Damage Response	1/53	0.9074211913583086	0.9999916093609006	0	0	0.4186643835616438	0.04067264118770683	TP53
p53-Dependent G1 S DNA Damage Checkpoint	1/53	0.9074211913583086	0.9999916093609006	0	0	0.4186643835616438	0.04067264118770683	TP53
Nuclear Envelope Breakdown	1/53	0.9074211913583086	0.9999916093609006	0	0	0.4186643835616438	0.04067264118770683	NUP210
Selenoamino Acid Metabolism	3/122	0.9075780721783077	0.9999916093609006	0	0	0.5481606830375171	0.05315825860191813	RPS28;RPS19;HNMT
Autodegradation of Cdh1 by Cdh1 APC C	1/54	0.9114914749477465	0.9999916093609006	0	0	0.41074351684328425	0.03806484941314637	ANAPC11
Ion Homeostasis	1/54	0.9114914749477465	0.9999916093609006	0	0	0.41074351684328425	0.03806484941314637	FXYD3
NR1H2 and NR1H3-mediated Signaling	1/54	0.9114914749477465	0.9999916093609006	0	0	0.41074351684328425	0.03806484941314637	ANGPTL3
Chaperonin-mediated Protein Folding	2/91	0.9130613518156097	0.9999916093609006	0	0	0.4888346709470305	0.0444605900295274	TUBB1;TP53
Viral Infection Pathways	37/1029	0.9142944487651261	0.9999916093609006	0	0	0.8050679243471582	0.0721361835442383	ITGB1;LY96;CXCR4;NR3C1;EGFR;IKBKB;GJA1;RPS19;CTSL;TUBB1;NLRP3;IL6R;GOLGA7;SKP1;MED1;ITGA4;NUP210;PDPK1;IL1R1;SIGMAR1;HLA-B;HLA-C;HLA-A;HLA-F;HLA-G;NFKB1;RBX1;HLA-E;NFKBIA;ACE2;ANO1;CD4;RPS28;FXYD3;GRB2;MASP2;BCL2L1
APC C Cdc20 Mediated Degradation of Securin	1/55	0.915382996685967	0.9999916093609006	0	0	0.40311601555893795	0.03564058569755008	ANAPC11
G1 S DNA Damage Checkpoints	1/55	0.915382996685967	0.9999916093609006	0	0	0.40311601555893795	0.03564058569755008	TP53
Ion Transport by P-type ATPases	1/55	0.915382996685967	0.9999916093609006	0	0	0.40311601555893795	0.03564058569755008	FXYD3
RHOJ GTPase Cycle	1/55	0.915382996685967	0.9999916093609006	0	0	0.40311601555893795	0.03564058569755008	GJA1
Regulation of RAS by GAPs	1/55	0.915382996685967	0.9999916093609006	0	0	0.40311601555893795	0.03564058569755008	RBX1
Scavenging of Heme From Plasma	2/92	0.9161499687416823	0.9999916093609006	0	0	0.4833777777777778	0.04233190864605868	ALB;HBB
Deadenylation-dependent mRNA Decay	1/56	0.9191035989208461	0.9999916093609006	0	0	0.3957658779576588	0.03338539773781135	DDX6
Golgi Associated Vesicle Biogenesis	1/56	0.9191035989208461	0.9999916093609006	0	0	0.3957658779576588	0.03338539773781135	TBC1D8B
Regulation of PTEN Stability and Activity	1/56	0.9191035989208461	0.9999916093609006	0	0	0.3957658779576588	0.03338539773781135	XIAP
TCF Dependent Signaling in Response to WNT	5/189	0.9213443363680718	0.9999916093609006	0	0	0.5901912145991225	0.04834931436512557	RSPO3;XIAP;KREMEN2;RSPO4;RBX1
Peptide Chain Elongation	2/94	0.9220204015046009	0.9999916093609006	0	0	0.4728198757763975	0.03838726613789438	RPS28;RPS19
RAC3 GTPase Cycle	2/94	0.9220204015046009	0.9999916093609006	0	0	0.4728198757763975	0.03838726613789438	ITGB1;TIAM1
Recruitment of NuMA to Mitotic Centrosomes	2/94	0.9220204015046009	0.9999916093609006	0	0	0.4728198757763975	0.03838726613789438	ODF2;TUBB1
Ub-specific Processing Proteases	5/190	0.9234207076029864	0.9999916093609006	0	0	0.5869699975204562	0.04676410148689804	NFKBIA;AR;CYLD;TP53;CFTR
Antigen Activates B Cell Receptor (BCR) Leading to Generation of Second Messengers	2/95	0.9248083588915813	0.9999916093609006	0	0	0.46771121351766515	0.03656039741898559	CD19;GRB2
Mitotic Anaphase	6/221	0.9259393931747187	0.9999916093609006	0	0	0.6058152884949136	0.04661536404440118	APITD1;TUBB1;CENPL;BUB1;ITGB3BP;ANAPC11
SUMOylation of Chromatin Organization Proteins	1/58	0.9260617114461083	0.9999916093609006	0	0	0.38183930144997197	0.029330758183721856	NUP210
Transcriptional Regulation of Granulopoiesis	1/58	0.9260617114461083	0.9999916093609006	0	0	0.38183930144997197	0.029330758183721856	IL6R
Mitotic Metaphase and Anaphase	6/222	0.92778575553064	0.9999916093609006	0	0	0.6029786962622784	0.045195930350410106	APITD1;TUBB1;CENPL;BUB1;ITGB3BP;ANAPC11
tRNA Processing in the Nucleus	1/59	0.9293132476028734	0.9999916093609006	0	0	0.3752361832782239	0.027508342852653012	NUP210
Formation of Paraxial Mesoderm	1/59	0.9293132476028734	0.9999916093609006	0	0	0.3752361832782239	0.027508342852653012	EPHA4
Anchoring of the Basal Body to the Plasma Membrane	2/97	0.9301045609260237	0.9999916093609006	0	0	0.45781654135338345	0.033172593671788125	AHI1;ODF2
Protein Folding	2/97	0.9301045609260237	0.9999916093609006	0	0	0.45781654135338345	0.033172593671788125	TUBB1;TP53
CDK-mediated Phosphorylation and Removal of Cdc6	1/60	0.9324219443745406	0.9999916093609006	0	0	0.3688568996207724	0.025808857044032015	ANAPC11
Cdc20 Phospho-APC C Mediated Degradation of Cyclin A	1/60	0.9324219443745406	0.9999916093609006	0	0	0.3688568996207724	0.025808857044032015	ANAPC11
DNA Damage Telomere Stress Induced Senescence	1/60	0.9324219443745406	0.9999916093609006	0	0	0.3688568996207724	0.025808857044032015	TP53
Recruitment and ATM-med Phosphorylation of Repair and Signaling Proteins at DNA Double Strand Breaks	1/60	0.9324219443745406	0.9999916093609006	0	0	0.3688568996207724	0.025808857044032015	TP53
Eukaryotic Translation Termination	2/98	0.9326185106284575	0.9999916093609006	0	0	0.45302380952380955	0.03160250894593556	RPS28;RPS19
Selenocysteine Synthesis	2/98	0.9326185106284575	0.9999916093609006	0	0	0.45302380952380955	0.03160250894593556	RPS28;RPS19
Regulation of Expression of SLITs and ROBOs	4/164	0.9327609829365948	0.9999916093609006	0	0	0.543041237113402	0.03779908700483601	RPS28;RPS19;LHX3;RBX1
Eukaryotic Translation Elongation	2/99	0.9350467106035696	0.9999916093609006	0	0	0.4483298969072165	0.03010929477641033	RPS28;RPS19
APC C Cdh1 Mediated Degradation of Cdc20 and Other APC C Cdh1 Targets in Late Mitosis Early G1	1/61	0.9353940697647439	0.9999916093609006	0	0	0.3626902587519026	0.024223129774566227	ANAPC11
APC Cdc20 Mediated Degradation of Cell Cycle Proteins Prior to Satisfation of the Checkpoint	1/61	0.9353940697647439	0.9999916093609006	0	0	0.3626902587519026	0.024223129774566227	ANAPC11
DNA Double Strand Break Response	1/61	0.9353940697647439	0.9999916093609006	0	0	0.3626902587519026	0.024223129774566227	TP53
HIV Infection	6/227	0.9364220046400991	0.9999916093609006	0	0	0.589180792868238	0.03870272329357319	CD4;NUP210;CXCR4;HLA-A;SKP1;RBX1
Gene Silencing by RNA	3/134	0.9369898030003716	0.9999916093609006	0	0	0.4976330637413314	0.032387392676208854	NUP210;PRKRA;TARBP2
Nonsense Mediated Decay (NMD) Independent of the Exon Junction Complex (EJC)	2/100	0.9373918360311566	0.9999916093609006	0	0	0.443731778425656	0.028688991224508714	RPS28;RPS19
Gap-filling DNA Repair Synthesis and Ligation in TC-NER	1/62	0.9382356171357722	0.9999916093609006	0	0	0.35672580282955313	0.02274275767060564	RBX1
TP53 Regulates Transcription of DNA Repair Genes	1/62	0.9382356171357722	0.9999916093609006	0	0	0.35672580282955313	0.02274275767060564	TP53
APC C Cdc20 Mediated Degradation of Mitotic Proteins	1/63	0.9409523169429117	0.9999916093609006	0	0	0.35095374871115037	0.021360032530352287	ANAPC11
rRNA Modification in the Nucleus and Cytosol	1/63	0.9409523169429117	0.9999916093609006	0	0	0.35095374871115037	0.021360032530352287	WDR36
Ca2+ Pathway	1/63	0.9409523169429117	0.9999916093609006	0	0	0.35095374871115037	0.021360032530352287	FZD3
Dual Incision in TC-NER	1/63	0.9409523169429117	0.9999916093609006	0	0	0.35095374871115037	0.021360032530352287	RBX1
Peroxisomal Protein Import	1/63	0.9409523169429117	0.9999916093609006	0	0	0.35095374871115037	0.021360032530352287	TYSND1
Translation of Structural Proteins 9694635	1/63	0.9409523169429117	0.9999916093609006	0	0	0.35095374871115037	0.021360032530352287	GOLGA7
Cilium Assembly	5/200	0.9416534256706416	0.9999916093609006	0	0	0.5565749235474006	0.033460163129655655	AHI1;IFT52;ODF2;TUBB1;RAB11FIP3
Viral mRNA Translation	2/102	0.9418432181000514	0.9999916093609006	0	0	0.43481142857142857	0.026052358695869117	RPS28;RPS19
Metabolism of Carbohydrates	8/290	0.9427556829817725	0.9999916093609006	0	0	0.6150707179524847	0.036257259274709686	VCAN;NUP210;NCAN;STAB2;AKR1A1;AKR1B1;HMMR;CD44
Activation of APC C and APC C Cdc20 Mediated Degradation of Mitotic Proteins	1/64	0.9435496485242905	0.9999916093609006	0	0	0.3453649344060303	0.020067876385024244	ANAPC11
Semaphorin Interactions	1/64	0.9435496485242905	0.9999916093609006	0	0	0.3453649344060303	0.020067876385024244	ITGB1
Epigenetic Regulation of Gene Expression	8/291	0.9440842653020811	0.9999916093609006	0	0	0.6128647932109935	0.03526414994430322	MED1;ADIPOQ;TASP1;PLIN2;PPARG;THRSP;ANGPTL4;MGLL
Cell Cycle	21/649	0.9449238006815323	0.9999916093609006	0	0	0.7225039436871242	0.04093056292216189	NUP210;ODF2;CABLES1;HMMR;ANAPC11;RBX1;CKS1B;APITD1;PPME1;TUBB1;CENPL;E2F2;E2F3;E2F4;PPP1R12B;E2F6;TP53;BUB1;ITGB3BP;SKP1;MAPK3
ABC Transporter Disorders	1/65	0.9460328512257566	0.9999916093609006	0	0	0.3399507705479452	0.018859783436075462	CFTR
HCMV Early Events	5/205	0.949216985767178	0.9999916093609006	0	0	0.5425172018348624	0.028274835440658036	ITGB1;NUP210;TUBB1;EGFR;NFKB1
Formation of a Pool of Free 40S Subunits	2/106	0.9498592141424725	0.9999916093609006	0	0	0.418	0.02150254742180878	RPS28;RPS19
Deubiquitination	7/268	0.9521427296150252	0.9999916093609006	0	0	0.5814682696965694	0.028515395459680303	NFKBIA;AR;CYLD;NLRP3;TP53;ESR1;CFTR
Chromatin Modifying Enzymes	6/238	0.9522668666491803	0.9999916093609006	0	0	0.5609188803990657	0.027434520768202107	MORF4L1;SETD6;SMYD2;PADI4;NFKB1;NFKB2
Chromatin Organization	6/238	0.9522668666491803	0.9999916093609006	0	0	0.5609188803990657	0.027434520768202107	MORF4L1;SETD6;SMYD2;PADI4;NFKB1;NFKB2
Bacterial Infection Pathways	3/143	0.953086115506805	0.9999916093609006	0	0	0.46542170644001307	0.022363520843264897	GRB2;LTF;MAPK3
DNA Replication	3/143	0.953086115506805	0.9999916093609006	0	0	0.46542170644001307	0.022363520843264897	SKP1;RBX1;ANAPC11
Loss of Nlp From Mitotic Centrosomes	1/69	0.9549213226977018	0.9999916093609006	0	0	0.31988651625033576	0.014755189893091263	ODF2
Loss of Proteins Required for Interphase Microtubule Organization From the Centrosome	1/69	0.9549213226977018	0.9999916093609006	0	0	0.31988651625033576	0.014755189893091263	ODF2
Signaling by ROBO Receptors	5/210	0.9558804864143406	0.9999916093609006	0	0	0.529145222644887	0.023876296021566348	RPS28;RPS19;LHX3;CXCR4;RBX1
Infectious Disease	46/1311	0.9563672789907567	0.9999916093609006	0	0	0.7814462312657259	0.03486286128568392	ITGB1;APP;LY96;CXCR4;NR3C1;EGFR;IKBKB;GJA1;RPS19;CTSL;TUBB1;C3AR1;NLRP3;IL6R;GOLGA7;SKP1;MAPK3;MED1;ITGA4;NUP210;PDPK1;IL1R1;SIGMAR1;HLA-B;HLA-C;HLA-A;MAPK14;HLA-F;HLA-G;NFKB1;RBX1;NFKB2;HLA-E;NFKBIA;ACE2;ANO1;IL6;CD4;RPS28;FXYD3;IL1B;GNAS;GRB2;MASP2;BCL2L1;LTF
RHOB GTPase Cycle	1/70	0.9569047706880004	0.9999916093609006	0	0	0.3152339355436437	0.013886496391046907	NET1
Diseases of Glycosylation	3/146	0.9575361195369113	0.9999916093609006	0	0	0.4555856043270231	0.019768695774466057	VCAN;NCAN;GFPT1
FCERI Mediated MAPK Activation	2/111	0.9584029495888006	0.9999916093609006	0	0	0.3987208387942333	0.01694044191429506	GRB2;MAPK3
Mitotic Prophase	2/111	0.9584029495888006	0.9999916093609006	0	0	0.3987208387942333	0.01694044191429506	NUP210;MAPK3
Influenza Viral RNA Transcription and Replication	3/149	0.9615882139109417	0.9999916093609006	0	0	0.44615372558853955	0.017475382796202695	RPS28;RPS19;NUP210
Hedgehog 'On' State	1/73	0.962347173009665	0.9999916093609006	0	0	0.30205162354134957	0.011592743340077837	RBX1
RAC1 GTPase Cycle	4/184	0.9631764450087875	0.9999916093609006	0	0	0.48219422171312204	0.01809128089415709	NISCH;ITGB1;TIAM1;IQGAP2
Glycolysis	1/74	0.9640042000880957	0.9999916093609006	0	0	0.29789829236254456	0.01092084041398357	NUP210
Transport of Mature mRNA Derived From an Intron-Containing Transcript	1/74	0.9640042000880957	0.9999916093609006	0	0	0.29789829236254456	0.01092084041398357	NUP210
L13a-mediated Translational Silencing of Ceruloplasmin Expression	2/116	0.9655416799107028	0.9999916093609006	0	0	0.3811328320802005	0.013364807241982513	RPS28;RPS19
Nuclear Envelope (NE) Reassembly	1/75	0.9655883793943719	0.9999916093609006	0	0	0.29385721337776133	0.010290187245797519	TUBB1
Transcriptional Regulation by Small RNAs	1/75	0.9655883793943719	0.9999916093609006	0	0	0.29385721337776133	0.010290187245797519	NUP210
GTP Hydrolysis and Joining of the 60S Ribosomal Subunit	2/117	0.9668206708564159	0.9999916093609006	0	0	0.37779875776397515	0.012747780015482138	RPS28;RPS19
Transcription-Coupled Nucleotide Excision Repair (TC-NER)	1/76	0.9671029097586518	0.9999916093609006	0	0	0.28992389649923894	0.009698060889957973	RBX1
Major Pathway of rRNA Processing in the Nucleolus and Cytosol	4/189	0.9684635400607702	0.9999916093609006	0	0	0.4690381102752237	0.015030064813675713	EBNA1BP2;RPS28;WDR36;RPS19
G2 M DNA Damage Checkpoint	1/77	0.968550850055328	0.9999916093609006	0	0	0.2860940879596251	0.00914193447938726	TP53
CDC42 GTPase Cycle	3/155	0.9686260948200436	0.9999916093609006	0	0	0.42840690112007707	0.013656159115397878	TIAM1;FMNL2;IQGAP2
SRP-dependent Cotranslational Protein Targeting to Membrane	2/119	0.9692429643048698	0.9999916093609006	0	0	0.3713015873015873	0.011599447241674818	RPS28;RPS19
Nonsense Mediated Decay (NMD) Enhanced by the Exon Junction Complex (EJC)	2/120	0.9703893124037114	0.9999916093609006	0	0	0.368135593220339	0.011065395736532768	RPS28;RPS19
Nonsense-Mediated Decay (NMD)	2/120	0.9703893124037114	0.9999916093609006	0	0	0.368135593220339	0.011065395736532768	RPS28;RPS19
Signaling by WNT	7/287	0.9706217361724764	0.9999916093609006	0	0	0.5414655172413793	0.016145661201181268	FZD3;RSPO3;XIAP;KREMEN2;RSPO4;SKP1;RBX1
PCP CE Pathway	1/79	0.9712585304616621	0.9999916093609006	0	0	0.2787290715372907	0.008128462851459968	FZD3
RNA Polymerase I Promoter Clearance	1/79	0.9712585304616621	0.9999916093609006	0	0	0.2787290715372907	0.008128462851459968	MAPK3
HIV Life Cycle	3/158	0.9716701528142727	0.9999916093609006	0	0	0.4200487192736399	0.012071730186850526	CD4;NUP210;CXCR4
MAPK6 MAPK4 Signaling	1/80	0.9725237405085997	0.9999916093609006	0	0	0.2751864054100919	0.007666911189552171	RAG1
Anti-inflammatory Response Favouring Leishmania Parasite Infection	3/159	0.9726211241500381	0.9999916093609006	0	0	0.4173340961098398	0.011585470779262946	IL6;GNAS;MAPK14
Leishmania Parasite Growth and Survival	3/159	0.9726211241500381	0.9999916093609006	0	0	0.4173340961098398	0.011585470779262946	IL6;GNAS;MAPK14
Centrosome Maturation	1/81	0.9737333111215744	0.9999916093609006	0	0	0.27173230593607306	0.007232921801939236	ODF2
RNA Polymerase I Transcription	1/81	0.9737333111215744	0.9999916093609006	0	0	0.27173230593607306	0.007232921801939236	MAPK3
RNA Polymerase II Transcribes snRNA Genes	1/81	0.9737333111215744	0.9999916093609006	0	0	0.27173230593607306	0.007232921801939236	INTS6
Recruitment of Mitotic Centrosome Proteins and Complexes	1/81	0.9737333111215744	0.9999916093609006	0	0	0.27173230593607306	0.007232921801939236	ODF2
Cell Cycle Checkpoints	6/261	0.9744657556433592	0.9999916093609006	0	0	0.5097048693185655	0.013183975734766108	APITD1;CENPL;TP53;BUB1;ITGB3BP;ANAPC11
Cap-dependent Translation Initiation	2/124	0.9745760959104642	0.9999916093609006	0	0	0.35599063231850114	0.009167711395627325	RPS28;RPS19
Eukaryotic Translation Initiation	2/124	0.9745760959104642	0.9999916093609006	0	0	0.35599063231850114	0.009167711395627325	RPS28;RPS19
Transport of Mature Transcript to Cytoplasm	1/83	0.9759952037130639	0.9999916093609006	0	0	0.2650768459739392	0.006440732977787119	NUP210
rRNA Processing in the Nucleus and Cytosol	4/199	0.9769809566971049	0.9999916093609006	0	0	0.444749904543719	0.010357388586280453	RPS28;WDR36;EBNA1BP2;RPS19
Global Genome Nucleotide Excision Repair (GG-NER)	1/84	0.9770520968885404	0.9999916093609006	0	0	0.26186939538977827	0.00607937789356043	RBX1
Reproduction	2/127	0.9773346568062833	0.9999916093609006	0	0	0.347392	0.007964361266579019	CATSPER1;CXCR4
Glucose Metabolism	1/85	0.9780625023298279	0.9999916093609006	0	0	0.25873831267666886	0.005739256322854926	NUP210
RUNX1 Regulates Transcription of Genes Involved in Differentiation of HSCs	1/85	0.9780625023298279	0.9999916093609006	0	0	0.25873831267666886	0.005739256322854926	TP73
Fcgamma Receptor (FCGR) Dependent Phagocytosis	3/168	0.9799183667487541	0.9999916093609006	0	0	0.39438319117952986	0.008000461369193813	GRB2;PLA2G6;MAPK3
Influenza Infection	3/169	0.9806037609220173	0.9999916093609006	0	0	0.39198671114664607	0.007677770976131561	RPS28;RPS19;NUP210
Classical Antibody-Mediated Complement Activation	1/88	0.9808347732847258	0.9999916093609006	0	0	0.24977693801501075	0.004833498576215259	C1QC
ABC-family Proteins Mediated Transport	1/90	0.9824856459251894	0.9999916093609006	0	0	0.24413832025037197	0.004313813058055735	CFTR
M Phase	9/372	0.9840421543376674	0.9999916093609006	0	0	0.5358571047720608	0.008620088397118343	APITD1;NUP210;ODF2;TUBB1;CENPL;BUB1;ITGB3BP;ANAPC11;MAPK3
FCGR3A-mediated Phagocytosis	2/142	0.9873139731585225	0.9999916093609006	0	0	0.3099265306122449	0.003956888287990584	GRB2;MAPK3
Leishmania Phagocytosis	2/142	0.9873139731585225	0.9999916093609006	0	0	0.3099265306122449	0.003956888287990584	GRB2;MAPK3
Parasite Infection	2/142	0.9873139731585225	0.9999916093609006	0	0	0.3099265306122449	0.003956888287990584	GRB2;MAPK3
Regulation of Actin Dynamics for Phagocytic Cup Formation	2/143	0.9877994659721311	0.9999916093609006	0	0	0.30771225937183383	0.0037773438411097962	GRB2;MAPK3
tRNA Processing	2/146	0.9891497849194343	0.9999916093609006	0	0	0.3012539682539683	0.0032865325609871348	TRMU;NUP210
Assembly of the Pre-Replicative Complex	1/101	0.9893297534927402	0.9999916093609006	0	0	0.21715753424657533	0.0023295752135886424	ANAPC11
RHO GTPase Cycle	11/450	0.9895687103093281	0.9999916093609006	0	0	0.5406050913529068	0.005668826575081088	NISCH;ITGB1;NET1;TIAM1;GJA1;FMNL2;DDRGK1;C1QBP;GRB2;IQGAP2;CFTR
HCMV Infection	5/259	0.9897769438616839	0.9999916093609006	0	0	0.4259598714151557	0.004377023272131973	ITGB1;NUP210;TUBB1;EGFR;NFKB1
Role of Phospholipids in Phagocytosis	1/107	0.9918578034292511	0.9999916093609006	0	0	0.20480098216593434	0.001674355608947855	PLA2G6
HATs Acetylate Histones	1/108	0.9922166437059544	0.9999916093609006	0	0	0.2028762855801647	0.0015852356755002247	MORF4L1
Nucleotide Excision Repair	1/108	0.9922166437059544	0.9999916093609006	0	0	0.2028762855801647	0.0015852356755002247	RBX1
Maternal to Zygotic Transition (MZT)	1/109	0.9925596810730095	0.9999916093609006	0	0	0.20098723152376122	0.0015010000124791878	TP53
FCERI Mediated Ca+2 Mobilization	1/110	0.9928876106501069	0.9999916093609006	0	0	0.19913283900967702	0.0014213709684590995	GRB2
rRNA Processing	4/237	0.9933876481516747	0.9999916093609006	0	0	0.371468322443943	0.002464436117094751	RPS28;WDR36;EBNA1BP2;RPS19
DNA Replication Pre-Initiation	1/118	0.9950410999591903	0.9999916093609006	0	0	0.1854388635210553	9.2186038843843E-4	ANAPC11
Beta-catenin Independent WNT Signaling	1/134	0.9975898296362089	0.9999916093609006	0	0	0.16299309918632196	3.9331530623328443E-4	FZD3
G2 M Checkpoints	1/137	0.9978947949471839	0.9999916093609006	0	0	0.15937248186946013	3.358654110655562E-4	TP53
Neddylation	3/234	0.9981591560451952	0.9999916093609006	0	0	0.28072156676275667	5.172408251810267E-4	FBXO41;SKP1;RBX1
Late Phase of HIV Life Cycle	1/145	0.9985323061253015	0.9999916093609006	0	0	0.15045503551496703	2.2098414227697012E-4	NUP210
DNA Double-Strand Break Repair	1/152	0.9989294594731499	0.9999916093609006	0	0	0.143427379116393	1.5362706868548683E-4	TP53
Antigen Processing Ubiquitination & Proteasome Degradation	4/296	0.9991561888564697	0.9999916093609006	0	0	0.2954855717177423	2.4943927279352237E-4	FBXO41;SKP1;ANAPC11;RBX1
DNA Repair	4/312	0.9995258375196654	0.9999916093609006	0	0	0.27989765103167163	1.3274843910532377E-4	ALKBH5;APITD1;TP53;RBX1
HCMV Late Events	1/171	0.9995447963582922	0.9999916093609006	0	0	0.12726967499328498	5.7946809336056734E-5	NUP210
mRNA Splicing - Major Pathway	1/204	0.9998953237174624	0.9999916093609006	0	0	0.10639494342848145	1.113761009087545E-5	PPIL2
mRNA Splicing	1/215	0.9999351155864831	0.9999916093609006	0	0	0.1008673665343746	6.54493225492181E-6	PPIL2
Processing of Capped Intron-Containing Pre-mRNA	2/285	0.9999598208206907	0.9999916093609006	0	0	0.1521655729429581	6.114010668768344E-6	PPIL2;NUP210
Metabolism of RNA	12/761	0.9999916093609006	0.9999916093609006	0	0	0.34031965549441645	2.8555113874884525E-6	TRMU;DDX6;MAPK11;WDR36;EBNA1BP2;RPS28;PPIL2;NUP210;RPS19;TGS1;MAPK14;CD44
